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Abstract  
Vitamin D deficiency is a worldwide health problem and more extensively 
present in the gulf countries such as Saudi Arabia and in high latitude 
countries such as the United Kingdom. Many previous cross-sectional 
studies have investigated the correlation between vitamin D status and 
lung function, but the effect of vitamin D status on lung function and 
airway inflammation is still debatable. This project aimed to investigate the 
effect of vitamin D intervention through pharmacological supplements or 
dietary intake, on lung function and airway inflammation, among asthmatic 
adults in Saudi Arabia and in healthy individuals in the United Kingdom. 
The main findings of the study were; vitamin D deficiency is highly 
prevalent in asthma participants in Saudi Arabia (86%) and in healthy 
individuals in the UK (81%). Asthma participants with higher serum vitamin 
D levels had trend of better lung function (FEV1, P 0.287; FVC, P 0.391), 
slightly lower fractional exhaled nitric oxide levels (P 0.719) and lower 
blood inflammatory biomarkers, however, did not reach significant levels. 
Healthy participants with higher vitamin D levels had also better lung 
function (FEV1, P 0.104, FVC, P 0.158) but no differences in airway 
inflammation. 
Vitamin D intervention through oral supplements or dietary intervention 
for three weeks, significantly increased serum vitamin D levels 
(Supplement, P <0.001, dietary, P 0.002) and improved lung function, 
especially the forced vital capacity (P 0.031), but did not have effects on 
airway inflammation. Dietary vitamin D intake was lower than the 
recommendation in both groups. During the study sun-exposure was at the 
minimal level due to hot weather in Saudi and cold and cloudy weather in 
the UK. Vitamin D intervention did not affect weight or percentage of body 
fat. 
Both chemiluminescence immunoassay and liquid chromatography-
tandem mass spectrometry method can be used in measuring serum 
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vitamin D levels but they cannot be used interchangeably due to systematic 
differences. However, they showed an acceptable agreement levels. 
Overall, the study found that vitamin D supplement in high dose, low dose 
or dietary intervention were effective in raising serum vitamin D level and 
had a trend of positive effect on lung function but not airway 
inflammation.     
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Chapter 1: Literature review 
 
1.1. Introduction   
Vitamin D, also called calciferol, is one of the fat soluble vitamins that is 
essential for biological functions. Vitamin D is mainly obtained from 
sunlight exposure and only small amounts are present in foods and dietary 
sources. Vitamin D is also considered a hormone, because it can be 
produced in the body both in the skin and in other cells such as monocytes 
and macrophages and not only obtained from dietary sources like other 
vitamins (Deluca, 2008; Christakos et al., 2010). 
Vitamin D has become a topic of interest for researchers worldwide (Spiro 
and Buttriss, 2014; Cashman, 2012). Many studies have been conducted in 
different areas concerning vitamin D such as: non-calcaemic functions of 
vitamin D (Bischoff-Ferrari, 2010), daily recommendation (Cashman, 2015), 
safe dose of vitamin D supplementation (Glade, 2012), vitamin D deficiency 
and factors that can affect its levels and the correlation between vitamin D 
deficiency and diseases (Zhang et al., 2016; Yousef et al., 2013). Although 
many investigational studies have been published about vitamin D, only 
few clinical control trials have been conducted to investigate the effect of 
vitamin D supplementation on disease outcome. The causal correlation 
between vitamin D and disease is still debatable and more clinical trials are 
needed (Aspray et al., 2014). 
 
1.2. Vitamin D overview, structure and metabolism  
Vitamin D generally consists of two main substances: vitamin D2 
(Ergocalciferol) and vitamin D3 (Cholecalciferol). The form of vitamin D 
present in food sources is generally vitamin D3 or its metabolite 25(OH)D3, 
except in mushrooms, which contain the vitamin D2 form (Holick, 2007; 
16 
 
Holick et al., 2011). The functional and biological form of vitamin D that 
acts in the body is 1,25(OH)2D3 (Calcitriol), while the form 25(OH)D 
(Calcidiol) can reflect the vitamin D status in the body (Holick, 2007).  
Structurally, vitamin D is a seco-steroid component and it is stable during 
heating and storage. The steroid ergosterol is derived from plants and 
activated to ergocalciferol by irradiation while cholecalciferol is mainly 
obtained from animal steroids. The ultraviolet irradiation of ergosterol 
obtained from yeast or fungi can be used to produce vitamin D2 
supplements or used in food fortification. Vitamin D2 as a supplement is 
widely used in the United State while in the UK both vitamin D3 and D2 
forms are available as supplements (SACN, 2015; Holick, 2007). The effect 
on blood vitamin levels (25(OH)D) of supplementation with the D2 or D3 
forms will be discussed in more detail in section 1.5.3. Figure 1.1 shows the 
chemical structure of vitamin D2 and D3.  
 
 
 
 
 
 
 
 
Fig 1.1. Chemical structure of vitamin D2 and D3 
http://www.cyberlipid.org/vitd/vitd0001.htm 21-3-13 
 
Cholecalciferol formation is initiated by the component 7-
dehydrocholesterol, which is made in the sebaceous glands in the skin, 
17 
 
then absorbed by skin layers and distributed into the epidermis and 
dermis. The component 7-dehydrocholesterol absorbs the ultraviolet-B 
photons from the sunlight (wavelength 290-315 nm) to form pre vitamin 
D3 (Pre cholecalciferol). Rearrangement of the unstable double bonds by 
thermal isomerization of pre vitamin D3 then occur forming cholecalciferol. 
Figure 1.2 shows the process of formation of vitamins D2 and D3. Many 
factors can affect the photosynthesis of vitamin D in the skin, such as skin 
colour, age, type of clothing, use of sunscreen and geographical factors 
including latitude and season (Christakos et al., 2010; Holick, 2007). These 
factors will be discussed in more detail in section 1.6.2.   
 
 
 
 
 
 
 
 
 
 
Fig 1.2. Formation of vitamin D2 and D3 (Jovicic et al., 2012) 
 
Cholecalciferol is transported from the skin to the blood by α-2 globulin 
vitamin D-binding protein (DBP). This binding protein is generated in the 
liver. Bound vitamin D will mainly be transported to the liver and may also 
be taken up by other tissues such as muscular or adipose tissues 
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(Christakos et al., 2010). Vitamin D that comes from food follows a 
different mechanism. It is absorbed by the intestine from the micelles with 
help of fats and bile. In the intestine it compounds with chylomicrons that 
can enter into the lymphatic system and then into the blood flow. 
Subsequently chylomicrons transport the vitamin to the liver (Searing and 
Leung, 2010). 
In the liver the enzyme 25-hydroxylase hydroxylates the cholecalciferol to 
25(OH)D3 (Calcidiol), which is released into the blood and transported by 
vitamin D binding protein (DBP). The serum concentration of 25(OH)D is 
the best biomarker to reflect vitamin D status due to its long half-life and 
because the blood is the storage site of this form of vitamin D (Christakos 
et al., 2010). Bound 25(OH)D3 is then absorbed by kidney tissues and 
another hydroxylation occurs by the enzyme 1-hydroxylase to form 
1,25(OH)2D3 (Calcitriol) the active form of vitamin D. Once calcitriol is 
released from the kidneys it is transported to the target tissues and bound 
to the vitamin D receptors (VDR) which creates the biological effects 
(Christakos et al., 2010). Figure 1.3.  
Vitamin D receptors are present in many tissues including the intestine, 
bones and kidneys. They are also present in cardiac muscles, the pancreas, 
the brain, skin and hematopoietic cells. The form 1,25(OH)2D3 is then 
degraded by the enzyme 24-hydroxylase that converts 1,25(OH)2D3 to 
calcitroic acid, which can be discharged from the body (Deluca, 2008; 
Jovicic et al., 2012). 
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[Click on link to view image] 
 
Figure 1.3. Vitamin D metabolism pathway 
http://www.nature.com/nrc/journal/v7/n9/images/nrc2196-f1.jpg 
 
1.3. Vitamin D sources  
Dietary vitamin D, sunlight exposure and supplements are the three 
sources of vitamin D (Matyjaszek-Matuszek et al., 2015). Sun exposure 
supplies the body with the largest amount, about 80% of vitamin D can be 
obtained from skin production via sun exposure, compared to a low 
percentage obtained from food (Searing and Leung, 2010). Vitamin D 
supplementation is also a source and it can be delivered via an oral or in 
intramuscular route (Pearce and Cheetham, 2010). 
1.3.1. Dietary sources of vitamin D  
Vitamin D is present in a small amount in a few types of foods. Food 
sources that provide vitamin D contain vitamin D naturally such as; fatty 
fish, egg, meat and liver, or be fortified with artificial vitamin D such as; fat 
spread, cereals, juices, babies’ food, milk and milk products (Allen et al., 
2014; Buttriss, 2015). Table 1.3 shows the content of vitamin D in some 
food sources (Spiro and Buttriss, 2014; O´Connor and Benelam, 2011; 
McCance and Widdowson´s, 2010). 
In the UK, the main food sources of vitamin D are, fatty fish such as 
sardines and salmon, eggs, liver, fortified fat spread and fortified cereals 
(O´Connor and Benelam, 2011). Milk contains a small amount of vitamin D 
unless it is fortified with vitamin D (More, 2013). Although meat and meat 
products contain a small amount of vitamin D, it had been stated that it is 
the main contributor to vitamin D intake for individuals in the UK (except 
for children), providing 23-35% of total vitamin D intake, followed by 
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fortified fat spreads which provide 19-21%, then fish with 17-23% and 
breakfast cereals with 13-20% of the vitamin D intake (Spiro and Buttriss, 
2014; Bates et al., 2014). According to the NDNS, fish was the main source 
of dietary vitamin D in people who are 65 years and older, providing 31% of 
vitamin D intake followed by fat spreads with 21% and cereals with 20% of 
vitamin D intake (Smithers et al., 1998). Generally, in the UK, infant formula 
is fortified with 1-1.25 µg vitamin D/100 kcal formula (Pearce and 
Cheetham, 2010). 
In France and Spain, the main food source of vitamin D is oily fish, while in 
the US fortified milk is the main source of dietary vitamin D intake (Spiro 
and Buttriss, 2014). Vitamin D2 (ergocalciferol) and D3 (cholecalciferol) are 
suitable to be used in food fortification, usually vitamin D2 can be obtained 
from fungi and yeast, while vitamin D3 can be obtained from sheep´s wool 
(Lanolin) and also can be extracted from Lichens (Spiro and Buttriss, 2014). 
Vitamin D2 and D3 that extracted from the Lichens are suitable choice for 
vegetarians (Spiro and Buttriss, 2014). 
 
 
Table 1.1. Food sources of vitamin D  
Food source Vitamin D 
 (µg/100g) 
 Food source Vitamin D 
(µg/100g) 
Salmon, raw 
Sardine, fresh 
Tuna, fresh 
Mackerel, raw 
Egg 
Pork, raw or grilled 
5.9 
11 
7.2 
8 
1.75 
0.9 
 Lamb, cocked 
Beef, stewed 
Chicken cooked 
Margarine 
Butter 
Fat spread 
0.5 
0.8 
0.1 
7.9 
0.9 
5.8 
(Spiro and Buttriss, 2014; O´Connor and Benelam, 2011; McCance and Widdowson´s, 
2010). 
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It has been reported that consuming the daily vitamin D recommendation 
is not easy even if the individual follows a balanced diet (Spiro and Buttriss, 
2014). Dietary supplements may be needed to achieve body requirements 
especially in winter months in high latitude countries, where food and 
supplements are the primary sources of vitamin D (Spiro and Buttriss, 
2014). Heaney and colleagues (2003) stated that each 1 µg of vitamin D3 
consumed can equal approximately 0.7 nmol/l of serum 25(OH)D. 
The mean dietary intake of vitamin D in European countries is typically 
about 4.8 µg per day for males and 3.3 µg per day for females, the lowest 
intake being reported for Spain (1.1 µg per day) and the highest reported in 
Norway (23.5 µg per day; Spiro and Buttriss, 2014). These differences could 
be due to differences in availability of vitamin D rich food sources and 
population dietary habits. Dietary vitamin D intake in the UK is low 
according to the (NDNS; Gregorgy et al., 2000; Ruston et al., 2002). It was 
reported that the mean vitamin D intake from diet is 3.7 µg per day for 
adult males and 2.8 µg per day for adult females between 19 and 64 years 
of age (O´Connor and Benelam, 2011). 
 
 
1.3.2. Sunlight exposure  
Sunlight exposure is a natural way to synthesise vitamin D via the skin and 
the photoreceptor 7-dehydrocholesterol in the keratinocytes. Production 
of vitamin D from the sunlight can never lead to excessive synthesis or 
toxicity, because when large amount of pre cholicalceferol is produced, 
other products can be also produced such as, lumisterol, eoxisterols and 
tachysterol that can be then extracted from the body. However, vitamin D 
supplements very rarely may lead to toxicity if taken in very large doses for 
long periods because the production of 25(OH)D is not limited (Hart and 
Gorman, 2013). 
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Sunlight exposure and ultraviolet radiation (UVR) have many benefits for 
human health and also have risks at the same time. Ultraviolet B (UVB) 
with wave length (290-315 nm) is one type of UVR and it is the main source 
of vitamin D synthesis via the skin. Ultra violet radiation can cause eye 
problem, immune system problems and also can affect skin health and 
cause sunburn. Sunburn is a risk factor for skin cancer including malignant 
melanoma (Seckmeyer et al., 2013). Even a sub-erythemal amount of UVB 
can lead to damage of the DNA in the skin cells. Despite these risks, short 
exposure to sun light is very important for human health and for obtaining 
the vitamin D that is required by the body (Rhodes et al., 2010).  
Many factors affect UVB intensity such as, cloudiness, ozone, latitude, 
season and diurnal variability (Terenetskaya and Orlova, 2011). For 
example, it is impossible to synthesis enough vitamin D from sunlight 
exposure if the UV index is less than 3, because the wavelength between 
290-315 which is needed for vitamin D synthesis is only available when the 
UV index is greater than 3 (Seckmeyer et al., 2013; Pearce and Cheetham, 
2010).  It is believed that 1000 IU of vitamin D3 can be produced in one 
minute via skin for a pale skinned person with a completely uncovered 
body in summer with UV index 10 in a place with mid latitude, in a vertical 
position. This amount will be different with different situations such as 
body orientation, standing vs lying down, winter months and different UV 
index (Seckmeyer et al., 2013).  
It has been recorded that in the UK in summer, people with fair skin can 
produced about 2000 IU if they have sunlight exposure for 20-30 minutes 
per day exposing their face, arms and legs. Two or three times per week of 
this amount of exposure are enough to achieve and maintain vitamin D 
levels during summer (Pearce and Cheetham, 2010).  A study by Seckmeyer 
et al (2013) in Germany, aimed to compare the time needed to produce 
1000 IU in five cases, four of them in Hannover (Latitude 52.39) in different 
seasons and of different UV indexes. They found a large difference in 
vitamin D production (Table 1.2). 
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Table 1.2. Differences in vitamin D production according to season and UV index 
(Seckmeyer et al., 2013) 
Situation  Case 1 Case 2 Case 3 Case 4 
Place  
Latitude 
Date 
Cloudiness 
UV index 
Required exposure time to 
produce 1000IU with 
uncovered body (vertical 
position) 
Hannover  
52.39 
June 21 
None 
8 
1.1 minute 
Hannover 
52.39 
March 21 
None 
3.3 
2.3 minutes 
Hannover 
52.39 
December 21 
None 
0.4 
39 minutes 
Hannover 
52.39 
December 21 
Homogeneous 
0.04 
2.1 days 
 
People in high latitude countries >40°N such as the UK are at risk of having 
low vitamin D in winter months because the UVB radiation is unavailable or 
insufficient to initiate vitamin D synthesis in the skin, because the angle of 
the sunlight is skewed and prevents the UVB from passing through the 
ozone layer (Lanham-New, 2011; Cashman, 2012). However, a sufficient 
vitamin D level can be achieved in winter because vitamin D can be stored 
in the body from the intake in the summer (Seckmeyer et al., 2013). Webb 
and colleagues concluded that having a level of ≥32 ng/ml in late summer 
can maintain the winter levels at sufficient level ≥20 ng/ml (Webb et al., 
2010).  
Rhodes and colleagues found that 5% of white Caucasians in Manchester 
(latitude 53.5 N) in winter have vitamin D deficiency 25(OH)D< 15ng/ml, 
62.5% have vitamin D insufficiency 25(OH)D <20 ng/ml and only 2.9% have 
the optimum level 25(OH)D ≥32 ng/ml. They investigated the effect of 
summer sun exposure on 25(OH)D levels and found that after sunlight 
exposure of 13 minutes three times per week for six weeks with 35% of 
skin surface area exposed, 25(OH)D increased by 10.4 ng/ml. They also 
stated that UVB was at a maximum at solar noon when the solar radiation 
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is reaching the earth in the shortest time and the sun is directly overhead 
(Rhodes et al., 2010). 
A study carried out in Saudi Arabia between October to December in 2010 
among healthy children (n=510), 4-15 years old from Jeddah, aimed to 
investigate the correlation between serum vitamin D levels and dietary 
vitamin D intake and sunlight exposure (Mansour and Alhadidi, 2012). The 
authors found that only 14% had normal vitamin D levels ˃20 ng/ml, 59% 
had vitamin D insufficiency 7-20 ng/ml and 27% had severe vitamin D 
deficiency ˂7 ng/ml. Mean serum 25(OH)D among these children was 13±8 
ng/ml, mean dietary intake was 3.3±1.9 µg/D with 83% of them consuming 
less than 5 µg/D. The average of daily sunlight exposure was 7.64±7.49 min 
per day. They stated that this low duration of direct sunlight exposure 
could be due to the avoidance and reduction of outdoor activity due to the 
hot and humid weather resulting in children spending more time indoors 
playing video games or watching television. The authors also found a 
significant correlation between higher 25(OH)D levels and higher duration 
of sunlight exposure and also with more BSA (body surface area) exposed 
to the sunlight and concluded that 20% of the body surface should be 
exposed to sunlight at least to increase vitamin D concentration. In 
addition they also found a significant positive correlation between 25(OH)D 
levels and dietary intake (Mansour and Alhadidi, 2012).  
From October to March, people cannot synthesis enough vitamin D from 
the sunlight exposure in the northern hemisphere such as in the UK and 
50% of northern America. People living in these areas are dependent on 
the vitamin D stored in their body from summer sunlight (Pearce and 
Cheetham, 2010). Heaney et al (2003) concluded that healthy individuals 
need a minimum of an additional 12.5 µg/day of dietary vitamin D3 to 
maintain the autumn 25(OH)D concentration throughout the winter. 
Cashman and colleagues (2008) concluded that healthy adults from 20-40 
years old need approximately from 7.2 to 41.1 µg per day vitamin D to 
maintain serum 25(OH)D above the cut-off value (>25nmol/l) during 
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winter. This wide range is because of the variety in sunlight exposure 
(Cashman et al., 2008).  
However, the current Cancer Research UK´s Sunsmart and NHS (National 
Health Services) sun exposure recommendations are;  
• Spend time in the shade between 11.00 am and 3.00 pm 
• Make sure you never burn 
• Aim to cover up with a T-shirt, hat and sunglasses 
• Remember to take extra care with children 
• Then use factor 15+ sunscreen  
 
1.3.3. Vitamin D supplements  
Many vitamin D supplements are available to be used in different 
countries. They are safe and effective to treat vitamin D deficiency and 
physicians usually use three forms of vitamin D supplements; pills, drops or 
injections (Pearce and Cheetham, 2010). Each supplement form has 
different doses, and their use depends on the level of vitamin D deficiency 
(Lewis et al., 2012). Many doses are available in the UK as pills; 400 IU, 10 
000 IU, 20 000 IU and 50 000 IU. The intramuscular injection usually has 
higher doses such as 200 000 IU or 300 000 IU per ampoule and it is used 
for one single load dose followed by a maintenance dose. High doses of 
200 000 IU and 300 000 IU are also available as oral solutions (Aspray et al., 
2014; Pearce and Cheetham, 2010). Although the prevalence of vitamin D 
insufficiency is high during winter and spring in the UK, the prevalence of 
using vitamin D supplements in the UK population is only about 5% of the 
population (Hypponen and Power, 2007; Glass et al., 2009). 
Both vitamin D2 and D3 forms of supplement elevate serum 25(OH)D and a 
number of studies have been conducted to compare the effect of D2 and 
D3 on serum 25(OH)D concentration. A study by Romagnoli and colleagues 
(2008), studied the difference between vitamin D3 and D2 supplement 
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either by an oral or intramuscular route. They found that the D3 form 
increased the total 25(OH)D significantly more than the D2 form due to 
faster metabolism. The authors found that oral route increased the level 
more promptly than the intramuscular injection and stated that the 
intramuscular route may be not the proper physiological route of 
administration (Romagnoli et al., 2008). Another study used the dose (4000 
IU) of D2 or D3 daily for two weeks in winter among 72 healthy adults and 
found that 25(OH)D concentration increased after using the supplements 
in both groups but the increase was greater by 70% in D3 group (Tranget 
al., 1998). Another study by Glendenning and colleagues used supplement 
with 1000 IU of D2 or D3 for three months among 95 patients who had hip 
fracture and they found that 25(OH)D increased by 52% more in D3 group 
when compared to D2 group (Glendenning et al., 2009).  
Heaney and colleagues aimed to study the response of oral vitamin D3 
supplementation on serum 25(OH)D and they concluded that an additional 
1 µg of vitamin D3 was equal to 0.7 nmol/l of serum 25(OH)D, the vitamin 
D3 required to maintain serum 25(OH)D concentration in winter was 12.5 
µg per day and the body´s stores can provided 78 to 82 µg per day. They 
also concluded that healthy man uses about 3000-5000 IU cholecalciferol 
per day to meet winter requirements, in addition to the accumulated 
vitamin D in the body from the summer (Heaney et al., 2003).  
Overdose (toxicity) of vitamin D is rare and can increase the absorption of 
calcium causing hypercalcemia that can lead to renal failure, accumulation 
of calcium stones, aortic calcification or accumulation in soft tissues. 
Vomiting, anorexia and headache are symptoms of vitamin D toxicity 
(Deluca, 2008; Spiro and Buttriss, 2014; Heaney, 2008). Vitamin D toxicity 
has not been observed with dietary intake or sunlight exposure (Hart and 
Gorman, 2013); however, very high doses of the pharmacological form of 
vitamin D over a long period could lead to toxicity. Up to 10 000 IU per day 
is safe but 20 000 to 50 000 IU per day for a sustained period could cause 
vitamin D toxicity (Heaney, 2008). In a systematic review and meta-analysis 
27 
 
done in 2016 by Malihi and colleagues including 48 studies and 19833 
participants, found that vitamin D supplementation for long period can 
increase the risk of hypercalciuria or hypercalcemia and this finding is not 
related to the supplement dose. The National Institute of Health (2008) 
considered serum 25(OH)D more than 500 nmol/l as vitamin D toxicity. 
Heaney agreed that the toxicity cannot happen with 25(OH)D of less than 
500 nmol/l (Heaney, 2008). 
Previous intervention studies have been conducted to investigate the 
effect of oral vitamin D supplementation on serum 25(OH)D levels and 
toxicity. Holick et al. (2011), stated that 2000 to 4000 IU of vitamin D 
supplement per day for deficient people is not enough to achieve a normal 
serum 25(OH)D level, and up to 10 000 IU of vitamin D supplement per day 
is safe and patients did not show any symptoms of toxicity. However, Ross 
et al (2011) stated that over 10 000 IU of vitamin D supplement per day 
may cause renal and tissue damage. A study by Ilahi et al (2008) found that 
a single oral dose of 100 000 IU of vitamin D3 is safe and increased serum 
25(OH)D by 27 ng/ml in 30 healthy people. In another study in adolescents 
in Normandy, the authors used a single dose of 200 000 IU of vitamin D3 in 
winter and measured serum 25(OH)D at baseline, after three weeks and 
over three months after the supplementation. Their results showed, that 
serum 25(OH)D increased significantly after three weeks then decreased 
after three months without any adverse reaction (Mallet et al., 2010).   
 
The UK National Osteoporosis Society (NOS) published vitamin D guidelines 
in 2014 (Aspray et al., 2014) stated that oral vitamin D3 is the best choice 
rather than vitamin D2 for treatment and correction of vitamin D 
deficiency due to the availability of vitamin D3 supplementation in the UK. 
They stated also that when there is the need for fast or urgent correction 
of vitamin D levels such as in symptomatic diseases, the treatment strategy 
should be a high dose of vitamin D3 (300 000 IU) given as separate doses, 
daily or weekly over a period of 6 to 10 weeks in total. This high load dose 
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is then followed by a maintenance dose of 800-2000 IU daily. With less 
urgent cases, an oral maintenance dose can be used without the high load 
dose. When a high dose is used, calcium levels should be measured and 
checked after one month of completing the total dose because in rare 
situation increased calcium levels may be occurred after using a high dose 
of vitamin D supplementation (Aspray et al., 2014).      
 
1.4. Vitamin D recommendations  
Dietary vitamin D recommendations vary by country, health situation, and 
age. In the UK there was no reference nutrient intake (RNI) for dietary 
vitamin D for individuals 4 years and above until the new SACN 
recommendations published in 2016. When the past RNI was established 
by the Department of Health in the UK, they assumed that healthy adults 
have sufficient sunlight exposure in the summer, providing them with an 
adequate amount of vitamin D synthesised by the skin, and that this 
amount will maintain the serum level of 25(OH)D above 25 nmol/l in the 
winter months (Buttriss, 2015). However, the current UK RNI for vitamin D 
is 10 µg per day for people who are 4 years and above, young children and 
pregnant women, who are at a higher risk of developing vitamin D 
deficiency (SACN, 2016; Table 1.3). The SACN reviewed many studies in 
order to set the RNIs for vitamin D and they found that evidence regarding 
non-musculoskeletal outcomes were insufficient. So the DVRs of vitamin D 
were set according to the high quality studies of the musculoskeletal 
health. The available data about non-musculoskeletal outcomes were tend 
to be observational, cross-sectional studies, case reports, in addition to, 
high inter-assay and inter-laboratory variations in measuring serum vitamin 
D . In a meta-analysis by Cashman and colleagues (2011), they reviewed 44 
RCTs including studies in adults, adolescents, children and elderly to 
investigate a model of relationship between vitamin D intake and serum 
25(OH)D concentration in order to established the reference intake value 
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of vitamin D. using this meta analysis and meta regression they concluded 
that the model to predicted serum 25(OH)D in nmol/l is (0.044 X (total 
vitamin D intake in IU) + 33.035) and by using this model they found that 
the predicted RDA of vitamin D at serum 25(OH)D 50 nmol/l is about 359 IU 
per day (Cashman et al., 2011). 
In the light of above, SACN considered the threshold 25(OH)D of 25 nmol/l 
as desirable levels based on RCTs and meta analysis. According to the 
threshold, the RNI established to be 10 µg per day vitamin D to achieve 
serum 25(OH)D ≥ 25 nmol/l in 97.5% of the UK population (SACN, 2016). 
There is no dietary reference intake of vitamin D in Saudi Arabia.     
Table 1.3. The UK Reference Nutrient Intake (RNI) for vitamin D   
Age  Men Women 
0-11 months  
1- <4 years 
4 years and above 
Pregnancy 
Lactation 
8.5-10 µg 
10 µg 
10 µg 
- 
8.5-10 µg 
10 µg 
10 µg 
10 µg 
10 µg 
 
Older adults experience a higher rate of muscle pain, loss of bone strength 
and were more likely to experience bone fracture (Bischoff-Ferrari et al., 
2004). Their skin is less effective at producing vitamin D from the sunlight 
(Spiro and Buttriss, 2014) due to a decrease of VDR (Wicherts et al., 2007). 
They therefore need to ensure they consume sufficient daily vitamin D to 
meet their needs. Data from the National Diet and Nutrition Survey (NDNS) 
shows that people who are 65 years and above are more vitamin D 
deficient compared to younger individuals (Ruston et al., 2002; Finch et al., 
1998). In addition, they also consume a lower amount of dietary vitamin D 
because the most common foods eaten by this age group were potatoes, 
bread, biscuits and milk however; none of these foods are high source of 
vitamin D (Smithers et al., 1998). Loss of mobility, lower sunlight exposure 
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and lower dietary intake of vitamin D, could be factors leading to vitamin D 
deficiency in older people (Salamone et al., 1993).  
Pregnant women need more calcium to supply the foetus with the calcium 
needed for bone formation. Vitamin D plays an important role in calcium 
homeostasis, so maintaining sufficient levels of vitamin D is particularly 
important during pregnancy (SACN, 2015). In a randomized trial done 
(Hollis et al., 2011) 350 pregnant women received a 400, 2000 or 4000 IU 
vitamin D supplement for 4-5 months until they delivered their baby. The 
authors aimed to achieve the level 80 nmol/l, this level being considered 
the optimal level for calcium absorption and preventing secondary 
hyperparathyroidism. They found that the concentration of 25(OH)D 
increased after the supplementation in all groups. They also found that the 
concentration of vitamin D in neonates was correlated with 25(OH)D levels 
of the mothers during the maternal period. They concluded that the level 
of serum 25(OH)D at 100 nmol/l was needed to optimize the production of 
the active form 1,25(OH2)D during the period of pregnancy (Hollis et al., 
2011). New born infants and young children need calcium and vitamin D to 
form healthy bones. In addition, vitamin D deficiency can lead to seizures in 
neonates (Hollis et al., 2011). A study by Hazell et al (2015) found that 
children who had serum 25(OH)D of >75 nmol/l had higher bone mineral 
content compared to children who had levels <75 nmol/l. 
In the UK, the cut-off level of vitamin D of 25 nmol/l is considered as 
vitamin D deficiency. This value was based on the absence of rickets in 
children or osteoporosis in adults (SACN, 2016). However, for the non-
calcaemic effects of vitamin D, higher levels are reported (Lanham-New et 
al., 2011). According to other studies, SACN (Scientific Advisory Committee 
on Nutrition) in 2016 stated evidence supporting the value of >50 nmol/l as 
desirable for bone and muscle functions. The US Institute of Medicine 
(IOM) in 2011, (Ross et al., 2011) concluded that a serum 25(OH)D level  
<30 nmol/l was considered to be deficiency, 30-50 nmol/l considered to be 
inadequate and >50 nmol/l was the sufficient level. The level at 50 nmol/l 
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is agreed also by the World Health Organization, and by the Netherlands 
recommendation (Spiro and Buttriss, 2014). The Endocrine Society in the 
USA recommended a level of 25(OH)D at 75 nmol/l (>30ng/ml) to be 
sufficient and recommended consumption of 1500-2000 IU of vitamin D 
daily to achieve this level (Holick et al., 2011). Heaney (2005) stated that 
4000 IU (100 µg) of vitamin D per day is needed to maintain a serum 
25(OH)D of 80 nmol/L.  
The first reference value for vitamin D in the USA in 1997 was 200 IU (5 µg) 
per day for adults >50 years old, 400 IU (10 µg) per day for people from 51 
to 70 years old and 600 IU (15 µg) for people above 70 years irrespective of 
gender (Institute of Medicine, 1997). In 2011 the Institute of Medicine 
increased the recommendation for vitamin D based on numerous studies 
about its beneficial effects (Table1.4). They reviewed a large number of 
studies on the beneficial effects of vitamin D on non-calcaemic functions 
such as cancers, CVD, diabetes, falls and infection and concluded that only 
bone health had sufficient evidence to identify an increase in the DRI. 
Accordingly, people who had serum 25(OH)D <40nmol/l were at high risk 
to have adverse bone outcomes. It is still debatable as to whether other 
diseases should be considered in deciding the vitamin D recommended or 
desirable levels; however, more evidence is needed to investigate the 
causal relationship with vitamin D (Ross et al., 2011). It has been reported 
that consuming a daily amount of 10 µg can maintain serum 25(OH)D at 
the level 40 nmol/l and 15 µg daily can maintain the level at 50 nmol/l 
(Ross et al., 2011).  
 
Table 1.4. The dietary reference intake for vitamin D (IOM, 2011) 
Category, age groups  (EAR) 
µg/day 
 (RDA) 
µg/day 
 (UL) 
µg/day 
Infant 0-6 months  
Infants 6-12 months 
1-3 years old 
- 
- 
10 
- 
- 
15 
25 
37.5 
62.5 
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4-8 years old 
9-13 years old 
14-18 years old 
19-30 years old 
31-50 years old 
51-70 years old males 
51-70 years old females 
>70 years old 
14-18 years, pregnant/lactating 
19-50 years, pregnant/lactating 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
15 
15 
15 
15 
15 
15 
15 
15 
15 
15 
75 
100 
100 
100 
100 
100 
100 
100 
100 
100 
EAR, Estimated Average Requirement.RDA, Recommended Dietary Allowances. UL, Upper 
level. 
 
The highest recommended dietary intake of vitamin D in European 
countries is 20 µg per day for adult (in Austria, Germany and Switzerland), 
while in France, the recommendation for adults is 5 µg per day. However, 
France has the highest recommendation for children <1 year of age at 20-
25 µg per day (Spiro and Buttriss, 2014). Recently, the SACN proposed 10 
µg per day vitamin D as the RNI for individuals of 4 years and above in the 
UK (Buttriss, 2015). There are no recommended reference intakes in Saudi 
Arabia; here, dietitians and practitioners apply the same recommendations 
as the USA (The Institute of Medicine, 2011) and vitamin D research studies 
in Saudi Arabia usually use the US recommendation. For example, in a 
study done in Saudi Arabia to investigate the prevalence of vitamin D 
deficiency in children, they used the US recommendation (10 µg per day) 
when measuring and comparing the dietary vitamin D intake in this group 
(Mansour and Alhadidi, 2012). Another recent study done in Saudi Arabia 
among pregnant women also used the US recommendation 15 µg per day 
to compare and assess the intake of vitamin D in this group (Al-Faris, 2016). 
Researchers should be aware of the recommendation of vitamin D that 
used in the study when compare to other studies.   
 
1.5. Vitamin D functions  
1.5.1. Vitamin D and calcium homeostasis  
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The main function of vitamin D in the body is calcium homeostasis and 
promoting bone health (Jovicic et al., 2012; Weaver, 2007). Calcium 
homoeostasis refers to ensuring that the calcium concentration is 
maintained in the desirable range. Calcium homeostasis is essential for the 
body because calcium is an important mineral that is involved in many 
functions including: bone calcification, muscle function, muscle contraction 
and neurological function (Sunyecz, 2008). Calcium regulation depends on 
calciotropic hormones which are; parathyroid hormone PTH, calcitonin (a 
hormone secreted by the thyroid gland) and vitamin D. Calcitonin hormone 
works as inhibitor of calcium absorption and bone re-absorption, its 
activity being the opposite of that of PTH (Carter and Schipani, 2006). 
Vitamin D´s role in the process is well known. When calcium intake or 
calcium level in the blood is low, PTH is released and vitamin D is converted 
to the active form 1,25(OH)2D in the kidney. The active form of vitamin D 
then binds to the VDR and stimulates the synthesis of ca-binding protein, 
increasing calcium re-absorption in the kidney and increasing bone 
resorption. When the calcium level is high, PTH secretion is suppressed and 
vitamin D regulates and decreases the absorption of calcium in the kidney 
and bone resorption; this is a negative feedback process for vitamin D 
(Weaver, 2007).  
Phosphorus is an important element that has many essential functions in 
the body, it is involved energy release, protein synthesis and important for 
enzymes function. Phosphorus also is important in bone health because 
due to its essential role in combine the calcium in the blood to form 
hydroxyapatite the component needed for bone rigidity. Vitamin D 
deficiency and low calcitriol levels can decrease phosphorus absorption 
from the gut leading to hypophosphatemia. In contrast, high level of 
phosphorus in the blood can affect calcium metabolism leading to 
hypocalcemia (Ahmed, 2010). Measuring calcium status is difficult as 99% 
of calcium is located in the bones and because serum total calcium 
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measurement is also effected by albumin concentrations as half of the 
calcium in the blood is bound to albumin (Ahmed, 2010).   
Low levels of vitamin D and high levels of PTH increase bone remodeling 
and fractures. A level of 25(OH)D between 75-80 nmol/l is the desirable 
level for optimum calcium absorption  (Weaver, 2007). Calcium 
homeostasis and a normal range of vitamin D levels are needed to prevent 
the incidence of rickets and osteoporosis. 
Building bone mass in childhood is necessary to prevent osteoporosis in the 
future (Weaver, 2007). Osteoporosis is a widespread health problem 
worldwide requiring a large amount of resources and resulting in morbidity 
and mortality (Sunyecz, 2008). The bone becomes fragile, weak and thin in 
osteoporosis patients. This loss of strength in bones can increase the 
fracture rates, especially causing hip fractures (Sunyecz, 2008). In 
summary, vitamin D maintains calcium and phosphorus concentrations at 
the optimum range for bone mineralisation. This function of vitamin D is a 
result of three actions: active transportation of calcium into the enterocyte 
of the small intestine; active transportation of phosphorus into the 
enterocyte of the small intestine with help of parathyroid hormone 
supporting bone resorption when calcium intake is insufficient to avoid 
hypocalcaemia (Deluca, 2008). (figure 1.4) 
 
 
[Click on link to view image] 
 
 
Figure 1.4. Calcium homeostasis 
http://accesspharmacy.mhmedical.com/data/Books/gano24/gano24_c021f003.png 
 
35 
 
 
1.5.2. Vitamin D and falls, muscle function and bone fractures  
Vitamin D can prevent bone fractures and increasing bone density. Vitamin 
D also has a role in muscle health, it can decrease muscle pain and in 
addition, vitamin D receptors (VDR) are located in muscles tissues and VDR 
can activate synthesis of muscle protein. There is also a correlation 
between vitamin D deficiency and muscle weakness (Bischoff-Ferrari, 
2010). Bone fractures can cause pain, loss of mobility, need of long term 
care and also can lead to psychological problems (Sunyecz, 2008).  
Among older adults, muscle weakness and pain, falls, decrease in muscle 
function and bone fractures are common. In a study by Bischoff-Ferrari and 
colleagues (2004), they studied the correlation between VDR expression 
and age. They included 20 women with a mean age of 72 years and 
investigated a gluteus mediusspecimen taken by biopsy during surgery 
(total hip arthroplasty). They assessed VDR expression and found that older 
patients had decreased VDR expression in skeletal muscle. 
A large cross-sectional study from Amsterdam on 1234 participants aged 
65 years and above found that participants who had serum 25(OH)D of >30 
ng/ml (75 nmol/l) had better physical performance compared to 
participants who had serum 25(OH)D <10 ng/ml (25 nmol/l). Physical 
performance was assessed as a total score of: walking test, chair stands 
and tandem stand (Wicherts et al., 2007).  
Among older adults hip fracture is costly and nearly all cases involve falls 
(Bischoff et al., 2003). Vitamin D status and supplementation can benefit 
muscle function and strength and vitamin D deficiency is a predictor of falls 
(Bischoff et al., 2003). In a clinical randomized control trial in Switzerland, 
122 women who were 63 years and above were enrolled from a geriatric 
care unit. Sixty-two women were enrolled to receive 1200 mg calcium and 
800 IU vitamin D3 supplement, and 60 women were enrolled to receive 
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1200 mg calcium supplement alone, every day for 12 weeks. They found 
that the group who received calcium and vitamin D had 49% less falls 
compared to the calcium only group, these falls were recorded by nurses. 
The authors also found improvement in musculoskeletal function 
measured as a sum score of “knee flexor and extensor strength, grip 
strength and the timed up and go test” (Bischoff et al., 2003).  
In a systematic review and meta-analysis (Dao et al., 2014), they found that 
low vitamin D levels was associated with stress fractures, imbalanced bone 
remodelling and structural bone fatigue.  
1.5.3. Vitamin D and other chronic disease  
In the past it was believed that vitamin D was important only for calcium 
homeostasis and bone and muscle health. Recently, many studies have 
focused on the non-calcaemic effects and functions of vitamin D such as 
the positive effect on diabetes, cardiovascular disease, cancers, 
autoimmune disorders and anti-inflammatory effects from epidemiological 
studies and randomized controlled trials (Bischoff-Ferrari, 2010; 
Matyjaszek et al., 2015; Wang et al., 2008).  
 
1.5.3.1. Cardiovascular disease (CVD)  
Different levels of serum vitamin D are associated with positive effects for 
many diseases. Bischoff-Ferrari (2010), reported that a 25(OH)D levels of 
100 nmol/l was associated with a decreased risk of CVD. Vitamin D can play 
a role in reducing CVD in different ways: vitamin D supplements of 800 IU 
per day for two months may reduce blood pressure, thus vitamin D 
deficiency may be associated with the prevalence and incidence of CVD, 
renin activity in plasma and associated with calcification of the coronary 
artery (Wang et al., 2008).  
Forman et al (2007), studied the correlation between serum 25(OH)D and 
the risk of hypertension from two large cohort studies included 613 males 
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and 1198 females who did not have hypertension at baseline. They found 
that a higher level of 25(OH)D was inversely correlated with the incidence 
of hypertension (Forman et al., 2007). Raising renin enzyme can lead to 
increased blood pressure due to its role in the renin-angiotensin system 
which results in high blood pressure, after the angiotensin1 is converted to 
angiotensin2 (Li et al., 2002). Increased angiotensin2 constricts the blood 
vessels and enhances the secretion of the hormone aldosterone from the 
adrenal gland. Aldosterone hormone stimulates the kidneys to reabsorb 
water and sodium into the blood, causing high blood pressure (Li et al., 
2002).  In an animal study, Li and colleagues (2002) found that vitamin D 
receptor-null mice had more plasma renin and angiotensin2, causing higher 
blood pressure, increased water consumption and cardiac hypertrophy. 
They also found that 1,25OH2D3 injection suppressed renin expression in 
these mice. 
Moreover, an intervention study in Germany enrolled 148 older females to 
a calcium 1200 mg supplementation group or a calcium 1200 mg plus 800 
IU vitamin D3 supplementation group for eight weeks. They found that the 
calcium and vitamin D supplementation group increased serum 25(OH)D 
significantly and decreased the systolic blood pressure by 9.3% compared 
to the calcium only supplement group (Pfeifer et al., 2001).   
 
1.5.3.2. Diabetes mellitus  
A review by Mathieu et al (2005) reported that vitamin D is linked to both 
type 1 and type 2 diabetes mellitus. By reviewing previous studies they 
explained the vitamin D effect on diabetes as follows: firstly, VDR were 
founded in beta cells of the pancreas. Secondly, low 25(OH)D levels may 
impair the secretion and synthesis of the insulin hormone in the pancreas 
and this can play a role in type 2 diabetes. Thirdly, vitamin D supplements 
may have an effect in decreasing the risk of type 1 diabetes and treating 
vitamin D deficiency in diabetic patients may improve their glucose 
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tolerance. In addition to these effects, the active form 1,25(OH)2D3 may 
protect beta cells and prevent the damage that can be caused by the 
inflammatory cytokines such as IFN-α. This damage in the beta cells is a 
step in the development of type 1 diabetes (Mathieu et al., 2005; Bikle, 
2009).  
In a large cross sectional study which included 960 adult participants from 
the first national nutritional survey in Kuwait, Zhang and colleagues (2016), 
aimed to examine the correlation between 25(OH)D levels and the 
prevalence of diabetes. They found that median serum vitamin D was 13.8 
ng/ml and 83% of the participants had vitamin D deficiency or insufficiency. 
They also found a two-fold increase in diabetes prevalence among vitamin 
D deficient or insufficient participants compared to participants who had 
serum 25(OH)D> 20ng/ml (50 nmol/l). Their explanation of these results 
were similar to Mathieu et al (2005) which were that VDR are located in 
beta cells in the pancreas, vitamin D may regulate insulin secretion, 
increase insulin sensitivity and decrease insulin resistance and decrease 
inflammation (Zhang et al., 2016).   
In a randomized clinical trial done in India, 137 participants diagnosed with 
pre-diabetes were enrolled into a vitamin D supplement group (n=69) or 
placebo (n=68). The supplement was as 60 000 IU once a week for four 
weeks followed by 60 000 IU per month for total period of 12 months. 
After 12 months, fasting glucose, 2-hour glucose and HbA1c (Glycated 
haemoglobin) were significantly lower in the supplementation group than 
placebo (Kuchay et al., 2015). 
In the light of the above, vitamin D can play a role in diabetes in many 
ways; vitamin D may improve insulin secretion, improve insulin resistance, 
decrease the inflammation and prevent the cells in the pancreas from the 
pro inflammatory cytokines.   
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1.5.3.3. Cancers  
Many studies have found that vitamin D is linked to cancer and cancer 
markers, especially breast, colon and rectal cancers (Feskanich et al., 2004; 
Lappe et al., 2007; Yousef et al., 2013). Vitamin D receptors are expressed 
in many malignant cells and the active form of vitamin D can reduce the 
proliferation of the malignant cells and at the same time increase the 
differentiation of the normal cells. It has also been found that high vitamin 
D intake and higher 25(OH)D levels were associated with lower incidence 
of colon and rectal cancers (Bischoff-Ferrari, 2010). 
A case control study was done by Feskanich et al (2004), on 193 women 
aged 46-78 years with colorectal cancer. They aimed to investigate the 
association between vitamin D levels and the risk of colorectal cancer and 
they located these women within a large cohort of data which included 
121,700 females, from the Nurses’ Health Study. 193 cases of colorectal 
cancer were recorded and they found that mean 25(OH)D in cases 27 
ng/ml, was significantly lower than matched control women 30.3 ng/ml (P 
0.03). They also found that higher level of 25(OH)D was negatively 
correlated with the risk of colorectal cancer (Feskanich et al., 2004).  
A study in Saudi Arabia on 120 women with breast cancer found that 
patients with breast cancer had significantly lower serum 25(OH)D than 
control subjects, despite all Saudi women being at high risk of vitamin D 
deficiency due to low sunlight exposure and clothing style. The author 
explained the role of vitamin D in breast cancer by the anti-proliferation 
and pro-differentiation action of vitamin D on cancer cells (Yousef et al., 
2013).     
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In a 4-year randomized control clinical trial done in Nebraska, Lappe and 
colleagues (2007) recruited 1179 women of 55 years and above to 
investigate the effect of 1500 mg of calcium supplement, calcium with 
1100 IU of vitamin D supplement or placebo, on the risk of cancer.  They 
found that both intervention groups reduced the risk of all type of cancers; 
however the calcium and vitamin D group had the better effect with 
significantly lower incidence of cancer compared to the placebo group. 
Participants’ baseline vitamin D was 72±20 nmol/l and the dose of 1100 IU 
per day increased the level by 24±19 nmol/l. The authors concluded that 
increasing serum 25(OH)D by 25 nmol/l may reduce the risk of cancers by 
35%. They explained this benefit by the role of vitamin D on genes 
including the regulation function of cell proliferation, differentiation and 
cell apoptosis and they stated that if the vitamin D level was low these 
functions will be defective (Lappe et al., 2007).  
 
1.5.3.4. Asthma  
Many studies have focused on the effect of vitamin D on immunity and the 
relationship between vitamin D deficiency and diseases involving immune 
dysfunction, including asthma. It has been found that vitamin D has effects 
on different immune cells such as macrophages, dendritic cells, T 
lymphocytes and B lymphocytes (Szczawinska-Poptonyk and Breborowicz, 
2012). Recent studies have found a positive correlation between higher 
25(OH)D levels and asthma outcomes such as better asthma control, better 
lung function, lower inflammation and better response to corticosteroid 
(Raissy and Blake, 2015). 
Asthma is a chronic inflammatory disease and it is a potentially fatal 
condition. Wheezing, cough, shortness of breath, lung obstruction and 
chest tightness are the most common symptoms of asthma. These 
symptoms can range from occasional mild symptoms to life threatening 
attacks (Al-Zahraniet al., 2015). The pathophysiology of asthma starts with 
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airway inflammation followed by airway hyper responsiveness and if 
chronic inflammation is not treated then airway remodelling can occur. 
Airway remodelling is a late stage of asthma, causing change and damage 
of the epithelial cells in lungs (Al-Moamary et al., 2012).  According to the 
global initiative for asthma (FitzGerald et al., 2012) family history of 
asthma, allergy, environmental allergens exposure, exercise, smoking, 
respiratory infection, genetics and some medications such as aspirin are 
risk factors that can both increase the chances of developing asthma or 
increase the symptoms and exacerbation periods (FitzGerald et al., 2012). 
 
A diagnosis of asthma should be made based on patient medical history, 
physical examination, blood analysis such as eosinophil counts and total 
Immunoglobulin E (IgE) and clinical assessment such as spirometry to 
measure lung function (Al-Moamary et al., 2012). The most important 
spirometer measurements are: forced expiratory volume in one second 
(FEV1), which is “the volume of air that the patient is able to exhale in the 
first second of forced expiration”. The second measurement is forced vital 
capacity (FVC), which is “the total volume of air that the patient can 
forcibly exhale in one breath” and the FEV1/FVC ratio, which is “the ratio of 
FEV1 to FVC expressed as a percentage” (Bellamy et al., 2005).   
 
Asthma outcomes or asthma biomarkers are classified as core or required, 
supplemental and emerging (Szefler et al., 2012). These biomarkers can be 
used in studies to investigate treatments or measure the improvement and 
monitoring asthma. The only core outcome that is required in every study 
is total IgE to determine if the patient has atopy or allergy. Eosinophil count 
in blood or sputum, fractional exhaled nitric oxide, leukotrienes in urine 
and specific IgE are supplemental outcomes that can be measured 
depending on the study aims. Airway imaging, skin prick test and genetic 
analysis are emerging outcomes that need more research (Szefler et al., 
2012). Asthma control is the physician’s goal and consists of treating 
asthma, as well as giving safe treatment with minimum adverse effects of 
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medication and with a supplemental aim of cost effectiveness. Asthma 
control means minimal symptoms, normal physical activity, no night-
waking due to symptoms, minimum use of quick relief medication, no 
exacerbation and normal lung functions (FitzGerald et al., 2012). 
 
Asthma can be correlated with other allergic diseases such as food allergy, 
eczema, conjunctivitis and rhinitis (Pawankar, 2014). The prevalence of 
allergic diseases including asthma has increased recently (Anandan et al., 
2010). The World Health Organization (2011) stated that 235 million 
people have asthma. In 2014, the worldwide prevalence of asthma was 300 
million (Pawankar, 2014). The prevalence of asthma in the United Kingdom 
is 5.4 million, 8% of the total population (Asthma UK, 2012). In Saudi 
Arabia, the Saudi Health Interview Survey found that prevalence of asthma 
among adults is 4% and authors stated that although the prevalence is low, 
asthma in these patients is not well controlled and patients are not taking 
the proper medical care (Moradi-Lakeh et al., 2015). 
 
Asthma prevalence is estimated to be 20% in adolescents from 16 to 18 
years and from 8% to 25% in children depending on a number of factors 
such as the environment and weather (coastal, humid, dry), presence of 
sand storms, dust, allergens and locations such as urban or rural dwelling 
(Al-Moamaray et al., 2012). A study undertaken by Hijazi et al (1998) found 
that the prevalence of asthma in Yunbu (urban) is 14% and in Al-Furash and 
Al-Gafure villages (rural) is 8%. Animal dander, smoking, dust, pollen, dust 
mites and emotional stress can be triggers of asthma however, in addition 
to these triggers, a high rate of asthma in Saudi Arabia can be due to 
changes in climate (sand storms), poor knowledge about the disease as 
well as patient fear of using new medications, and an unhealthy lifestyle. 
Physicians also have lack of awareness regarding the effect of controlling 
asthma symptoms can also increase the burden of the disease (Al-
Moamary et al., 2012). 
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In recent years there has been an emergence of epidemiological data, 
supported by animal and in vitro studies, which suggest that low vitamin D 
status may be an underlying cause of the increase in the prevalence of 
asthma and its symptoms, both in the UK (SACN, 2007) and in Middle-
Eastern countries (Ardawi et al., 2012). Vitamin D deficiency is also 
correlated with higher prevalence of asthma among children in Saudi 
Arabia (Aldubi et al., 2015). 
A cross sectional study of 100 children, 50 asthmatics and 50 non-
asthmatics, by Alyasin et al (2011) found that serum 25(OH)D was 
significantly lower in the asthmatic children than in non-asthmatic children. 
They found also that lower 25(OH)D was significantly correlated with lower 
FEV1 in asthmatic children (Alyasin et al., 2011). Similar findings have been 
found in adults with asthma. According to the Third National Health and 
Nutrition Examination Survey (a cross-sectional study on 14 091 
individuals), there was a significant correlation between serum 25(OH)D 
and improved lung function including FEV1 and FVC (Black and Scragg, 
2005). Another large cross-sectional study in Canada on 3359 adults found 
that vitamin D less than 50 nmol/l was associated with reduced FEV1 and 
FVC, especially in obese and overweight participants (Khan et al., 2013).  In 
China, in a cross-sectional study on 435 adults with asthma, Li and 
colleagues found that 89% of the patients had vitamin D deficiency (<50 
nmol/l) and they also found that higher serum 25(OH)D concentration had 
a positive correlation with better FEV1 and FVC (Li et al., 2011). 
In adults with asthma, vitamin D deficiency was also correlated with poorer 
asthma control, higher severity and higher level of exhaled nitric oxide 
(Korn et al., 2013) and reduced response to corticosteroid medication 
(Korn et al., 2013; Sutherland et al., 2010).    
Previous studies have highlighted the inflammation suppression effect of 
vitamin D.  Vitamin D in its active form 1,25(OH)2D3 is known to suppress 
the synthesis of inflammatory cytokines in the lung. It also regulates the 
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activity of other immune cells involved in the pathophysiology of asthma, 
such as mast cells (Chang, Chung and Dong, 2010; Sandhu and Casale, 
2010). Histamine can stimulate bronchial hyper-responsiveness (Bradding, 
2007) and that can lead to worsening asthma symptoms. Levels of mast 
cells which are responsible for releasing histamine in airways of patients 
with asthma are higher than in normal healthy people. Vitamin D may 
suppress the activity of mast cells (Yip et al., 2014).  
 
Vitamin D regulates the levels of inflammatory cells by suppressing their 
maturation in the bone marrow and increasing the likelihood of apoptosis 
(Baroni et al., 2007). Vitamin D supplementation has been shown to reduce 
the maturation and activation of dendritic cells in patients with the 
autoimmune disease systemic lupus erythematosus (Ben-Zvi et al., 2010). It 
can also regulate the differentiation of the immune cells and cell 
proliferation by stimulating the innate immunity and cellular differentiation 
and suppressing the adaptive immunity and cell proliferation (Di Rosa et 
al., 2011). While these studies provide preliminary evidence that vitamin D 
deficiency may increase the risk of asthma and its severity, thus far there 
have been no clinical trials to determine the efficacy of vitamin D 
supplementation in improving outcomes in patients with asthma in Saudi 
Arabia.  
 
1.6. Measuring vitamin D status 
Three methods can be used to estimate vitamin D status in humans. The 
first method is estimating vitamin D level from sunlight exposure by direct 
methods such as a special watch worn around the wrist. These ambulatory 
watches can calculate the absorbed UVB and can be used to estimate 
vitamin D synthesised via the skin (Hoon Lee et al., 2012). Film badge 
dosimeters can also be used to calculate the UVB absorbed by the skin 
(Webb et al., 2010) and a specific formula used to calculate and estimate 
25(OH)D (Seckmeyer et al., 2013; Rhodes et al., 2010). However, these 
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methods are not very easy to use and do not give a strong correlation 
between the sunlight exposure and the level of serum 25(OH)D, this could 
be due to different age groups, variability in skin pigmentation and 
differences in high vitamin D food consumption  (McCarty,2008). Sunlight 
exposure can also be estimated indirectly using a sunlight exposure 
questionnaire (Kimlin et al., 2007; Hoon Lee et al., 2012). Another way to 
estimate vitamin D status is using dietary intake assessment methods such 
as food frequency questionnaires and dietary records followed by analysis 
of the food consumed through the dietary analysis data base (Macdonald 
et al., 2008). However, according to the National Osteoporosis Society 
Vitamin D guidelines, the best way to estimate 25(OH)D level in humans is 
by measuring total 25(OH)D concentration in serum (Aspray et al., 2014).       
Measuring total serum 25(OH)D is the best biomarker of vitamin D status in 
the body due to its long half-life, from two to three weeks, and because the 
concentration of total 25(OH)D is an indicator for both forms of vitamin D 
both from skin and from foods (Deluca, 2008). The levels also can be 
replenished by vitamin D stored in the fat stores, although the active form 
of vitamin D (1,25(OH)2D3) is not the best biomarker to measure to reflect 
vitamin D status in the body due to its very short half-life (about four-six 
hours) and the fact it is linked to PTH levels (Pearce and Cheetham, 2010). 
A number of methods are available to assess and measure serum 25(OH)D 
levels. These methods are valid and are prepared to give an accurate 
quantifying 25(OH)D. Examples of these methods that can be used to 
assess circulating 25(OH)D are; competitive protein blinding assay (CPBA), 
radio immunoassay (RIA), automated direct chemiluminescent assay (CLIA), 
high performance liquid chromatography (HPLC), enzyme-linked 
immunosorbent assay (ELISA), and liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) method (Hollis, 2008; Gerbe and Singh, 2011).  
The chemiluminscent assay is widely used in many countries and it is 
suitable to be used in large laboratory and clinical laboratories that need 
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high throughput; however, this method is not able to detect vitamin D2, it 
can only measure 25(OH)D3, this will not affect countries that use only 
vitamin D3 form such as the UK, however, this method cannot be used in 
countries that use vitamin D2 supplementation such as the United States 
because it will underestimate the 25(OH)D levels (Hollis, 2008; Wallace et 
al., 2010).          
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) has been 
considered as a gold standard to measure 25(OH)D concentration (Lai et 
al., 2011). This method offers specific analysis for low molecules weight 
components when compared to the immunoassays or HPLC. LC-MS/MS 
method developed and spread through the clinical laboratories and it is 
able to do hundreds of variable tests. It is easier to be used and have 
higher throughput when compared to HPLC method. The test reagents are 
variable in costs but in general its cost is lower in total when compared to 
other techniques for large laboratories (Grebe and Singh, 2011).  
There is large variability in results measured and reported when 
chemiluminscent assay and LC-MS/MS method were used to measure 
25(OH)D concentration in the same samples (Grebe and Singh, 2011). Thus, 
standardization of methods is urgently needed. The National Institute of 
Standards and Technology developed a quality control solution to be used 
in LC-MS/MS method containing D2 and D3 in known different 
concentrations by using human serum (SRM 972). LC-MS/MS then have the 
accurate results and the required sensitivity and specificity. However, the 
method still has some limitations such as it requires high manual workflow, 
the operation and maintenance are complex, the cost is high initially to set 
the method in the laboratory, and the throughput is still limited when 
compared to immunoassays (Grebe and Singh, 2011). In addition, the UK 
Standard Agency recommend using LC-MS/MS method and using the 
control standard solution (SRM 972) that was developed by the National 
Institute of Standard and Technology in the US, to measure vitamin D levels 
in the National Diet and Nutrition Survey of the UK (Lai et al., 2011). 
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1.6.1 Vitamin D deficiency and vitamin D status  
Globally, vitamin D deficiency is widely spread. Holick and Chen (2008) 
estimated that over one billion individuals have vitamin D deficiency 
worldwide. Generally, it had been estimated that 2% to 30% of adults in 
Europe are vitamin D deficient (Lips, 2007). In the United Kingdom, 24% of 
adult males and 28% of adult females have serum 25(OH)D of less than 25 
nmol/l (Ruston et al., 2002). These percentages are higher in older people, 
36% of males and 38% of females who are 65 years old and above have 
vitamin D lower than 25nmol/l (Finch et al., 1998).  
 
Saudi Arabia is one of the countries that has the lowest level of vitamin D in 
the world (Hussain et al., 2014). Vitamin D deficiency is a major problem in 
Saudi Arabia although it is a sunny country, it is estimated that 85% of the 
population are vitamin D deficient (Mansour and Alhadidi, 2012). Alarge 
study done by Ardawi and colleagues (2012) on 834 adult males estimated 
that 88% had vitamin D deficiency and 49% had severe deficiency with 
serum 25(OH)D less than 25 nmol/l. Eighty percent of Saudi adult females 
had vitamin D deficiency and 56% had severe deficiency with serum 
25(OH)D less than 25 nmol/l according to a study done on 1172 females 
(Ardawi et al., 2011; Soliman et al., 2014). In a recent large retrospective 
observational study done in Saudi Arabia among 10,709 participants, they 
found that mean vitamin D level was 44.6±34.8 nmol/l, over all 83.6% of 
the subjects had serum 25(OH)D<75 nmol/l, 31.9% of them had severe 
vitamin D deficiency <25 nmol/l, 32% had levels at <50 nmol/l and 19.7% 
had levels at <75 nmol/l. They also found that vitamin D deficiency was 
higher among females than males (Hussain et al., 2014). They explained 
the lower levels of vitamin D among females by low sunlight exposure, 
covered traditional clothing style, low dietary vitamin D due to few natural 
sources of vitamin D and few fortified foods being available in Saudi Arabia. 
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Additionally females could be pregnant or lactating and also females are 
more likely to be overweight or obese, which can lead to decreased vitamin 
D levels (Hussain et al., 2014). Vitamin D may store in the body fat in obese 
individuals decreasing the vitamin D bioavailability in the body (Lagunova 
et al., 2009). In a cross-sectional study of 331 Saudi children and 
adolescents from 6-17 years old who were recruited into the study during 
the summer, authors found that all participants (100%) had vitamin D 
deficiency, with serum 25(OH)D of <30 nmol/l ( Al-Othman et al., 2012).  
 
Vitamin D deficiency in children can lead to low calcium levels in the blood, 
causing seizures or tetany (Pearce and Cheetman, 2010). Vitamin D 
deficiency also can cause rickets, bow legs, soft and deformable skulls and 
defective growth especially height. More frequent infections and 
respiratory symptoms can also be associated with vitamin D deficiency in 
children (Pearce and Cheetman, 2010). Among adults, painful and weak 
muscles, fibromyalgia, low density of bones and osteopenia can be caused 
by vitamin D deficiency (Pearce and Cheetman, 2010). Vitamin D deficiency 
is also correlated with the incidence and severity of a number of diseases. 
Vitamin D deficiency seen as low concentration of 25(OH)D can lead to 
decreased bone mass, causing rickets in children and osteoporosis in 
adults. Low concentration of 25(OH)D is found more often in 
postmenopausal women which is linked to a higher risk of developing 
osteoporosis (Wozniak-Holecka and Sobczyk, 2014; Matyjaszek-Matuszek 
et al., 2015). In a recent study by Kanel et al (2015), they found that 
vitamin D deficiency of 25(OH)D less than 50 nmol/l was associated with 
depression and low mood in adult patients. According to many studies and 
clinical trials, vitamin D deficiency is correlated to an increase in the risk of 
cardiovascular disorders, both types of diabetes, obesity, cancer and 
autoimmune diseases (Matyjaszek-Matuszek et al, 2015). More details 
about vitamin D and diseases are discussed in section 1.3.  
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A number of studies found that vitamin D deficiency is also correlated with 
asthma and exacerbated asthma symptoms in both adults and children. 
This relationship can be explained by the role of vitamin D in growth and 
maturation of foetal lungs, the effect of decreasing wheezing in children, 
the immune modulatory effects of vitamin D and a reduction in steroid 
resistance when used to treat asthma (Litonjua, 2009; Litonjua and Weiss, 
2007; Raissy and Black, 2015).  
 
1.6.2. Factors affecting vitamin D status 
Many factors can affect vitamin D status in humans such as: season and 
latitude, sunlight exposure pattern and physical activity, skin colour, 
ethnicity, clothing style, dietary intake and body weight. Latitude, sunlight 
exposure and dietary intake were discussed previously in section 1.5.1 and 
section 1.5.2. 
In general, Asian people have lower 25(OH)D levels than Caucasian people. 
In a study in the UK done by Smith (2010) among 200 healthy individuals 
Caucasian and Asian they found that during summer and winter, Asian 
males and females had significantly lower 25(OH)D levels than Caucasians. 
During winter 64% of Asian have 25(OH)D levels <10 ng/ml and 53% in 
summer while for Caucasians the percentage are 7.7% in winter and 3.5% 
in summer, Smith (2010) concluded that these different levels could be due 
to skin pigmentation and darker skin colour, lower dietary vitamin D intake 
and a covered clothing style. Glass et al (2009) stated that Asian and 
African American individuals have lower 25(OH)D levels and this difference 
between ethnicities could be related to genetic variation in vitamin D 
metabolism, different vitamin D dietary intake and dietary habits, darker 
skin colour and cultural differences (Glass et al., 2009; Mansour and 
Alhadidi, 2012).      
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Previous studies have investigated the relationship between 25(OH)D 
status and skin colour in different ethnic groups. Generally, individuals with 
dark skin had lower serum 25(OH)D than individuals with fair skin and need 
more time exposed to sunlight to synthesis the same amount of 25(OH)D. 
Melanin pigmentation can reduce and limit 25(OH)D synthesis as it limits 
the penetration of UVR. However, a large study done in the UK investigated 
the relationship between 25(OH)D level and skin type using the Fitzpatrick 
skin type scale in the Caucasian population and found that females with 
fairer skin (type 1 and type 2) had lower vitamin D than females with 
darker skin. This finding could be due to avoidance of sunlight as a result of 
the primary care recommendations for individuals with light skin due to the 
risk of skin cancer (Glass et al., 2009).  
Despite Saudi Arabia being a sunny country, vitamin D status is markedly 
low in the Saudi population in all age groups. A review by Christie and 
Mason (2011) reported the most important factors that may lead to low 
25(OH)D in the Saudi population, especially in women. These factors are 
poor knowledge about vitamin D, low sunlight exposure because of the 
extreme hot weather, covering style clothing and low dietary vitamin D 
intake (Christie and Mason, 2011). Another study on adults in Saudi Arabia 
reported that a vitamin D intervention, including advice to eat more food 
sources of vitamin D and to increase exposure to sunlight before 10 am or 
after 3 pm (the time between 10 am to 3 pm is reported to be carcinogenic 
in Saudi Arabia) twice a week for 5 to 30 minutes led to a significant 
increase in serum 25(OH)D (Al-Daghri et al., 2012). However, it is estimated 
that exposing face and arms to sunlight between 10 am and 3 pm in the UK 
in summer, spring and autumn for 5 to 15 minutes can lead to production 
of an additional 1000 IU of vitamin D through skin (Glass et al., 2009).  
Being overweight or obese is correlated with lower serum 25(OH)D. In a 
large study included 2126 adult participants in Norway, the authors found 
that half of males and one third of females who had BMI of 40 or more 
were vitamin D deficient (Lagunova et al., 2009). It is also reported that UV 
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radiation and oral supplementation interventions have less effect on obese 
individuals when compared to normal weight individuals (Wortsman et al., 
2000). In a recent systematic review and meta-analysis including 15 trials, 
authors found that serum vitamin D was increased with weight loss 
(Mallard et al., 2016). 
Possible explanations of the negative correlation between obesity and 
vitamin D levels could be because vitamin D can be stored in body fat and 
that leads to reduced vitamin D bioavailability in the body. Secondary 
hyperparathyroidism is also common in obese individuals and this can lead 
to lower vitamin D in addition to the slower release of vitamin D from fat to 
blood flow (Lagunova et al., 2009). Limited outdoor activity and lower 
mobility of obese people can also decrease vitamin D levels. Obese 
individuals tend to wear more clothes and cover a larger part of their body 
in the summer this is also can lead to a decrease in sunlight exposure 
(Lagunova et al., 2009; Wortsman et al., 2000). 
From a large cohort study in 2007 undertaken by Forman, which included 
613 males and 1198 females, they found that higher BMI and lower 
physical activity were correlated with lower 25(OH)D levels (Forman et al., 
2007). In a large cross-sectional study in Kuwait, it was found that among 
960 adults, 83% of them were vitamin D deficient or insufficient with 
25(OH)D<20 ng/ml. They also found that people with low 25(OH)D had 
significantly higher BMI than people with adequate 25(OH)D level. 
However, their physical activity did not differ significantly (Zhang et al., 
2016).    
In a large study in the US, Wanner et al (2015) collected the data from 
NHANES 2003-2006 included 6370 adults. They aimed to investigate if 
there was a correlation between physical activity assessed by 
accelerometers and by self-reported physical activity and vitamin D levels. 
They found that a 10 minute increase in physical activity measured by the 
accelerometer was associated with increased 25(OH)D by 0.32ng/ml, and 
52 
 
by 0.18 ng/ml for self-reported moderate or vigorous physical activity 
(Wanner et al., 2015). Another study from Saudi Arabia among 331 
children and adolescents aimed to investigate the correlation between 
physical activity and 25(OH)D levels. Physical activity and sunlight exposure 
were measured by a questionnaire which found that children and 
adolescents who were moderately active or very active had higher serum 
25(OH)D when compared to inactive participants (17.7±1.6 nmol/l vs 
22.7±1.5 nmol/l). They also found that BMI was higher in children who 
were inactive. The authors concluded that outdoor exercise or physical 
activity during the daytime can increase sunlight exposure, which may 
result in increasing vitamin D synthesis and physical activity also can 
decrease calcium excretion and increase its absorption. Finally, exercise 
and physical activity can lead to weight loss and reduce adiposity resulting 
in increased vitamin D levels (Al-Othman et al., 2012). 
1.7. Rationale and aims of study  
This project is important because it is one of the few studies investigating 
the outcomes and characteristics of adult asthma patients in Saudi Arabia. 
A number of studies have previously been undertaken but these have been 
carried out in Saudi asthmatic children. Therefore, this current study will 
provide baseline characteristics of adult asthma outcomes in Saudi Arabia. 
To the best of our knowledge, this is the first study to investigate the 
prevalence of vitamin D deficiency among adult asthma patients in Saudi 
Arabia. In addition, it is also the first intervention study using two doses of 
oral vitamin D3 supplement in Saudi asthma patients. 
The second study is also an intervention study to investigate the effect 
vitamin D intake via diet on serum 25(OH)D levels and on lung function 
after the winter months in healthy adults living in the UK. This is of 
importance as there is currently no reference nutrient intake (RNI) for 
vitamin D for healthy adults aged 18 to 65 years in the UK as it is assumed 
that this age group is able to have normal vitamin D levels due to a 
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balanced diet and proper sun exposure. However, people in the UK do not 
have sufficient sunlight exposure during the winter months and during 
cloudy weather which can be up to half of the year.  The study will 
investigate the effect of consuming 15µg per day of dietary vitamin D for 
three weeks on the total 25(OH)D, lung function and airway inflammation, 
adding the novelty of studying the effect of dietary intervention on vitamin 
D levels and the feasibility of consuming this amount via diet only. This 
study is also novel in investigating the role of dietary vitamin D intervention 
and its correlation with lung function in healthy individuals.   
 
1.7.1 Main objective  
The main objective of this project is to investigate the effect of vitamin 
intervention by oral supplementation or by a diet rich in vitamin D on lung 
function and airway inflammation among asthma patients and healthy 
individuals.   
1.7.2 Specific objectives  
- The specific objectives for the study were; to investigate the 
prevalence of vitamin D deficiency in adult asthma patients in Saudi 
Arabia and to investigate if there any correlation between vitamin D 
levels and asthma outcomes in adults with asthma in Saudi Arabia. 
- To compare the effect of oral vitamin D supplements on 25(OH)D 
using different doses. 
- To investigate the prevalence of vitamin D deficiency in healthy 
adult living in the UK after the winter months. 
- To investigate the effect of a daily intake of 15 µg dietary vitamin D 
for three weeks on 25(OH)D levels after the winter months.  
- To investigate if there any difference between chemiluminescence 
immunoassay, the method widely used to measure vitamin D levels, 
and the LC-MS/MS method, the gold standard method to measure 
vitamin D status. 
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Chapter 2: Methods 
 
2.1. Introduction  
A cross-sectional study, two randomized interventional studies, followed 
by a vitamin D measurement study were conducted to answer the 
following research question “To what extent can vitamin D affect lung 
function and airway inflammation?”. 
In this chapter, the study design, participants, instruments used in 
measurements, variables and outcomes assessment methods for each 
study will be discussed. Figure 2.1 shows the studies in the order that they 
were conducted. 
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Figure 2.1. Flow chart shows the four studies conducted. 
 
2.2. STUDY 1: The correlation between vitamin D level and 
asthma outcomes in Saudi Arabia 
2.2.1. Study design and participants  
A cross-sectional study was conducted between December 2013 and June 
2014, in Saudi Arabia (KSA). Male and female adult asthma patients aged 
between 18–60 years were recruited from the out-patient allergy and 
asthma clinic in King Abdul Aziz University Hospital (KAUH). The eligibility 
criteria were: physician diagnosed with asthma, normal calcium level, low 
or normal serum 25(OH)D level. Any patient with chronic illnesses such as 
cancer, tuberculosis, cardiac problems, hepatic or renal diseases were 
excluded. For this study, 58-66 participants were aimed to be enrolled 
based on study sample calculation and study power of 80%. However, 58 
participants took part in the study.  
The study methods were approved by the University Research Ethics 
Committee (UREC) of Oxford Brookes University (OBU) in the UK and also 
by the ethics committee of King Abdul Aziz University in KSA (Appendix 
1,2). Each participant signed a consent form before taking part in the study 
(Appendix 3). 
 
2.2.2. Study protocol 
Participants were invited to take part in the KAUH study after checking the 
patient list of the allergy and asthma clinics and sending the information 
sheet to eligible participants via email (Appendix 4), before their routine 
clinical appointment, to allow at least 24 hours to decide if they wanted to 
take part. The investigator informed them that the clinical services would 
not be affected if they decided not to participate. Once informed consent 
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had been obtained, initial baseline data were collected including: age, 
gender, ethnicity, smoking habits, medical history, and use of medications 
or any dietary supplements (Appendix 5).  
 
Following this, four short questionnaires were completed by the 
participants with the help of the investigator at their visit time in the clinic. 
These questionnaires were: 
• An asthma control test ACT (Appendix 6) 
• A self-designed sun exposure questionnaire SEQ (Appendix 7) 
• The international physical activity questionnaire IPAQ (Appendix 8) 
• A self-designed food frequency questionnaire FFQ to estimate 
vitamin D dietary intake (Appendix 9)  
 
A non-fasting venous blood sample was collected by a nurse or other 
qualified clinician at the hospital, and used to screen vitamin D level by 
measurement of serum 25(OH)D as well as serum calcium. Those who did 
not meet the inclusion criteria were excluded from participating in the 
study and reverted to routine clinical care.   
 
Inclusion criteria  
• Adults with asthma with physician diagnoses, according to global 
initiative asthma GINA guidelines (FitzGerald et al., 2012) 
• Vitamin D as 25(OH)D < 75nmol/l  
• Serum calcium within the normal range (2.2-2.6 mmol/l) 
• No severe asthma exacerbation in last 4 weeks  
Exclusion criteria  
• Any serious medical illnesses such as cancer, renal or hepatic or 
gastrointestinal diseases, tuberculosis and chronic obstructive 
pulmonary disease.  
• Currently taking vitamin D supplement  
• Abnormal serum calcium  
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• Taking medications that can interact with vitamin D supplement. 
These medications are; Atorvastatin (Lipitor), Calcipotrine 
(Dovonex), Calcium channel blokers (Niedipine, Procardia) 
(Verapamil, Calan) (Nicardipine, Cardene) (Diltiazem, Cardizem, 
Dilacor) (Amlodipine, Norvasc), Digoxin (Lanoxin), Anti acids, Anti 
seizures, Bile acid sequestrants, Rifampin, Orlistat (Xenical), 
Omalizumab, Mepolizumab. 
 
Anthropometric measurements (see section 2.2.5) were then taken by the 
investigator. After that, lung function (see section 2.2.4) was assessed by 
portable spirometer (Appendix 10) including forced vital capacity (FVC) and 
forced expiratory volume in one second (FEV1). Fractional exhaled nitric 
oxide (FeNO) was also measured using a portable device. 
 
2.2.3. Blood tests  
Venous blood samples were taken by venepuncture by a trained person. 
Six ml of whole blood sample were collected in a serum tube (BD 
vacationer® serum tubes, UK) at the clinic in KAUH to measure 25(OH)D 
and calcium levels. Samples were then centrifuged at 4000 rpm for five 
minutes and collected in 1.5 ml aliquots. Aliquots were then kept in a 
freezer at –40°C until the time of analysis. Measurements of serum 
25(OH)D, calcium, eosinophil and total IgE were conducted in the central 
laboratory in KAUH. Eosinophil cationic protein was measured in the King 
Fahad Research Centre.  
 
Serum 25(OH)D concentrations were measured using 
electrochemiluminescence immunoassay by (Cobas® e 601 analyser, Roche 
Diagnostic, USA). The detection limits were 7.5-175 nmol/l and with CV% 
for inter-assay analysis 18.4% at a serum 25(OH)D level of 39.5 nmol/l and 
11.7% at 12-125 nmol/l (Snellman et al., 2010). The levels and status 
classified as deficiency at<30 nmol/l, insufficiency 30-50nmol/l and 
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sufficiency at >50nmol/l (The US Institute of Medicine, 2011). Total serum 
calcium levels were measured using the spectrophotometry method by 
(Dimension Vista®, Siemens, USA). The detection range was 1.25–3.75 
mmol/l. Normal range is 2.2-2.6 mmol/l. Total calcium was measured at 
the baseline to identify the eligible participants who could participate in 
the study.  
 
Total immunoglobulin E (IgE) was measured using fluoroenzyme 
immunoassay (ImmunoCAP 250, Phadia, Sweden). Total IgE is a core 
measurement in asthma patient to identify allergic patients (Szefler et al., 
2012). Normal range of IgE is <75kU/L (NHS Foundation Trust), however it 
can be different according to the laboratory ranges (Phillips, 2009). 
According to Laurent et al (1985) the accepted normal level for total IgE is 
150-300 Ku/L. In the present study, this was dependent on the KAUH 
laboratory, normal range which was <195 kU/L. 
 
Eosinophils were measured as part of the complete blood count test (CBC) 
using stain with flouresinse by (Sysmex XE-2100-1, Japan). High eosinophils 
in blood can be an indicator of an airway inflammation (Reddel et al., 
2009). The normal level of eosinophils percentage in the blood sample is 
1%-6% (Curry, 2015). However, according to KAUH the normal range is less 
than 3%. Eosinophilic cationic protein (ECP) was measured by enzyme-
linked immunosorbent assay ELISA (Cusabio, China). Eosinophil cationic 
protein is a granular protein released from activated eosinophils during 
inflammation in asthma patients. ECP has a pro-inflammatory role and 
increase airway narrowing. It is correlated with severity of asthma, allergy 
and inflammation (Blay et al., 1998). ECP is recommended to be measured 
in chronic asthma patients due its sensitivity to airway inflammation and 
airway obstruction, giving the chance to prevent the exacerbation 
symptoms (Wever et al., 1994). Serum range of ECP in healthy adults is 3.5 
to 19 µg/l (Kroegel et al., 1998).   
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2.2.4. Lung function and fractional exhaled nitric oxide (FeNO) 
Spirometer and lung function is an essential measurement at baseline in 
the intervention studies (Tepper et al., 2012). Spirometer is a standard test 
and it is used to measure the lung function and airway limitation. 
Bronchoconstriction, structural pulmonary change and airway 
inflammation can cause airway limitation and reduce spirometer readings. 
Spirometer is a simple, safe and repeatable valid test to be used in asthma 
patients including children above 5 years, adolescents, adults and older 
adults. The change or improvement of spirometer readings can be 
detected in weeks or months responding to anti-inflammatory treatment 
and rapid change can be happening within minutes with bronchodilators 
(Tepper et al., 2012). The minimal clinically important difference in FEV1 
and FVC is 100-200 ml, or about 10% (Reddel et al., 2009).   
Forced expiratory volume in one second (FEV1) and forced vital capacity 
(FVC) were assessed using a portable spirometer (Micro I diagnostic 
spirometer, CareFusion, UK). The values and predicted percentages 
presented in the screen of the spirometer after each exhalation were 
recorded. These percentages are dependent on age and height of the 
participants according to the ATS/ERS 2005 guidelines (The American 
Thoracic Society/ European Respiratory Society). The researcher first asked 
the participants some question before use the spirometer (appendix 10). 
Participants were asked to wear comfortable loose clothing and were 
seated in a comfortable position with a straight back resting on the chair. 
Participants first inhaled deeply and then exhaled through the disposable 
mouthpiece attached to the spirometer. Initially the participant completely 
exhaled in a relaxed way and the reading was recorded, then second and 
third readings were taken for faster and stronger exhalation. The 
differences between each measurement could be not more than 5% 
(Reddel et al., 2009); if the differences were more than 5%, up to five 
further manoeuvers can be completed if the participant agreed. 
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Measuring fractional exhaled nitric oxide is a simple, valid, repeatable and 
non-invasive way to assess the airway inflammation (Dillon et al., 2014). 
Three devices for measuring FeNO were assessed by the National Institute 
for Health and Care Excellence (NICE). They recommended FeNO 
measurement in asthma patients and agreed that all three devices (NIOX 
MINO aerocrine, NIOX VERO, NO breath) are diagnostic and monitoring 
methods that are valid to be used in asthma patients (Dillon et al., 2014). 
Fractional exhaled nitric oxide was measured in this study using the NIOX 
MINO®(Aerocrine, Sweden).The time for change in FeNO readings with 
inhaled corticosteroid is about 3 days to 8 weeks (Raddel et al., 2009).  
The participant first exhaled the air then deeply inhaled from the 
disposable mouthpiece attached to the machine, then exhaled again 
through the mouthpiece for 10 seconds. Supportive visual symbols were 
available on the laptop in front of participant. Then the result was shown 
immediately on the screen of the set. The results 20-25 part per billion 
(ppb) was considered as normal, the level 25-50 ppb indicated an airway 
inflammation and >50 ppb was significantly high and indicated airway 
inflammation according to American Thoracic Society (ATS) guidelines 
(Dweik et al., 2011; Berry et al., 2005).  
2.2.5. Anthropometric measurements  
Body weight and height were measured using digital scale (Detecto scale, 
Weight-Height 750, USA). Height was taken for each participant with his or 
her heels touching the wall, back against the height scale. Participants were 
asked to remove their shoes and the height recorded to the nearest 0.5 
cm. Weight was taken with minimal clothing and without shoes and 
recorded to the nearest 0.1 kg. Body mass index (BMI) was calculated as 
weight in kg divided by height in m². BMI status was classified as normal 
(BMI 18.5-24.9 kg/m²), overweight (25-29.9 kg/m²), or obese (≥30 kg/m²) 
(WHO, 2006). 
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2.2.6. Food frequency questionnaire  
Many FFQs are valid and available to use to estimate all nutrient intakes or 
a single nutrient in special groups. They are adapted for different countries, 
to match the dietary habits of the population being studied (Thompson and 
Subar, 2013). No valid FFQ is available to assess vitamin D intake in Saudi 
Arabia. A self-designed new FFQ was therefore developed to estimate 
dietary vitamin D intake in the Saudi population based on the study by 
Taylor et al (2009). It was designed to estimate vitamin D intake over the 
last year. The developed FFQ included five food groups and 60 food items. 
Food groups included: milk and milk products, fish, meats (e.g. camel meat 
and camel liver) and other foods such as cornflakes, eggs, mushrooms and 
butter. Camel milk, meat and liver are tradition foods in Saudi Arabia. Each 
liter of camel milk contains 640 IU of vitamin D (Zhang et al., 2005). Most 
milk and milk products in Saudi Arabia are fortified with vitamin D (400 
IU/l). Specific brand names of milk products were used in the developed 
FFQ due to differences in vitamin D content. The choice (per Ramadan 
month) was added to the Arabic version that was used in this study. 
Although Ramadan accounts for 1/12 of the year, many families only 
consume some special foods that can affect the vitamin D intake during 
this period such as yogurt and Laban. The average of daily dietary vitamin D 
intake was estimated in µg per day using the UK food composition tables to 
calculate the content of vitamin D in foods (McCance and Widdowsons 
food composition tables, 2010). 
 
2.2.7. Questionnaires and forms  
2.2.7.1. Development of the sun exposure questionnaire (SEQ) 
The developed SEQ included eight questions. The first two questions were 
asking about the period of time the participant was exposed to sunlight 
and the duration in minutes at week days and weekends. Other questions 
asked about which part of the body was exposed to sunlight, the type of 
clothes usually worn in daytime, skin colour type, use of sunscreen and 
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frequency of getting a tan. This questionnaire was developed to match the 
present study participants based on the study undertaken by McCarty 
(2008). The FitzPatrick skin scale (Sachedeva, 2008) was used in the 
questionnaire allowing the investigator to classify the skin colour to one of 
the six types from fair skin to darker skin, (Figure 2.2). The Fitzpatrick skin 
scale is a valid scale used by dermatologist and used within research to 
help identify the skin colour (Sachedeva, 2008).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2. FitzPatrick skin colour scale (Sachedeva, 2008). 
 
2.2.7.2. Asthma control test (ACT)  
The asthma control test (ACT) is a questionnaire recognized by the National 
Institute of Health. It is a valid method used to measure the control level of 
asthma. The asthma control test is simple, short, reliable, valid and free 
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cost method (Schartz et al., 2006). The questionnaire is previously 
translated into 34 languages, Arabic is one of them (FitzGerald et al., 2012). 
The Arabic version was used in study 1. The asthma control test consists of 
five simple questions that the patients can answer by themselves usually 
taking no more than five minutes. Every question has five choices to 
answer and each answer have a score. Then by calculating the score 
patients can be divided into three categories; well controlled asthma if the 
score ≥20, not well controlled asthma if the score 16-19 and very poor 
controlled asthma when the score ≤15 (Al-Moamary et al., 2012). 
2.2.7.3. International physical activity questionnaire (IPAQ) 
Physical activity was measured using the short form of the IPAQ. The 
questionnaires in Arabic and in English were used in studies 1 and 3. 
Participants answered questions about the type of activity, intensity and 
duration of the physical activity during the last week. Participant´s activity 
was then classified as; low level of activity, moderate level of activity and 
high level of activity depending on the calculated score of the 
questionnaire. The IPAQ test is a valid and reliable instrument to assess a 
person’s physical activity levels. This IPAQ test has been translated into 
many languages and consists of a long and a short version of which the 
short version was used in the studies (Craig et al., 2003). 
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2.3. STUDTY 2: The effect of different doses of oral vitamin D 
supplements on asthma outcomes 
2.3.1. Study design and participants  
A randomized intervention study was conducted using a sub-sample of 
participants from study1.For the intervention studies 2 and 3, the sample 
size estimated to be 30 to 35 in each group to detect the minimal clinical 
important difference for FEV1 and FVC, which is 10%. Considering the 
confidence level as 95%, and error of 0.05 and a standard deviation taken 
from previous studies of 15-17% for the FEV1% and power of study at 80%.  
Baseline data, post 3 weeks of the intervention and post 6 weeks of the 
intervention data were measured to investigate the effect of different 
doses of oral vitamin D3 supplementation on lung function among adult 
asthma patients. Eligible patients were randomly allocated to a low dose 
vitamin D3 supplementation group (LDG) or to a single high dose vitamin 
D3 supplementation group (HDG).  
 
2.3.2. Intervention and study protocol  
Participants in the HDG were provided with oral 200,000 IU of vitamin D3 
(cholecalciferol D3 ampoule, Devarol-S by Memphis, Egypt) as a single high 
dose. Participants in the LDG were provided with oral vitamin D3 drops 
(cholecalciferol D3 drops Novartis, Switzerland) 800IU per day for three 
weeks, 16 800 IU in total over three weeks. The 800 IU per day is the lower 
maintenance dose of vitamin D supplement and the 200 000 IU is a safe 
load dose, which has been used in previous studies without any adverse 
effects (Groningen et al., 2010; Aspray et al., 2014; Pearce and Cheetham, 
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2010). The difference between the two doses allowed an excellent 
separation of vitamin D status between the two groups, enabling the effect 
of vitamin D status on lung function and airway inflammation to be 
observed. It was considered unethical to give nothing to any participants as 
serum 25(OH)D measured and participants with levels ˂75nmol/l were only 
included in the study.  
 
Participants who were allocated in the study 2 then attend a second 
appointment. In the second visit, participants attended the clinic again and 
start their supplementation. Participants in the HDG provided the 
supplement at the clinic and participants in the LDG provided with the first 
dose of supplement and given the instruction to use the supplement every 
day until the next visit. The third appointment was arranged after 3 weeks 
of the second visit.  
 
The third visit was three weeks after the start of the intervention and the 
following were carried-out: 
• A blood sample was taken to measure 25(OH)D and calcium (see 
section 2.2.3) 
• Lung function was measured using the spirometer (see section 
2.2.4) 
• FeNO level was measured (see section 2.2.4) 
• Advice on how to  take the supplement were given to participants 
in LDG 
• Last visit appointment was arranged for 3 weeks time 
 
 In the last visit: 
• A blood sample was taken to measure 25(OH)D and calcium (see 
section 2.2.3) 
• Lung function was measured using the spirometer (see section 
2.2.4) 
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• FeNO level was measured (see section 2.2.4) 
 
Three weeks was the duration between the start time of taking the 
supplement, the middle visit and the last visit, as the half-life of 25(OH)D 
concentration in the blood is 2-3 weeks and3 weeks can show potential 
change in 25(OH)D levels in blood (Wootton, 2005; Holick, 2004). A 
summary of the recruitment and protocol study 2 is shown in Figure 2.3. 
 
 
   
 
 
                                                                  Randomization  
                                                                    Second visit  
 
 
 
 
                                   High dose group                                                           Low dose group  
                              200 000 IU single dose                                                      800 IU per day 
 
 
                                                 3 weeks    
  
   
                    
                                   Third visit                                                                           Third visit 
 
    Measurement of serum 25(OH)D                                     Measurement of serum 25(OH)D                                         
Measurement of calcium level                                                Measurement of calcium level                                   
       Lung function assessment                                                     Lung function assessment   
                 FeNO measurement                                                                FeNO measurement  
 
   
 
                                                                    3 weeks 
 
                                    Final visit                                                                           Final visit      
     Measurement of serum 25(OH)D                                       Measurement of serum 25(OH)D                                                                                           
Measurement of calcium level                                                    Measurement of calcium level                                   
               Lung function assessment                                                  Lung function assessment   
                  FeNO measurement                                                                     FeNO measurement  
 
 
Figure 2.3. Recruitment and study protocol for study 2 
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2.4. STUDY 3: Dietary intervention and lung function among 
healthy adults in the UK  
2.4.1. Study design and participants  
A randomized intervention study was conducted between February 2015 
and May 2015 in the United Kingdom (UK). Advertisements containing the 
contact details of the researchers were attached to the University 
advertisement boards, in each department. A detailed participant’s 
information sheet (Appendix 11) and consent form (Appendix 12) were 
sent to any participant responding to the advertisement. Eligible 
participants were randomly assigned to a control group (CG) or to a dietary 
intervention group (IG). Baseline data and post intervention data were 
measured to investigate the effect of a dietary vitamin D intervention on 
lung function and airway inflammation in healthy adults. This study was 
approved by the University Research Ethics Committee (UREC) of Oxford 
Brookes University (OBU) (Appendix 13). 
 
2.4.2. Study protocol 
Healthy male and female adults aged between 18–60 years were recruited 
from OBU. Eligible participants, not taking any vitamin D supplements were 
recruited via advertisement displayed in the University advertisement 
boards. 
Inclusion criteria  
• Healthy adults who are not having any chronic diseases or on any 
medications  
• Body mass index ≤30 kg/m² 
Exclusion criteria  
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• Any serious medical condition such as cancer, renal failure, hepatic 
failure and cardiac problems 
• Taking vitamin D supplement 
• Known current or past hypercalcemia 
• Food allergies  
 
The study included three visits: the first visit was the screening visit to 
assess the eligibility of the participant. The participants were given time to 
read and understand the participant information sheet (Appendix 11) and 
had the chance to ask any questions. Then each participant signed a 
consent form (Appendix 12). Baseline data were collected including age, 
gender, medical conditions, use of any medications or dietary supplements 
and food allergies (Appendix 14). Anthropometric measurements were 
taken in the nutrition department laboratory at OBU.  
 
Eligible participants were randomly assigned to either a control group (CG) 
or to a diet intervention group (IG). Participants who were assigned to the 
control group were asked to consume their normal diet. Participants 
assigned to the intervention group were asked to choose their preferred 
food items from a food list, to be provided in a weekly basis (Appendix 15). 
The dietary intervention was consumption of 15 µg vitamin D via diet only. 
There is no dietary recommendation fot vitamin D for adults in the UK, so 
the US recommended dietary allowance of vitamin D for adults (15 µg) per 
day was used in the dietary intervention (O´Connor and Benelam, 2011). 
Measured and selected food items were provided to participants to be 
consumed within their normal diet for three weeks. All foods provided 
were containing vitamin D in the form D3 due to its greater effect in raising 
serum vitamin D. A four-day diet record was also provided for all 
participants at the end of the first visit to be taken away, filled in and 
returned for the next visit (Appendix 16) to estimate the dietary intake of 
vitamin D. A sheet of the available food items containing vitamin D, were 
shown to the participants to choose their preferred items (Table 2.1). For 
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each participant, the researcher then drew up a weekly plan to ensure that 
each day include food choices that totalled 15 µg vitamin D. 
 At the second visit, after at least four days, a sample of blood was 
collected to measure baseline vitamin D as 25(OH)D before the dietary 
intervention commenced.  
 
Table 2.1 Food items that provided to the participants and their content of 
vitamin D (µg) 
Product Quantity Vitamin D content 
 
Actimel Danone flavoured 0% fat, 100ml  
Petitsfilous flavoured yogurt, 47 g  
Nestle Munch Bunch flavoured yogurt 100g 
Tesco dried skimmed milk powder 
Nestle evaporated milk  
Tesco UHT unsweetened soya milk 
Flora light low fat spread 
Cheese fingers  
Egg  
Vitamin water (flavoured water) 
Mango and passion fruit drink (vitamin drink) 
Sardines in sunflower oil 
Tuna canned in oil 
Kellogg’s Corn Flakes 
Kellogg’s Coco Pops 
Kellogg’s Rice Krispie 
Kellogg’s Special K  
Nesquik Chocolate cereals 
Cheerios’ cereals 
Alibi juice pomegranate or blue berry or citrus 
 
2 bottles 
4 pots 
2 pots 
100g 
170g 
250ml 
30g 
2 fingers 
2 medium eggs 
500 ml 
Bottle (500ml) 
Can (84g) 
Can (120g) 
50 g 
50 g 
50 g 
50 g 
50 g 
50 g 
Can (330ml) 
 
 
1.5 
2.4 
1.5 
1.5 
2.6 
2 
2.25 
2.5 
1.8 
1.25 
10 
4.2 
3.6 
2.2 
2.2 
2.2 
4.2 
1.5 
1.5 
5 
 
 
 
Lung function was assessed using a spirometer and FeNO was measured 
(see section 2.2.4). The participants completed three questionnaires with 
the investigator´s assistance, SEQ, IPAQ and a self-designed FFQ (Appendix 
17). In addition, a four-day diet record was collected and a daily sun 
exposure form was given to the participants to be completed over the next 
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three weeks (Appendix 18). At the third visit after three weeks of the 
second visit, a blood sample was collected to measure 25(OH)D, lung 
function (FVC and FEV1) was assessed, FeNO was measured and the daily 
sun exposure form was collected. A summary of the study protocol is 
shown in Figure 2.4 
 
 
 
 
First visit  
 Screening 
 
Time to read the PIS and answer any questions  
  Sign the consent form 
Basic information sheet 
Anthropometric measurements 
Give the participant the 4 day diet record to be completed before next visit 
 
 
                                  At least 4 days  
 
                                                 Randomization 
 
 
 
                                  Second visit  
Control group  
                   Blood sample to measure 25(OH)D  
Lung function, and FeNO measurement   
                   SEQ – FFQ – IPAQ  
                   Sun exposure daily record given 
                   Collect the 4-day diet record  
 
 
Second visit (intervention strat) 
Diet intervention group  
Blood sample to measure 25(OH)D  
Lung function, and FeNO measurement  
SEQ – FFQ – IPAQ  
Sun exposure daily record given  
Collect the 4-day diet record 
Provide food items for three weeks  
Direction how to consume provided foods was given  
 
                                                              After 3 weeks  
 
 
                         Third visit                                                                                    Third visit  
         Blood sample to measure 25(OH)D                            Blood sample to measure 25(OH)D 
          Anthropometric measurements                                  Anthropometric measurements             
      Lung function and FeNO measurement                 Lung function and FeNO measurement  
          Collect the sun exposure record                                  Collect the sun exposure record 
                                                                                                                 Fill the compliance form  
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Figure 2.4 Protocol for study 3 
 
 
 
 
2.4.3. Blood tests  
 
Venous blood samples were taken by venepuncture by a trained person. 
Four ml were collected in a serum tube (BD vacationer® serum tubes, UK) 
to measure vitamin D concentration. Samples were then centrifuged at 
4000 rpm for five minutes and collected in 1.5 ml aliquots. 
 
Aliquots were then kept in a freezer at –40°C until analysis time. Serum 
25(OH)D was measured at the Functional Food Centre laboratory at OBU, 
using the electrochemiluminescence immunoassay (Cobas® e 411 analyser, 
Roche Diagnostic, USA).The detection limits were 3.00-70.0 ng/ml and CV% 
of 43.5 (37.7-48.9) with 95% confident levels (Snellman et al., 2010). 
 
2.4.2. Lung function and fractional exhaled nitric oxide (FeNO) 
Lung function assessment and FeNO were measured as described in 
section 2.2.4. 
2.4.3. Anthropometric measurements  
Body weight, body fat percent and fat-free mass were measured using the 
(Tanita body composition analyser BC-418 MA, UK). Height was taken using 
a somatometre (SECA, Germany). Waist and hip circumferences were taken 
using an inelastic non-stretchable tape. Participants were asked to remove 
any outer clothing, light clothing remained on and waist circumference was 
taken at the midpoint between the hip bone and the bottom rib. Hip 
circumference was taken around the widest circumference of the hip and 
results recorded to the nearest 0.5 cm. 
 
2.4.4. Dietary assessment  
Dietary assessment was estimated using two nutritional tools: a four-day 
dietary record and a food frequency questionnaire (FFQ). The developed 
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FFQ used in study 1 (see section 2.2.6) translated to English and few 
amendments were made in the English form. Some food items were 
removed such as camel meat and camel milk and few food items were 
added to the English FFQ such as soya milk, pork and fat spreads. The 
average of daily dietary vitamin D intake was estimated in µg per day. 
McCance and Widdowsons UK food composition table (2010), were used to 
calculate the content of vitamin D in food items.  
 
A four-day diet record was used to investigate food intake and to estimate 
vitamin D intake of all participants. Instructions to use and fill the record 
were given. Participants were asked to report all foods and beverages 
consumed for four days with details such as type of food, cooking method, 
serving size and any leftover. Serving size was estimated by household 
measurements such as; cups, table spoon, tea spoon, or by grams if known, 
then converted to a serving size or grams to estimate vitamin D content in 
each food item.  
 
2.4.5. Questionnaires and forms  
Basic information screening sheets were designed including; age, gender, 
ethnicity, smoking habits, medical history, medications, food allergies and 
if the participant was taken any vitamin D supplements (Appendix 14). Sun 
exposure questionnaire (SEQ) used in study 1 (see section 2.2.7.1) and the 
international physical activity questionnaire IPAQ (see section 2.2.7.3) used 
in study 1 were used in this study.  
Daily sunlight exposure record was used in study 3 to investigate the trend 
of sun-light exposure during the study period. Seasonal variation in Saudi 
Arabia may not play an important role in vitamin D level. The form 
included; the day and date, time of exposure to the sunlight, duration in 
minutes, parts of body exposed, use of sunscreen and weather conditions 
(sunny, cloudy, and partially cloudy) (Appendix 18) participants asked to fill 
out the questionnaire over three weeks between the second and third visit.   
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2.5. STUDY 4: Comparison of two methods in measuring serum 
25(OH)D 
2.5.1. Serum samples  
During study 3, an additional serum sample of was obtained during each 
participant´s visits. All samples were centrifuged and separated in aliquots, 
then stored at –40°C until analysis. Each aliquot had a number and the 
same serum sample for each participant was analysed by two methods: 
electrochemiluminescence assay and liquid chromatography-tandem mass 
spectrometry (LC-MS/MS).    
2.5.2 Electrochemiluminescence assay (CLIA) 
Total serum 25(OH)D concentration was assessed by 
electrochemiluminescence immunoassay using  (Cobas® e 411 analyser, 
Roche Diagnostic, USA) at Oxford Brookes University. 
Electrochemiluminescence by Roche Diagnostic is a competitive protein 
binding assay. This assay is able to quantify 25(OH)D in serum or plasma. 
The method uses vitamin D binding protein (DBP) as a capture to bind 
25(OH)D2 and 25(OH)D3. The assay includes three incubations. Firstly, the 
sample is incubated with the pre-treatment reagent, then bounded 
25(OH)D released from the DBP. Secondly, the sample is incubated again 
with a ruthenium labeled DBP making a complex component consist of 
25(OH)D and ruthenylated DBP. Then a third incubation occurs with added 
micro particles coated with streptavidin and 25(OH)D with biotin. The 
component then occupies the free sites of the ruthenium DBP creating a 
complex of rutheniumed DBP and biotinylated vitamin D (Abdel-Wareth et 
al., 2013). After the incubation steps, a washing step removes the unbound 
material and the reagent is added again. After that, the flash 
chemiluminescent reaction starts. A photomultiplier then measures the 
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light signals giving a proportional concentration of serum 25(OH)D 
(Snellman et al., 2010).   
 
2.5.3. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) 
assay  
LC-MS/MS method is widely used among laboratories and research centres 
(Grebe and Singh, 2011). The mass spectrometer is a tool assessing the 
mass-charge ratio in the charged particles. In clinical practice usually the 
mass spectrometer is either single or combined with tandem mass filter 
and can be fronted by LC. The LC-MS/MS consists of; atmospheric pressure 
ionization source attached to an ion-inlet component, two mass-filtered 
devices, collision chamber and an ion-impact detector. The sample first 
becomes ionized in the atmospheric pressure ionization source, then 
passes to the first mass-filter. After that the sample passes to the collision 
chamber, and then again through the second mass-filter. Finally to the 
detector that is quantifying the ions. An auxiliary component is attached to 
the MS which is the device for data reduction of detector signals attached 
usually to the computer software that quantify the detection component 
(Grebe and Singh, 2011).  
In this study, a water LC-MS/MS system was used to quantify 25(OH)D 
concentration in serum samples. The column used was water Acquity UPLC 
BEH pheny1.17µm,201X50 mm. This analysis was conducted in the clinical 
biochemistry laboratory (City Hospital), Sandwell and West Birmingham 
Hospitals. Samples were sent to Birmingham Hospital laboratory to be 
analysed as LC-MS/MS method was not available at OBU.  
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2.6. Statistical analysis  
Data were analysed using the Statistical Package for the Social Sciences 
(SPSS software version 21). Descriptive statistics with calculated means (M) 
and standard deviations (SD) were used to describe the baseline 
characteristics of the participants and to describe the baseline variables. 
The Shapro-Wilks test was used to assess the normality of the data.  
The independent t-test and Mann-Whitney U-test were used to compare 
parametric and non-parametric data between groups (control sv 
interventions). To compare the variables within the group (baseline vs after 
intervention) the paired sample t-test or Wilcoxon signed rank test were 
used for parametric and non-parametric data, respectively. The Freidman 
test was used to investigate differences between data at baseline, after 
three weeks and after six weeks of the supplement in Study 2. To 
investigate correlations and associations between variables, Pearson and 
Spearman rank test were used for parametric and non-parametric data, 
respectively. Statistical significance was set at P ˂0.05.  
MedCalc software (version 16.4.3, Ostend, Belgium) was used to do Bland 
Altman test, Passing-Bablok regression test and Kappa analysis to 
investigate the agreement between the two methods used to measure 
25(OH)D in Study 4.   
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Chapter 3 
 
The correlation between vitamin D levels and asthma 
outcomes in Saudi Arabia 
 
 
3.1. Justification and aims 
Vitamin D deficiency is a major public health problem in Saudi Arabia 
despite the almost unlimited availability of sunlight (Alharbi et al., 2013). It 
is estimated that vitamin D deficiency affects approximately 85% of the 
Saudi population (Mansour and Alhadidi, 2012) and may modulate the risk 
of type 2 diabetes, cardiovascular disease and allergic disorders such as 
asthma (Al-Daghri et al., 2012; Maki et al., 2011; and Bozzetto et al., 2012).  
The prevalence of asthma has risen globally over recent decades 
(Pawanker, 2014) and in Saudi Arabia in particular (Al-Moamary et al., 
2012). 
 
Vitamin D is an important element correlated with asthma and previous 
research has found that vitamin D has a positive impact on many 
functions involved in asthma such as immunity, improving lung function, 
lung capacity and reduction in airway hyper-responsiveness (Chinellato et 
al., 2011; Zosky et al., 2011; Black and Scragg, 2005). Most of these 
previous studies have been undertaken in different populations in 
different countries. To date, only one recent study (Aldubi et al., 2015) 
has been carried out in Saudi Arabia investigating the correlation 
between serum 25(OH)D levels and asthma severity biomarkers but this 
was in children. This study showed that vitamin D deficiency was more 
prevalent in asthmatic children than in healthy children, and those 
77 
 
children with vitamin D deficiency had increased asthma symptoms and 
allergy markers (Aldubi et al., 2015). To the best of our knowledge, the 
current study is the first study to investigate the prevalence of vitamin D 
deficiency and the correlation between vitamin D level and asthma 
outcomes in adult patients in Saudi Arabia.  
 
Aims and objectives  
1. To determine serum 25(OH)D levels among adult asthma 
participants in Saudi Arabia 
2. To estimate dietary intake of vitamin D among adult asthma 
participants in Saudi Arabia 
3. To evaluate the sun exposure patterns among adult asthma 
participants in Saudi Arabia 
4. To investigate the correlation between 25(OH)D levels and lung 
function, airway inflammation, control of symptoms and other 
inflammatory biomarkers  
 
3.2. Subject characteristics 
3.2.1. Demographic information  
Sixty-two asthma participants were initially recruited to the study and 
signed the consent form. Fifty-eight participants (mean age 36±12 years) 
attend the appointment and took part in the study. Personal information 
and medical history were taken by a questionnaire, 74% of the participants 
did not have any medical conditions except asthma. Other medical 
conditions such as diabetes, hypertension and allergic rhinitis were 
recorded for some participants. Only five participants were smokers and 
seven participants were exposed to passive smoking. The usage of inhaled 
corticosteroids, anti-histamine and rapid acting bronchodilators were 
recorded. Forty-nine percent of participants were using one medication to 
treat or control their symptoms, 45% were taking two medications and 6% 
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were taking three types of medications to control their symptoms. Fifty-
two percent of participants were using inhaled or oral corticosteroid and 
only 7% were using oral corticosteroid only.  
 
For any participant who was recently prescribed medication, two weeks 
were given before starting the study to decrease any effect of the 
medication on the study outcomes (only two participants were using 
medication for the first time and they were given two weeks before they 
took part in the study). Detailed baseline characteristic of the participants 
including, gender, smoking status, educational level, medical history and 
physical activity level are shown in, Table 3.1.  
 
Serum 25(OH)D levels were lower in smokers and passive smokers than 
non-smokers (28.6±20.5, 22.7±8.2, 34.2±20 nmol/l respectively); however, 
these were not significant (P 0.284). In addition, no significant differences 
were seen in serum 25(OH)D according to different educational levels (P 
0.695) or different activity levels (P 0.158). Moreover, serum 25(OH)D was 
similar in participants who took one type of medication to control their 
symptoms or two types of medication or three types of medication (P 
0.687). 
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Table 3.1. Baseline characteristics of the participants  
 
Variables Number of participants Percentage % 
Gender  
       Males  
       Females  
 
 
14 
44 
 
24% 
76% 
Smoking  
       Smoker  
       None smoker  
       Passive smoker* 
 
 
5 
46 
7 
 
9% 
79% 
12% 
Education  
       Secondary education  
       High school  
       University level  
       Postgraduate 
 
1 
7 
42 
8 
 
2% 
12% 
72% 
14% 
Medical history  
       Medically free except asthma  
       Diabetes  
       Hypertension  
       Diabetes and hypertension 
       Allergic rhinitis  
 
 
43 
2 
3 
2 
6 
 
74% 
3% 
5% 
3% 
10% 
 
Physical activity* 
       Inactive  
       Minimally active  
       Vigorous-intensity active  
 
 
32 
8 
9 
 
65% 
16% 
18% 
*Passive smoker defined as exposure to the exhaled smoke and side stream smoke (WHO, 2003) 
*Physical activity classified as the International Physical Activity Questionnaire scores (Craig et al., 
2003). 
 
 
 
3.2.2. Body weight status  
The mean body weight of the participants was 74.8±18.7 kg and the mean 
body weight for males and females were 80.4±17.8 kg and 73±18.8 kg 
respectively. The classification of body weight according to the BMI is 
underweight BMI <18.5 kg/cm², normal body weight BMI is between 18.5 
and 24.9 kg/cm², overweight BMI is between 25 and 29.9 kg/cm² and 
obese BMI ≥30 kg/cm² (WHO, 2006). Sixty-four percent of the participants 
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were found to be overweight or obese. No significant differences were 
found in serum 25(OH)D in obese, overweight and normal weight 
participants (P 0.717). Table 3.2 shows the percentages of body weight 
classifications according to the BMI among males and females participants. 
 
Table 3.2.Body weight classification according to the BMI among males and 
females participants   
 
Body weight status Number of participants Percentage % 
 
Total subject n=56* 
          Underweight BMI <18.5 
          Normal BMI 18.5-24.9 
          Overweight BMI 25-29.9 
          Obese BMI ≥30 
 
 
 
1 
19 
11 
25 
 
 
2% 
34% 
20% 
44% 
Males n=13 
          Underweight BMI <18.5 
          Normal BMI 18.5-24.9 
          Overweight BMI 25-29.9 
          Obese BMI ≥30 
 
 
0 
4 
3 
6 
 
0 
31% 
23% 
46% 
Females n=43 
          Underweight BMI <18.5 
          Normal BMI 18.5-24.9 
          Overweight BMI 25-29.9 
          Obese BMI ≥30 
 
 
1 
15 
8 
19 
 
2% 
35% 
19% 
44% 
                             *Two participants had missing data for weight and height 
 
3.2.3. Sunlight exposure patterns of asthmatic participants 
Participants´ most common skin colour was classified as type 3 or type 4 
according to the FitzPatrick skin colour scale (Sachdeva, 2008). Serum 
25(OH)D was higher in fairer skin type such as type 2 and type 3 compared 
to darker skin colour such as 4, 5 and 6; however, these differences were 
not significant (P 0.178). Spearman correlation showed a weak negative 
correlation between 25(OH)D and skin type colour (r -0.275, P 0.044; Table 
3.3).  
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Table 3.3. Serum 25(OH)D according to participants´ skin type (Means±SD) 
 
Skin colour type 
(FitzPatrick) 
Serum 25(OH)D 
(Mean±SD) 
 
Number of 
participants 
Type 2 
Type 3 
Type 4 
Type 5 
Type 6 
 
34±16 nmol/l 
39.4±26 nmol/l 
31±18.4 nmol/l 
18.3±2.3 nmol/l 
14 nmol/l 
7 
11 
31 
4 
1 
 
 
Eighty-two percent of the participants were exposed to the sunlight less 
than 10 minutes per day and 86% of females exposed a very small part of 
their body to the sunlight, face or face and hands only and 27% of them 
were using sunscreen most days or every day. All female participants were 
wearing a hijab or a niqab (hijab is a religious head cover used by Muslim 
females and niqab is covering the face) and 4% of males were wearing a 
ghotra (ghotra is a traditional head cover used by males in Saudi Arabia) 
when they were outside; Table 3.4 shows the sunlight pattern using the 
self-developed SEQ (see section 2.2.7.1).  
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Table 3.4. Sunlight exposure pattern of asthmatic patients  
 
Sunlight exposure patterns Total subject 
n=54* 
Males 
n=13 
Females 
n=41 
Time exposing to the sunlight per day (by minutes) 
       Less than 10 minutes  
       11-20 minutes  
       21-30 minutes  
       30-45 minutes  
       46-60 minutes  
       60-120 minutes   
 
 
44 (82%) 
6 (11%) 
1 (2%) 
0 (0%) 
1 (2%) 
2 (4%) 
 
 
8 (62%) 
2 (15%) 
0 (0%) 
0 (0%) 
1 (8%) 
2 (15%) 
 
36 (88%) 
4 (10%) 
1 (2%) 
0 (0%) 
0 (0%) 
0 (0%) 
Parts of body exposed to the sunlight usually  
       Face only  
       Hands only 
       Face and hands 
       Face, neck and hands  
       Face, neck and arms  
       Face, neck, arms and mid legs  
 
 
1 (2%) 
20 (37%) 
20 (37%) 
6 (11%) 
6 (11%) 
1 (2%) 
 
0 
0 
5 (39%) 
3 (23%) 
4 (31%) 
1 (8%) 
 
1 (2%) 
20 (49%) 
15 (37%) 
3 (7%) 
2 (5%) 
0 (0%) 
How often do you apply sunscreen? 
       Never  
       Occasionally  
       Most days  
       Every day  
 
 
37 (69%) 
6 (11%) 
3 (6%) 
8 (15%) 
 
11 (85%) 
2 (15%) 
0 (0%) 
0 (0%) 
 
26 (63%) 
4 (10%) 
3 (7%) 
8 (20%) 
Spend time in the sunlight for getting tan 
       Yes, once a year 
       Yes, sometimes 
       No  
 
 
2 (4%) 
2 (4%) 
50 (93%) 
 
0 (0%) 
0 (0%) 
13 (100%) 
 
2 (5%) 
2 (5%) 
37 (90%) 
    *Four participants had missing data for SEQ 
 
3.3. Vitamin D and calcium levels among asthmatic participants  
Mean total serum 25(OH)D was 32.3±19 nmol/l for all participants (n=58). 
Vitamin D deficiency and insufficiency (˂50nmol/l) was found in 86% of 
participants. Vitamin D levels were slightly higher among females 35±20.7 
nmol/l compared to males 24.2±9.8 nmol/l (P 0.081). All males and 82% of 
females had vitamin D deficiency or insufficiency (Table 3.5).  
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Table 3.5. Vitamin D status according to serum 25(OH)D among participants  
 
Serum vitamin D status 
nmol/l  
All patients 
n=58 (100%) 
Males 
n=14 (24%) 
Females 
n=44 (76%) 
Deficiency , 25(OH)D < 30 
Insufficiency , 25(OH)D between 30-50 
Sufficiency , 25(OH)D >50 
32 (55%) 
18 (31%) 
8 (14%) 
11 (79%) 
3 (21%) 
0 (0%) 
21 (48%) 
15 (34%) 
8 (18%) 
 
Mean calcium level was 2.24±1.3 mmol/l. No abnormal calcium level was 
found in any participant. Similar results of calcium levels were found 
among males and females, 2.23±0.14 and 2.24±0.13 mmol/l respectively (P 
0.381). 
 
Mean estimated dietary vitamin D intake measured by self-developed FFQ 
(see section 2.2.6) was 3.7±2.5 µg per day. Females had slightly higher 
dietary vitamin D intake than males at 4.0±2.7 µg/d vs 2.7±1.5 µg/d (P 
0.201). No correlation was found between dietary vitamin D intake and 
serum 25(OH)D (P 0.548). Participants with vitamin D deficiency had 
slightly lower dietary vitamin D intake compared to participants who were 
vitamin D insufficient or sufficient; however, no significant difference was 
found (P 0.691; Table 3.6). 
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Table 3.6. Dietary vitamin D intake in participants with different serum vitamin D 
status (Mean±SD)  
Participants Vitamin D 
Deficiency 
Vitamin D 
Insufficiency 
Vitamin D 
Sufficiency 
All participants (n=46)  
Dietary vitamin D intake (µg/D) 
(minimum – maximum) µg/D 
n=27 
3.2±2.0 µg/D 
( 0.34 - 9.1) µg/D 
 
n=13 
4.7±3.5 µg/D 
(1.5 - 11.3) µg/D 
 
n=6 
3.9±2.3 µg/D 
(1.1 - 7.1) µg/D 
 
Males (n=11) 
Dietary vitamin D intake (µg/D) 
(minimum – maximum) µg/D 
n=9 
2.6±1.7 
(0.4 – 5.1) 
 
n=2 
2.8±1 
(2.1 – 3.5) 
n=0 
---- 
---- 
Females (n=35) 
Dietary vitamin D intake (µg/D) 
(minimum – maximum) µg/D 
n=18 
3.5±2.2 
(0.35 – 9.1) 
n=11 
5±3.6 
(1.5 – 11.3) 
n=6 
3.9±2.3 µg/D 
(1.1 - 7.1) µg/D 
 
3.4. Asthma outcomes 
A lung function test was conducted using the portable spirometer and 
fractional exhaled nitric oxide was measured using the NIOX MINO device, 
to determine if any participants had airway inflammation (see section 
2.2.4). Other inflammatory biomarkers such as eosinophil%, eosinophilic 
cationic protein and total IgE were also measured for some participants 
(see section 2.2.3).   
 
3.4.1. Lung function  
Mean percentage of predicted forced expiratory volume in one second 
(FEV1%) for all participants was 79±17% and mean percent of predicted 
forced vital capacity (FVC%) was 81±16%. Females had significantly better 
lung function than males (Table 3.7). Although lung function followed the 
same trend as serum 25(OH)D levels, there were no significant differences 
in means of FEV1 and FVC among different serum 25(OH)D levels groups 
(Table 3.8). 
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Table 3.7. Lung function and FeNO among males and females participants 
(Means±SD) 
 
Variables Males, n=14 Females, n=44 P value 
FEV1% 
FVC% 
FeNO (ppb) 
71.1±17.2 
75.1±16.4 
28.5±19.5 
81.4±17.0 
83.4±16.2 
34.1±33.8 
0.038 
0.040 
0.719 
 
 
Table 3.8. Lung function and FeNO according to serum vitamin D status 
(Means±SD)  
 
Variables 
 
Vitamin D 
deficiency 
n= 32 
Vitamin D 
insufficiency 
n= 16 
Vitamin D 
sufficiency 
n= 7 
P value 
FEV1% 
FVC% 
FeNO (ppb) 
77.3±18.0 
79.4±18.3 
37.2±36.2 
78.4±19.3 
82.3±14.0 
27.3±23.4 
88.1±11.0 
87.0±14.1 
28.1±20.4 
0.287 
0.391 
0.502 
 
 
 
3.4.2. Asthma control scores   
According to the asthma control test (ACT), 22 participants (44%) had 
controlled asthma, twelve participants (24%) had partially controlled 
asthma and 16 (32%) had very poorly controlled asthma. Controlled 
asthma participants had slightly better lung function and slightly lower 
total IgE than participants who were partially controlled or poorly 
controlled, although there were no significant differences between 
controlled asthma participants and non-controlled participants, (Table 3.9).  
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Table 3.9. Vitamin D (mean±SD) and asthma outcomes in participants with 
different asthma control levels 
 
Variables Controlled 
n=22 
Partially 
controlled 
n=12 
Poorly controlled 
n=16 
P value 
25(OH)D (nmol/l) 
Dietary vitamin D (IU/d)  
FEV1% 
FVC% 
FeNO (ppb) 
IgE (KU/L)* 
31.1±22.2 
153.0±103.3 
84.0±13.0 
86.1±14.1 
35.3±38.4 
269.0±220.4 
28.4±17.4 
157.0±94.0 
81.1±12.4 
82.2±15.0 
41.1±30.0 
602.0±978.3 
38.7±18.5 
157.3±114.1 
69.3±24.1 
76.0±21.4 
19.4±13.1 
620.0±783.0 
0.177 
0.964 
0.126 
0.198 
0.059 
0.953 
*IgE could not be measured in all participants due to financial constraints, 7 participants in controlled group,  
5 in partially controlled and 8 in poorly controlled asthma were measured.  
 
3.4.3. Inflammatory biomarkers  
The mean fractional exhaled nitric oxide (FeNO), the airway inflammatory 
biomarker taken for all participants was 33±31 ppb. Forty-one percent of 
the participants had FeNO higher than the normal range (normal range 
<25ppb; Dweik et al., 2011). Other inflammatory biomarkers; total IgE, 
eosinophil and ECP were not measured for all participants due to financial 
constraints.  
 
Mean total serum IgE, measured for 25 participants (6 males and 19 
females), was 493.4±647.0 KU/L. Fifteen participants (60%) had higher IgE 
level than the normal range which according to the KAUH laboratory is 
˂195 KU/L (see section 2.2.3). Eosinophils (%) levels were taken for 34 
participants (6 males and 28 females). Eosinophil (%) normal range is ˂3% 
according to the KAUH laboratory. Eosinophil (%) was higher than 3% in 
53% of participants; Mean ECP (eosinophil cationic protein) was 19.5±11.0 
ng/ml in 19 participants (6 males and 13 females). Total IgE, eosinophil 
cationic protein and eosinophil percentage were higher in males compared 
to females (Table 3.10). 
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Table 3.10. Inflammatory biomarkers among males and females participants 
(mean±SD)  
 
         Variables Males Females P value 
IgE (KU/L) 
 
Eosinophil (%) 
 
ECP (ng/ml) 
1049.0±753.0 
 
6.4±4.2 
 
23.0±8.3 
318.0±515.1 
 
3.3±2.8 
 
18.0±12.5 
0.03* 
 
0.008* 
 
0.416 
 
                                      *Significant differences, Mann Whitney U test 
 
3.5. Correlation between vitamin D level and asthma outcomes  
Participants with lower serum 25(OH)D also had poorer FEV1% and FVC. 
Moreover, males who had lower 25(OH)D also had lower FEV1%, FVC% and 
higher inflammatory biomarkers: IgE, ECP and eosinophil. However, a 
Spearman rank test showed that there was no correlation between serum 
25(OH)D and FEV1% or FVC% (r 0.115, P 0.399 and r 0.2, P 0.140, 
respectively). Serum 25(OH)D was not correlated to the inflammatory 
biomarkers: IgE (r 0.038 P 0.858), Eosinophil % (r -0.036 P 0.833) or ECP (r -
0.235 P 0.332). There was a weak trend showing that participants with 
higher 25(OH)D had lower FeNO levels (r -0.236,  P 0.08).  
Patients who had higher IgE also had poorer lung function (FEV1% r -0.423, 
P 0.044) and (FVC% r -0.373, P 0.079; Figures 3.1 and 3.2). A positive weak 
correlation was found between eosinophil% and FeNO levels (r 0.388, P 
0.023; Figure 3.3). Better asthma control score measured by ACT was 
correlated with improved FEV1% and FVC% although this was a weak 
correlation (r 0.293, P 0.039 and r 0.306, P 0.031 respectively).   
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Figure 3.1. The correlation between total IgE and FEV1% (n=25) 
 
 
 
Figure 3.2. The correlation between total IgE and FVC% (n=25) 
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Figure 3.3. The correlation between eosinophil and FeNO (n=34)  
 
3.6. Discussion   
Vitamin D deficiency is a worldwide health problem and it is more serious 
in high latitude countries and Middle Eastern countries (Cashman, 2012; 
Thomas et al., 2010; Alharbi et al., 2013). Asthma is a chronic inflammatory 
disorder, the prevalence of which is increasing globally (Pawanker, 2014). 
Previous cross-sectional studies and reviews have reported a positive 
correlation between higher vitamin D levels and better asthma outcomes 
(Alyasin et al., 2011; Black and Scragg, 2005; Khan et al., 2013; Li et al., 
2010). However, there have been no studies in Saudi Arabia investigating 
vitamin D levels or their correlation with asthma outcomes in adult asthma 
patients. In the light of the above, the aim of this cross-sectional study was 
to investigate vitamin D levels among adult asthma patients, to assess 
baseline asthma outcomes in a sample of Saudi adult asthma patients and 
to investigate the correlation between vitamin D levels and asthma 
outcomes. To the best of our knowledge, this is the first study to 
investigate this in Saudi adult asthma patients. 
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Previous studies in different countries found a higher incidence of vitamin 
D deficiency in asthma patients compared to healthy individuals (Samrah et 
al., 2014; Niruban et al., 2015; Hatami et al., 2014). In the present study, 
86% of asthma participants were found to be vitamin D deficient or 
insufficient. The level of vitamin D deficiency in adult asthmatics in the 
present study is similar to the levels among healthy adults in Saudi Arabia. 
Previous studies have shown that the prevalence of vitamin D deficiency 
and insufficiency in Saudi Arabia ranges from 80% to 88% among adults 
and adolescents (Ardawi et al., 2011, Ardawi et al., 2012, Mansour and Al 
hadidi, 2012). Moreover, a study undertaken in asthmatic children in Saudi 
Arabia found that all participants were vitamin D deficient (Aldubi et al., 
2015).This high rate of vitamin D deficiency in Saudi Arabia among healthy 
people or asthmatic patients can be explained by a number of factors such 
as very hot weather and low level of outdoor physical activity that lead to 
low sunlight exposure and outdoor activity usually is after sunset in malls 
or covered buildings. Also the type of clothing worn, along with poor 
dietary vitamin D intake and poor knowledge about vitamin D sources and 
vitamin D function. In addition they are only a few fortified foods available 
on the market (Hussain et al., 2014; Mansour and Alhadidi, 2012). 
 
In the present study, females had a higher level of serum 25(OH)D 
compared to males. This is in contrast to previous studies in Saudi Arabia, 
which have found that females have a lower level of serum 25(OH)D for a 
number of reasons. A study by Elshafie and colleagues (2012) investigated 
vitamin D levels among Saudi married couples and found that males had a 
higher level of serum 25(OH)D than females and this was explained by 
increased sunlight exposure in males because of traditional habits such as 
females spending most of the time at homes and covered clothes style. 
Another study (Kensara and Azzeh, 2012) found that female Saudi children 
had a significantly higher incidence of vitamin D deficiency compared to 
male children. This was attributed to the fact that boys could play out-door 
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more than girls, the girl’s school buildings are covered, and unlike girls, 
boys sometimes used bicycles outside (Kensara and Azzeh, 2012). 
 
Muslim females also usually wear fully-covered clothes when they are 
outside, and this covering style may limit vitamin D synthesis via the skin 
(Christie and Masaon, 2011). The higher level of serum 25(OH)D in females 
in our study could be explained by higher dietary vitamin D intake in 
females compared to males. 
 
Dietary vitamin D intake in the participants in this study was 3.7 µg/d, 
females consumed more dietary sources of vitamin D than males. In Saudi 
Arabia, dietary vitamin D intake in general is low. It was found the mean 
dietary vitamin D intake among children aged from 4 to 15 years was 
133±77 IU/d (3.3±1.9 µg/d) in Saudi Arabia (Mansour and Al hadidi, 2012). 
Another study (Al-Musharaf et al., 2012) in Saudi Arabia found a similar 
result; they found that the mean intake of vitamin D in children and 
adolescents was 3.45 µg/d. Among Saudi postmenopausal women the 
average intake is even lower, 0.172 µg/d (Alissa et al., 2014).   
In this study, more than half of the participants were physically inactive 
(65%) and 16% were minimally active. This result is similar to the results in 
a recent large study done in Canada, where the authors found that 57% of 
adult asthma patients were inactive or had less than 3 hours activity per 
week (Doggett and Dogra, 2015). Forty-four percent of the participants in 
the present study were found to be obese and 20% were overweight. The 
percentage of obesity among asthma participants in the present study is 
higher than the percentage of obesity in non-asthmatic individuals in Saudi 
Arabia, which was found to be 29% (Memish et al., 2014). Our findings are 
similar to those of a study done in Iran by Alipour and colleagues (2015) 
who found that 38% and 24% of adult asthma patients were overweight 
and obese respectively. In the present findings the high rate of obesity 
among asthmatic participants could be because they may be more likely to 
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have lower physical activity and limited outdoor activity as 81% of 
participants were as found to be inactive or minimally active.  
 
Asthmatic patients may reduce their physical activity because they are 
afraid to trigger or increase their symptoms such as shortness of breath 
during the exercise. However, a programmed physical activity for asthma 
patients can improve and control asthma, respiratory function and quality 
of life (Emtner and Hedin, 2005). Starting a balanced planned physical 
activity program for asthma patients will not lead to exacerbate symptoms. 
In addition, increasing their physical activity will increase their control of 
asthma symptoms, improve cardiac health, improve mental health, help in 
maintain healthy weight and it can also help improve lung function 
(Mancuso et al., 2013).    
 
The explanation of the correlation between obesity and asthma is 
controversial. Previous studies state that the increased prevalence of 
asthma among obese patients could be explained by accumulated 
abdominal fat, which can limit the movement of the respiratory system and 
lungs. Also, the fact that obese individuals secrete more inflammatory 
hormones from adipose tissue, such as leptin and resistin, which also can 
affect asthma symptoms and increase inflammation (Alipour et al., 2015; 
Sood, 2010). At the same time asthma patients who are obese or 
overweight and doing few physical activity, have lower serum 25(OH)D 
than non-asthmatic individuals (Forman et al., 2007). Decreasing physical 
activity results in lower sunlight exposure and this could lead to lower 
serum 25(OH)D concentration (Al-Othman et al., 2012). 
 
In the present study, 82% of participants were exposed to the direct 
sunlight in daylight hours (6 am to 5 pm) for 10 minutes or less per day. 
Furthermore, only very small parts of the body were exposed such as the 
face, hands or arms. There was no difference between males and females 
in exposure to sunlight patterns. The exact amount of 25(OH)D that 
93 
 
synthesized by sunlight exposure was not measured in the present study; 
however, no correlation was found between sunlight exposure measured 
by minutes and serum 25(OH)D levels. According to the Lund and Browder 
chart (Mimianas, 2007) of body surface area (BSA%), the front of the head 
and one side of each hand is equal to 6% of the body. This small BSA% 
combined with a very short period of sunlight exposure may lead to low 
serum 25(OH)D levels due to low level of skin vitamin D synthesis and could 
be also a reason of not detecting any correlation between sunlight 
exposure and serum levels. It has been reported in a previous study that, 
individuals who expose 5% of body surface area to the sunlight will not 
have more than 35 nmol/l of serum 25(OH)D (Davie et al., 1982). 
Moreover, skin synthesis of vitamin D can also be affected by many factors 
such as the period of time exposed to direct sunlight, whether the weather 
is clear or overcast, skin colour, sunscreen usage and clothing style (Christie 
and Mason, 2011; Glass et al., 2009; Smith, 2010). In addition, calculation 
and estimation of serum 25(OH)D synthesized by the skin from sunlight is 
complex and not easily measured (McCarty, 2008; Buttriss, 2015). In the 
present study, an overall trend of low sunlight exposure was found in 
general.  
 
The results from this study showed that, more than half of the asthma 
participants (58%) were not controlled asthmatics. This high percent of 
non-controlled asthma symptoms is in agreement with a study by Al-
Jahdali and colleagues (2008), which found that in Saudi adult asthma 
patients, 64% were not controlled. This could be explained by low level of 
awareness about asthma, poor knowledge of asthma and how to use 
medications and inhalers correctly, physician under-diagnosis of asthma as 
well as under-treatment (Al-Moamary et al., 2012). 
 
In the present study, participants with vitamin D deficiency 25(OH)D<30 
nmol/l had poorer FEV1% and FVC% compared to participants who had 
insufficient or sufficient levels of serum 25(OH)D. In addition, male patients 
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who had lower vitamin D also had significantly poorer lung function when 
compared to females, including FEV1% and FVC%. In spite of these findings 
we did not find a significant correlation between serum 25(OH)D levels and 
FEV1% or FVC%.  
 
The correlation between serum 25(OH)D levels and lung function and other 
asthma biomarkers is still debatable. Many studies have stated that there is 
a positive correlation between vitamin D level and better inflammatory 
biomarkers; however, many studies have also reported no correlation. A 
large study (THANES) found a positive correlation between vitamin D level 
and lung function (Black and Scragg. 2005). Another study on children from 
Costa Rica found that 25(OH)D was positively correlated to lung function 
and inversely correlated with IgE and eosinophil (Brehm et al., 2009). It has 
been reported that vitamin D deficiency can affect the immune cells, 
decrease the pro-inflammatory cytokines (Sutherland et al., 2010) and 
reduce the smooth muscle function, which can lead to poorer lung function 
and airway remodelling (Damera et al., 2009). Li et al., in 2011 found that 
89% of adult asthmatic patients in China had vitamin D deficiency. They 
also found that higher serum 25(OH)D levels was associated with better 
lung function. A study by Chinellato of Italian children with asthma found 
that serum 25(OH)D was positively correlated with FEV1 and FVC 
(Chinellato et al., 2011). Tanaka et al (2014) in Japan found that higher IgE 
was associated with poorer asthma control and lower FEV1. However, a 
study in 2013, stated that serum 25(OH)D was not correlated with asthma 
prevalence, severity or response to treatment (Gergen et al., 2013). The 
study by Li and colleagues found no significant correlation between serum 
25(OH)D and total IgE levels in adult asthma (Li et al., 2011). 
 
In our study, there was an inverse trend between serum 25(OH)D and 
fractional exhaled nitric oxide, however this was not significant. The 
correlation between FeNO level and serum 25(OH)D is controversial. A 
study by Checkley and colleagues did not find a correlation between serum 
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25(OH)D and FeNO in asthmatic children (Checkley et al., 2014). However, 
Korn et al., (2013) found an inverse correlation between serum vitamin D 
and FeNO levels in adult asthma patients. Airway inflammation is one of 
the most common features in asthma patients as asthma is defined as a 
chronic inflammatory disease (Al-Zahrani et al., 2015). Previous animal and 
in-vitro studies by Berry and colleagues (2005) showed that, vitamin D has 
an anti-inflammatory effect by reducing the production of IL-17, which is a 
cytokine related to chronic inflammatory diseases. This cytokine can 
stimulate IL-6 expression and enhance nitric oxide production that could 
result in increasing FeNO level. Other animal studies support the anti-
inflammatory effect of vitamin D supplementation in rats and murine 
models by inhibition of the pro-inflammatory cytokines (Liu et al., 2009; 
Agrawal et al., 2013). 
The findings of our study showed that there was no correlation between 
serum 25(OH)D and total IgE, ECP or eosinophil. However, it was found that 
controlled asthma patients had lower IgE than patients who are partially 
controlled or poorly controlled. IgE plays an important role in developing 
hyper-responsiveness in asthma and it was reported that vitamin D 
deficiency correlated with higher IgE levels (Paul et al., 2012) and has anti-
inflammatory effects (Lange at el., 2009). Eosinophilic cationic protein 
(ECP) is one of the granular proteins that is released in asthmatic patients 
and can reflect the severity of asthma and inflammatory activity, and also 
predict the response to treatment with corticosteroid. In the present study 
there was no correlation between ECP and lung function, asthma control or 
eosinophil count. Conversely, a number of studies have stated a correlation 
between inflammatory biomarkers and lung function. Zimmerman (1993) 
in Canada found that a higher ECP level was negatively correlated with 
FEV1 in children with asthma. Another study by Sorkness et al., (2002) 
found a strong correlation between ECP and eosinophil count; they also 
found a high level of ECP in adult asthma patients with exacerbated 
symptoms.  
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Our negative findings could be explained by small sample size, different 
population from previous studies. Moreover, IgE levels and eosinophil 
could be affected by the taken medication such as anti-histamine and anti-
inflammatory medication (Wilson, 2002; Banderia-Melo et al., 1997; 
Jayaram et al., 2005). In this study we did not control for the medications 
that participants therefore took different medications were used to control 
asthma symptoms.  
 
To the best of our knowledge, this study is the first to investigate the 
prevalence of vitamin D deficiency among adult asthma patients in Saudi 
Arabia. In addition, it is also the first study investigating the baseline 
characteristics of adult asthma patients in Saudi Arabia and investigating 
the correlation between vitamin D levels and asthma outcomes including 
inflammatory biomarkers and fractional exhaled nitric oxide which can 
reflect airway inflammation. The main findings of our study were; 
1. Vitamin D deficiency prevalence is high in adult asthma participants 
in Saudi Arabia 
2. Low serum 25(OH)D in asthma individuals  could be due to low 
sunlight exposure in addition to low dietary intake of vitamin D. 
3. Overweight and obesity is high as well as low physical activity in 
adult asthma individuals in Saudi Arabia. 
4. Participants with vitamin D deficiency had slightly reduced lung 
function compared to those with sufficient levels of serum 
25(OH)D. 
5. A trend of a negative correlation between FeNO level and vitamin 
D was observed. 
6. No correlation was found between serum 25(OH)D levels and IgE, 
ECP and eosinophil.  
 
The findings from this study have important implications and applications. 
Measuring serum 25(OH)D could be essential for people in Saudi Arabia as 
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they may be at high risk for vitamin D deficiency. Increasing sunlight 
exposure may not be the best solution to prevent and treat vitamin D 
deficiency in the Saudi population due to very hot and humid weather 
during daylight hours; traditional clothes type for males and females; very 
high UV index that could damage the skin if exposed for a long time; and 
traditional habits and lifestyle especially for women who spend most hours 
of the day at home or under covered buildings. Therefore, using over the 
counter vitamin D supplementation on daily basis for individuals who are 
not severely deficient could be an effective way to maintain serum 
25(OH)D levels at the desirable range. Individuals who are severely 
deficient or display vitamin D deficiency symptoms may be encouraged to 
take higher prescribed doses of vitamin D supplements from their 
physician. Encouraging people to consume more dietary sources of vitamin 
D is also important and could be effective to increase serum 25(OH)D 
levels. Although dietary vitamin D sources are limited, most milk brands 
and milk products are fortified with vitamin D in Saudi Arabia; cornflakes 
are also fortified in Saudi market and eggs and salmon are available to be 
consumed.  Dieticians, Nutritionist and Health Care Providers should 
increase their clients’ awareness of vitamin D and how to consume a 
balanced diet to achieve daily recommendations. Finally, it is also 
necessary that the food production market and policy makers within the 
Saudi Ministry of Health investigate ways to increase the fortification of 
foods with vitamin D.      
 
The main limitation of this study was that non-asthmatic participants were 
not included. The addition of a healthy control group may provide 
appropriate comparable data between asthma participants and healthy 
normal participants. Time restrictions and financial constraints were the 
main reasons for this. In addition, the blood inflammatory biomarkers were 
not available for all patients due to financial constraints. 
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Future research need to investigate the correlation between vitamin D with 
lung function and other inflammatory biomarkers among asthmatic and 
non-asthma participants to provide more conclusive evidence. Increase 
sample size for the correlation of serum 25(OH)D and other blood 
inflammatory biomarkers such as IgE, ECP and eosinophil in asthma 
patients can provide more informative data. It is also important to study 
the validity of the developed FFQ to measure vitamin D as there is no valid 
FFQ to measure the dietary intake of vitamin D in the Saudi population.  
Finally, randomized control trials and interventional studies are necessary 
to study the correlation and effect of vitamin D supplementation on 
asthma outcomes to define the causation relationship between vitamin D 
and asthma outcomes.  
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Abstract and poster presented in the Annual meeting of the British Society 
of Allergy and Clinical Immunology (BSACI), Telford, UK (2014) 
  
Vitamin D deficiency and asthma outcomes in adult asthmatics 
from Saudi Arabia  
S. Kokandi¹, S. Wheeler¹ and E. Koshak² 
1, Functional Food Centre, Department of Sport & Health Sciences, Oxford 
Brookes University, UK 
2, King Abdul Aziz University, Medicine department, Saudi Arabia   
 
Background:  vitamin D is an important element for normal lung health. Airway 
disease such as bronchial asthma is characterised by an immunological mediated 
inflammation. Few recent reports suggest the potential link of vitamin D 
deficiency and an increased airway inflammation which can leads to poor asthma 
control.   
Objectives: this study is aimed to investigate the prevalence of vitamin D 
deficiency in asthmatics and the correlation with asthma outcomes. 
Methods: asthmatic participants were recruited from the allergy clinic in King 
Abdul Aziz University Hospital at Jeddah, Saudi Arabia. Lung function tests (FEV1, 
FVC), fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) were 
assessed. Serum vitamin D 25(OH)D was measured by CLIA method.  
Results: forty-nine adult asthma patients were included. Their age ranged 18-60 
years (mean 35±12) years. 76% of them were females. Levels of asthma control 
were: 39.5% well controlled, 14% partially controlled and 46.5% poorly controlled. 
Mean serum 25(OH)D was 32.6±19 nmol/l. vitamin D levels were 50 nmol/l 
(normal) in 14%, 30-50 nmol/l (insufficiency) in 31% and <30 nmol/l (deficiency) in 
55%. Asthmatics who had vitamin D deficiency had lower mean predicted FEV1 
(76% vs. 82%), and higher FeNO levels (34 ppb vs. 27 ppb) when compared to ≥ 30 
nmol/l. patients who had FeNO levels ≥ 26 ppb had lower vitamin D level (29.6 vs. 
34.6) nmol/l, lower predicted FEV1 (76% vs. 81%) and lower predicted FVC (84 vs. 
86). None of these differences reached statistical significance.   
Conclusion: the study explored that low serum vitamin D is a very common 
findings in asthmatics (86%). More than half of asthmatic participants were not 
controlled. There was a trend of association between low vitamin D and poor 
asthma outcomes. 
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Chapter 4 
The effect of different doses of oral vitamin D supplements on 
asthma outcomes 
 
4.1. Justification and aims  
The prevalence of vitamin D deficiency in Saudi Arabia is markedly higher 
than in Europe (Ardawi et al., 2011; Ardawi et al., 2012; Ruston et al., 
2002). The hot climate encourages people to stay indoors during daylight 
hours so very little vitamin D is ever produced in the skin. Those who do go 
outside tend to wear clothing covering most of the body and there is little 
vitamin D in the Saudi diet to compensate for lack of continuous synthesis 
(Hussain et al., 2014) (see section 1.6.1). 
 
Vitamin D deficiency has been associated with greater risk of asthma 
(Aldubi et al., 2015; Alyasin et al., 2011; Black and Scragg, 2005). The 
combination of high rates of both asthma and vitamin D deficiency in the 
Saudi population provides an excellent opportunity to determine whether 
vitamin D supplementation in asthmatic individuals can improve asthma 
control and decreases airway inflammation.   
 
Studies that have explored the relationship between vitamin D status and 
asthma severity or lung function have tended thus far to be observational 
(Ji et al., 2010; Devereux and Wagner, 2011; Bozzetto et al., 2012). 
Associations in such studies may be highly susceptible to confounding bias 
or even reverse causation and therefore, an experimental study design is 
warranted. For example, severe asthma may lead to reduced time spent 
outdoors leading to poorer vitamin D status, or being asthmatic may lead 
to reduced levels of exercise, leading to greater adiposity and lower levels 
of serum 25(OH)D.  However, the hypothesis that vitamin D deficiency 
leads directly to increased levels of inflammation and an exacerbation of 
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asthma symptoms is both biologically plausible and supported by data 
from in vitro and animal studies (Agrawal et al., 2013; Zosky et al., 2011).  
 
Asthma is a chronic inflammatory disease characterised by breathlessness, 
airway hyper-responsiveness, broncho-constriction and airway 
remodelling.  Wheezing and cough are the most common symptoms and 
range from occasional, mild symptoms to acute, life threatening episodes 
(Al-Zahrani et al., 2015). Vitamin D deficiency may exacerbate the 
symptoms of asthma.  The active form of vitamin D, 1,25(OH)2D has 
receptors in many different types of lung cells. Emerging evidence suggests 
that adequate vitamin D status may prevent asthma through a combination 
of promoting lung immunity, reducing airway inflammation, slowing cell 
cycling, reducing hyperplasia and promoting the effects of exogenous 
steroids (Iqbal and Freishtat, 2011). However, no study to date has 
investigated the potential remedial effects of vitamin D in improving lung 
function and airway inflammation in vitamin D deficient Saudi adult 
asthmatic individuals. Therefore, this study aims to determine whether 
vitamin D supplementation for six weeks lead to significant improvements 
in asthmatic patients living in Jeddah, Saudi Arabia.   
 
Aims and objectives:  
1. To investigate the effect of two different doses (single high dose 
and continuous low dose) of oral vitamin D on serum 25(OH)D 
in adult asthma participants after three weeks and after six 
weeks. 
2. To determine whether increasing vitamin D status in adult 
asthma participants results in improving lung function. 
3. To determine whether increasing vitamin D status in adult 
asthma participants results in lower levels of airway 
inflammation.  
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4.2. Participants recruitment  
All participants who took part in the first study (n=62) were invited to 
participate in this intervention study. Thirty-seven adults with asthma were 
eligible to participate in this study (see section 2.2.2). However, 32 
participants completed the study for three weeks and only 16 completed 
the study for six weeks (Figure 4.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Flowchart of participant recruitment and completion 
 
Randomization  
High dose 
n=18 
Low dose 
n=19 
Included n= 37  
(Interventional study) 
First phase (correlation study)  
n=62 
Did not 
complete 
studyn=3 
Complete 
study 
n=15 
3 weeks 
 
Did not 
complete 
studyn=5 
Complete 
study n=7 
3 weeks 
Did not 
complete 
study n=6 
Complete 
study n=9 
3 weeks 
Did not 
complete 
studyn=2 
Complete 
study 
n=17 
3 weeks 
 
Excluded 
 n= 25  
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Twenty-five participants were excluded from the study (Figure 4.1) of the 
participants who were excluded:  
• One participant had tuberculosis 
• One participant was taking anti IgE medication  
• One participant refused to do the spirometer test and FeNO test 
• One participant was not able to provide a blood sample  
• Two participants had baseline serum 25(OH)D˃75nmol/l  
• One participant had a high baseline calcium level 
• Three participants had transport difficulties 
• Four participants were not interested to continue the study after 
they came for first visit 
• Eleven participants were too anxious to attend their appointments 
due to a new virus appearing in the Middle East (Coronavirus) with 
transmission that is hospital-related 
The large drop-out of participant’s number in the sixth week was also 
because of the virus. Of the 37 participants who were eligible to participate 
(see section 2.2.2), 18 were randomly assigned to the single high dose 
group (HDG), 15 completed the three week visit and 7 completed the six 
week visit. Nineteen participants were randomly assigned to the 
continuous low dose group (LDG), 17 completed the three week visit and 9 
completed the six week visit (Figure 4.1). The intervention study protocol is 
described previously in section (2.3.2). 
 
4.3. Participant baseline characteristics  
Baseline characteristics of participants of both groups are shown in (Table 
4.1). The mean age of the participants was 33±12 years. There was no 
difference in age of participants between the high dose group and the low 
dose group (32.8±9 and 34.8±14 years respectively; P 0.637). The majority 
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of participants were not smokers and tends to be educated. Most of 
participants were inactive.   
 
Table 4.1. Baseline characteristics of participants in HDG and LDG 
Variables HDG,(n=18) 
n (%) 
LDG,(n=19) 
n (%) 
Gender  
       Males  
       Females  
 
 
3 (17%) 
15 (83%) 
 
7 (37%) 
12 (63%) 
Smoking  
       Smoker  
       None smoker  
       Passive smoker* 
 
 
1 (6%) 
14 (78%) 
3 (17%) 
 
3 (16%) 
14 (74%) 
2 (11%) 
Education  
       High school  
       University level  
       Postgraduate 
 
- 
14 (78%) 
4 (22%) 
 
 
3 (16%) 
13 (68%) 
3 (16%) 
Medical history  
       Medically free except asthma  
       Diabetes  
       Hypertension  
       Diabetes and hypertension 
       Irritable Bowel syndrome  
       Allergic rhinitis  
 
 
14 (78%) 
1 (6%) 
1 (6%) 
- 
1 (6%) 
1 (6%) 
 
15 (79%) 
- 
1 (5%) 
1 (5%) 
1 (5%) 
1 (5%) 
 
Physical activity* 
       Inactive  
       Minimally active  
       Vigorous-intensity active 
       Missing   
 
 
11 (61%) 
1 (6%) 
5 (28%) 
1 (6%) 
 
12 (63%) 
5 (26%) 
1 (5%) 
1 (5%) 
 *Passive smoker defined as exposure to the exhaled smoke and side stream smoke (WHO, 2003) 
*Physical activity classified as the International Physical Activity Questionnaire scores (IPAQ) 
 
The mean weight, height and body mass index of participants in the HDG 
and the LDG are shown in (Table 4.2). No significant differences were found 
in weight, height and body mass index between the two groups.    
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Table 4.2: Height, weight and BMI in the HDG and the LDG (means±SD)  
 HDG LDG P value*  
Weight (kg) 
Height (cm)  
Body mass index (kg/m²) 
77.5±17  
161.6±6.3 
29.9±7.5 
69.6±22.2 
160±8.3 
27±7.8 
0.232 
0.510 
0.261 
                                   *Independent t-test  
Baseline mean serum 25(OH)D, dietary intake of vitamin D estimated by 
FFQ, serum calcium levels and lung function are described in (Table 4.3) for 
participants in the HDG and LDG. No significant differences were observed 
between groups at baseline.  
Table 4.3. Vitamin D and asthma outcomes in the HDG and LDG (means±SD) 
Variables HDG  LDG P value* 
25(OH)D (nmol/l) 
Dietary vitamin D (IU per day) 
Calcium (mmol/l)  
FEV1 (%) 
FVC (%) 
FeNO (PPB*) 
ACT 
27.2±22.3 
167±110 
2.23±0.06 
83±18.1 
87±16.8 
23.4±17.6 
19.5±5.9 
34.6±20.7 
129±69 
2.22±0.1 
79.7±15.7 
85.6±16.8 
39.6±43 
17.7±5.5 
0.159 
0.613 
0.621 
0.343 
0.443 
0.150 
0.245 
*Mann-Whitney U test  
*PPB, part per billion  
 
4.4. The effect of vitamin D supplementation on asthma outcomes  
To investigate the effect of a single high dose (200 000 IU) of oral vitamin 
D3 or a continuous low dose (800 IU per day) on serum concentration of 
25(OH)D and asthma outcomes, measurements were taken at baseline, 
after three weeks of the supplementation and after six weeks. However, 
few participants were able to complete the three visits. 
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4.4.1. Effect of single high dose vitamin D supplement on serum 25(OH)D 
concentration and asthma outcomes  
Only seven participants who were in the HDG completed all three visits. 
Serum 25(OH)D concentration was significantly increased after the single 
high dose vitamin D supplementation (P 0.002, Table 4.4). Post-hoc analysis 
with the Wilcoxon singed rank test with a significant level at ˂0.017 was 
conducted. The results showed that there were differences between 
25(OH)D level at baseline and after three weeks of the supplementation (P 
0.018), and between baseline and after 6 weeks after supplementation (P 
0.018) but did not reach the significant level which was ˂0.017. However, 
there was no significant difference between serum 25(OH)D levels at three 
weeks and after six weeks (P 0.043). Calcium level did not change 
significantly after the supplementation. Although EFV1% and FVC% slightly 
improved after the supplement, no significant differences were observed 
between the three visits, FeNO was significantly increased after 
supplementation (Table 4.4). 
 
Table 4.4. Effect of a single high dose vitamin D supplement on serum 25(OH)D 
and asthma outcomes after three and six weeks (means±SD), n=7 
Variables 
 
Baseline 
n=7 
After 3 weeks 
n=7 
After 6 weeks 
n=7 
P value 
25(OH)D (nmol/l) 
Calcium (mmol/l) 
FEV1 (%) 
FVC (%) 
FeNO (ppb) 
17.4±7.8 
2.22±0.06 
72.7±22.7 
77.1±19.2 
25.4±14 
45.7±14.8 
2.23±0.13 
85.7±11.0 
90.7±14.0 
34.1±19.3 
38.5±11.7 
2.22±0.05 
80.4±18.8 
92.6±15.8 
33.7±18.0 
0.002* 
0.651 
0.104 
0.158 
0.034* 
                        *Significant change, Friedman test  
 
Due to the small number of participants who complete both the three 
week visit and the six week visit, analysis was undertaken to assess the 
effect of supplementation within participants who completed the three 
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weeks visit only (n=15; Table 4.5). Serum 25(OH)D increased significantly (P 
0.001) after three weeks of the single high dose of oral vitamin D3. FEV1% 
was improved after three weeks, although this was not significant; 
moreover, FVC% was significantly improved (P 0.023) after three weeks. 
FeNO levels were also significantly increased (P 0.004).  
 
Table 4.5. Effect of a single high dose of vitamin D supplement on serum 25(OH)D 
and asthma outcomes after three weeks (means±SD), n=15 
Variables 
 
Baseline 
n=15 
After 3 weeks 
n=15 
P value* 
25(OH)D (nmol/l) 
Calcium (mmol/l) 
FEV1 (%) 
FVC (%) 
FeNO (ppb) 
21.9±12.0 
2.23±0.07 
82.4±19.0 
87.8±18.0 
25.7±18.0 
52.1±16.0 
2.25±0.11 
86.0±11.0 
98.0±14.0 
37.0±21.0 
0.001* 
0.683 
0.637 
0.023* 
0.004* 
         * Significant differences, Wilcoxon signed rank test  
 
 
4.4.2. Effect of a continuous low dose of vitamin D supplement on serum 
25(OH)D concentration and asthma outcomes  
Nine participants completed the study at three weeks and six weeks in the 
low dose group. Serum 25(OH)D concentration increased significantly after 
supplementation (P 0.002; Table 4.6). Post-hoc analysis with Wilcoxon 
singed rank test conducted with a significant level at ˂0.017 showed that 
the increase was significant only between the baseline and after six weeks 
of supplementation (P 0.008). Calcium levels did not change significantly 
after the supplementation. In addition, there was no significant change in 
lung function (Table 4.6).  
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Table 4.6. Effect of a continuous low vitamin D supplement dose on serum 
25(OH)D and asthma outcomes after three and six weeks (means±SD), n=9 
Variables 
 
Baseline 
n=9 
After 3 weeks 
n=9 
After 6 weeks 
n=9 
P value 
25(OH)D (nmol/l) 
Calcium (mmol/l) 
FEV1 (%) 
FVC (%) 
FeNO (ppb) 
31.2±17.2 
2.22±0.11 
72.3±15.5 
79.0±13.0 
49.8±58.5 
38.7±13.0 
2.20±0.06 
71.8±17.0 
80.1±13.5 
57.4±56.5 
46.9±17.7 
2.21±0.05 
71.0±17.5 
83.2±19.0 
52.2±45.0 
0.002* 
0.347 
0.459 
0.368 
0.490 
                 *Significant change, Friedman test 
 
Due to the small number of participants who completed the three week 
visit and the six week visit, analysis was undertaken to assess the effect of 
supplementation within participants who completed the three weeks visit 
only (n=17; Table 4.7). Serum 25(OH)D increased after three weeks of the 
continuous low dose of oral vitamin D3, although the different was not 
significant (P 0.076). Lung function improved after three weeks, although 
this was not significant.   
 
Table 4.7. Effect of a continuous low vitamin D supplement dose on serum 
25(OH)D and asthma outcomes after three weeks (means±SD), n=17 
Variables 
 
Baseline 
n=17 
After 3 weeks 
n=17 
P value* 
25(OH)D (nmol/l) 
Calcium (mmol/l) 
FEV1 (%) 
FVC (%) 
FeNO (ppb) 
36.0±21.5 
2.22±0.1 
77.3±14.5 
82.0±12.0 
42.8±44.4 
40.6±15.3 
2.22±0.07 
79.1±15.7 
86.5±13.0 
45.8±43.5 
0.076 
0.448 
0.139 
0.064 
0.794 
                               *Wilcoxon singed rank test  
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The change in serum 25(OH)D concentration between the baseline and 
three weeks in HDG was 28.3±11.6 nmol/l. However after six weeks the 
concentration decreased by 7.2±8 nmol/l from the three weeks. The 
change in serum 25(OH)D concentration between baseline and three 
weeks in LDG was 7.5±7.8 nmol/l and increased from three weeks to six 
weeks by 8.1±13.6 nmol/l. The change in 25(OH)D was significantly higher 
in HDG than LDG after three weeks (P 0.001). However, the change was 
higher in LDG than HDG after six weeks (P 0.003).  
Comparing the change in serum 25(OH)D from baseline and six weeks, it 
was found that no significant difference (P 0.174) between HDG and LDG 
(21.1±11.3 and 15.6±18.6) nmol/l respectively. 
The change in FVC% between baseline and three weeks in HDG was 
+13±20.5 % and the level slightly increased from three weeks to six weeks 
by 2.4±16 %. The change in LDG was 1.1±10 % after three weeks and 
increased from three weeks to six weeks by 3.1±11.9 %. No significant 
differences were found between the change in FVC% from baseline and 
after three weeks in both groups (P 0.351), or between three weeks and six 
weeks (P 0.536). The change in FVC% between baseline and six weeks is 
higher in HDG (15.4±12.8) % than in LDG (4.2±17.0) %, although this 
difference was not significant (P 0.174).   
 
4.5. The correlation between serum 25(OH)D and lung function after 
supplementation 
There were no significant correlation between serum 25(OH)D and lung 
function after vitamin D supplementation in both groups; HDG and LDG. 
However, a positive correlation was found between serum 25(OH)D and 
FVC after three weeks in LDG but this did not reach the significance level (r 
.619 P 0.075) 
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4.6. Discussion  
The present study aimed to investigate the effect of oral vitamin D3 
supplements, in a continuous low dose or in a single high dose on serum 
25(OH)D concentration and lung function (including FEV1 and FVC and 
airway inflammation), among adult asthma participants in Saudi Arabia. It 
was aimed to recruit at least 17 participants in each supplementation 
group. However, 32 participants in total from the 62 participants who 
participate in the first study agreed and completed the intervention study, 
moreover, only 16 participants in total completed the six weeks. This large 
drop-out percentage can be explained by the new virus (Coronavirus) that 
was spreading among health care providers and hospitals in Saudi Arabia in 
the same period as the study. Thus a large number of participants were 
anxious to come to the clinic for the study visits as a result.   
Present findings shows that after six weeks of the oral vitamin D3 
supplements given either as a single high dose or continuous low dose 
significantly increased 25(OH)D levels. In the present study both 
supplements were in D3 form. Vitamin D3 supplement is more effective 
and has more stability than D2 form. Houghton and Vieth (2006), gave 
possible mechanisms that could explain the greater effect of D3 than D2 on 
raising serum 25(OH)D concentration. Firstly, the component 25(OH)D2 has 
less affinity to the DBP, resulting in a shorter half-life when compared to 
25(OH)D3 and the enzyme 25-hydroxlase from the liver has higher affinity 
to the D3 form than vitamin D2. Also vitamin D3 and its metabolites have 
more affinity to the VDR. In addition, 25(OH)D2 metabolism is faster than 
25(OH)D3 to produce the component 24(OH)D.   
The single dose group had an average increase of 28 nmol/l at three weeks, 
and then the level decreased from three weeks by 7nmol/l after an 
additional three weeks. Similarly, Mallet and colleagues (2010) found that 
an average increase in 25(OH)D concentration in adolescents was 32nmol/l 
after two weeks of administrating an oral dose of 200 000 IU vitamin D3 
111 
 
supplements but the 25(OH)D concentration then decreased by 39 nmol/l 
after three months of supplementation. In addition, Stern et al, (1981) 
showed that adults receiving a 400 000 IU vitamin D supplement had 
increased serum 25(OH)D by 53 nmol/l after four days only, suggesting that 
the rapid increase after a high dose can be detected within days. The 
continuous low dose vitamin D3 supplement (800 IU/D) increased 25(OH)D 
concentration by only 7.5 nmol/l at three weeks and remained increased 
by 16 nmol/l after six weeks. A similar study found that a daily dose of 800 
IU oral vitamin D3 supplement increased 25(OH)D by 12 nmol/l after four 
weeks (Freaney et al., 1993).  
The rapid increase in serum 25(OH)D after the high dose at week three and 
the following decrease at week six in the present study, can be explained 
by the half-life of 25(OH)D which has been shown to be between two 
weeks to one month (Holick, 2004; Clements et al., 1992; Vieth, 1999). In 
the first few days of giving an oral vitamin D supplement, the vitamin D3 
converts rapidly to the form 25(OH)D. The following decreased is due to 
the half-life of 25(OH)D, subsequently, 25(OH)D is metabolised and 
converted by the liver to other metabolites such as 24(OH)D and then 
discharged from the body (Romagnoli et al., 2008; Vieth, 1999; Jovicic et 
al., 2012). 
No adverse reactions were observed in any patients in the high dose group. 
Calcium levels were always within the normal range. In very rare cases 
hypercalcemia can occur after a large dose of vitamin D supplement, and 
renal damage, calcium stones, headache and vomiting can results from 
hypercalcemia (Spiro and Buttriss, 2014; Heaney, 2008; see section 1.5.3). 
However, Ilahi et al, (2008) reported that a single dose of oral vitamin D 
containing 100 000 IU is safe and did not lead to toxicity symptoms. 
Vitamin D toxicity is a rare condition because of the homeostasis control 
system which means that serum levels can be maintained within the range 
due to the livers ability to catabolism 25(OH)D and produce other products 
that secreted into the bile (Vieth, 1999).     
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In our study, a trend for improvement in lung function was observed 
including FEV1 and FVC after three weeks of the oral vitamin D supplement 
in both high dose group and low dose group. However, the FVC% increased 
significantly in the HDG after three weeks and was slightly improved in the 
LDG after three weeks. Similarly, a study in Italy found that a higher 
vitamin D level was associated with higher FVC% and FEV1% but was not 
statistically significant (Chinellato et al., 2011). Another study found similar 
results; higher vitamin D concentration was significantly correlated with 
improved FVC (Hagman et al., 2011). 
The positive effects of vitamin D supplementation on the lung function 
could be explained by a number of different mechanisms. Firstly; the 
change in the histological and pathological structure of the lungs is 
supported by animal studies. Zosky and colleagues (2011) measured the 
lung function of mice with vitamin D deficiency and made a histological 
assessment of lung structure and found a decrease in lung volume and lung 
size. Another animal study on rats in China found that vitamin D 
supplements improved pathological changes in the lungs caused by vitamin 
D deficiency (Liu et al., 2009). Secondly, the effect of vitamin D on the 
respiratory infection and reduced airway inflammation can lead to better 
lung function (Iqbal and Freishtat, 2011; Sandhu and Casale, 2010). Thirdly, 
reducing airway hyper-responsiveness by decreasing the histamine levels 
can lead to better lung function (Bradding, 2007; Sears, 2007). Finally, the 
effect of vitamin D on the smooth muscle function and airway remodelling 
by reducing smooth muscle cells proliferation (Li et al., 2010).  
In the present study, no significant correlations were found between serum 
25(OH)D and lung function after supplementation in either groups and this 
could be due to small sample size in both groups. However, a positive 
correlation was found between serum 25(OH)D and FVC% after three 
weeks of a continuous low dose vitamin D supplement but did not reach 
significance. The correlation between vitamin D levels and lung function 
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and the effect of vitamin D supplementation on lung function are still 
debatable. 
Many studies have reported positive correlation between higher vitamin D 
status and improved lung function. Data from the Third National Health 
and Nutrition Examination Survey (NHANES) found a strong significant 
correlation between serum 25(OH)D and better FEV1 and FVC (Black and 
Scragg, 2005). Li et al, (2011) found a significant weak positive correlation 
between total 25(OH)D and better FEV1 % in Chinese adults with asthma. 
Another study found an association between higher vitamin D levels and 
FEV1 % in 54 adult patients with asthma (Sutherland et al., 2010). 
However, the effect of vitamin D supplementation on lung function is still 
debatable. Vitamin D supplementation of 100 000 IU per month for a 
period of one year resulted in no significant improvement in FEV1 
compared to a placebo group in 182 COPD patients (Lehouk et al., 2012). In 
a large randomized control trial (VIDA) by Castro et al, (2014), they found 
that vitamin D supplementation of 100 000 IU as a single dose followed by 
a daily dose of 4000 IU for 28 weeks among adult asthma patients did not 
significantly improve lung function or asthma control scores. These 
differences in findings could be due to differences in the baseline 
characteristics of the participants such as different baseline vitamin D 
status, different ethnicity, different duration of supplement and final 
vitamin D levels.   
The increase in FeNO levels after the supplement in our study could be un-
related to the supplementation and could be explained by the three 
sandstorms that occurred in the same period of the study in Jeddah. During 
the period between Februarys to July, sandstorms are very common in 
Saudi Arabia, and two to three sandstorms can happen during this period 
of time per month. Sandstorms in general can cause coughing, wheezing, 
headache, eye irritation and acute asthma attacks in healthy individuals 
who are exposed to the sandstorm for about 30 minutes (Meo et al., 2013). 
During the sandstorm, the air is high in bacteria, fungi, microorganisms and 
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aeroallergens such as Acacia, Alternaria and cat dander. It also can carry 
many other components such as, silica, iron, aluminium and nitrogen 
dioxide NO2 (harmful gas), these components can affect health and cause 
many problems especially to the respiratory system. Asthma symptoms 
and episodes of exacerbation can be triggered by dust and sandstorms 
(Kwaasi et al., 1998; Alangari et al., 2015). Nitrogen dioxide (NO2) can 
increase the level of FeNO and can also convert to Nitric oxide by 
combining with oxygen in the air. Nitric oxide is a free radical and 
atmospheric pollutant (Fedoseev et al., 2015; Grutta et al., 2012).  
The main limitations of this study were: small sample size, few patients 
completed the whole six week intervention, three sandstorms which 
happened at the period of the study that can affect the airway 
inflammation biomarkers of the participants. Obesity can affect vitamin D 
utilization in the body due to storing vitamin D in fat tissues. Compliance 
was not assessed in the low dose group. In addition, the inflammatory 
biomarkers such as eosinophil, IgE and ECP that were measured in study 1, 
were not available for patients after supplementation due to a limited 
budget.        
In a conclusion, oral vitamin D3 supplementation as a single high dose or a 
continuous low dose increased serum 25(OH)D. However, the single high 
dose increased serum 25(OH)D significantly after three weeks. In addition, 
no adverse reactions, such as high calcium levels were observed after the 
single high dose. Increasing levels of 25(OH)D may improve lung function. 
The single high dose improved FVC% significantly but did not affect airway 
inflammation. Sandstorms could be a strong factor contributing to this 
result. Up to this date, this is the first study done to investigate the effect 
of oral vitamin D supplement in two doses on asthma outcomes of Saudi 
adult asthma patients.  
As a practical implication of the study, High dose vitamin D3 could be 
better use to increase serum 25(OH)D levels as it increased serum 25(OH)D 
115 
 
significantly as well as, improving FVC in asthma participants. In addition 
to, there is an advantage of better compliance to the supplement 
(Romagnoli et al., 2008). However, further research needs to be completed 
with a larger sample. Investigating the effect of high dose vitamin D 
supplement on a larger sample size of asthmatic participants while 
monitoring calcium levels and investigating the changes in serum 25(OH)D 
as well as the lung function is needed. 
Treating vitamin D insufficiency by giving a continuous low dose is also 
effective in raising serum 25(OH)D levels, although a high dose followed by 
a maintenance dose could be more effective in severely deficient patients. 
A trend towards lung function improvement with the continuous low dose 
of vitamin D supplement was found in the present study, and a future 
study with a longer supplementation period until reaching the desirable 
level of 25(OH)D could be helpful to investigate any positive effect on lung 
function in adult asthma patients.  
Encouraging people in Saudi Arabia to consume more dietary sources of 
vitamin D is also necessary. As well as, increase the awareness of vitamin D 
function and beneficial effects in the body, along with, advising people who 
are in a risk of vitamin D deficiency to measure the 25(OH)D concentration 
and to reach the desirable level.   
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Abstract  
Background: Globally and locally, vitamin D deficiency is a common health 
issue. Few studies have been done to investigate the effect of vitamin D 
supplementation on asthma. The aim of this study was to investigate the effect of 
different doses of oral vitamin D supplements on lung function and airway 
inflammation in asthmatics.  
Methods: Adult asthma patients were recruited from an allergy and asthma clinic 
in King Abdul Aziz University Hospital in Jeddah. Sixty two patients were 
screened and 32 were randomly enrolled to receive either a single high dose (200 
000 IU, n=15) or low continues dose (800 IU per day, n=17) of vitamin D3 
supplement. Serum 25(OH)D, serum calcium, fractional exhaled nitric oxide 
(FeNO), forced expiratory volume in one second (FEV1) and forced vital capacity 
(FVC) were assessed at the baseline and after three weeks.  
Results: Serum vitamin D increased significantly by 30.21 nmol (from 
21.88±11.85 to 52.10±16.46) after three weeks of the high dose supplement 
(p<0.001) and increased by only 4.61 nmol (from 36.01±21.52 to 40.62±15.28) 
after continuous low dose (p=0.071). Predicted FVC improved significantly from 
88.14% to 98.07% (p=0.025) in the high dose group and from 81.94% to 86.47% in 
the low dose group (p=0.06). Predicted FEV1 increased from 81.64% to 86.07% 
and from 77.29% to 79.12% respectively. Calcium level did not differ in both 
groups. FeNO level (inflammatory biomarker) increased significantly from 26.29 
ppb to 37ppb (p=0.016) after the high dose supplement and increased from 42.82 
ppb to 45.82 ppb (p=0.607) after the low dose.  
Conclusion: Vitamin D deficiency is common in asthmatics from Saudi Arabia. 
Oral high dose vitamin D intake is safe and well tolerated in deficient patients and 
could be helpful in improving lung functions but not inflammatory marker. 
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Chapter 5 
Dietary intervention and lung function among healthy adults in 
the UK 
 
5.1. Justification and aims  
Very small quantities of vitamin D are present in food, the main food 
sources being oily fish such as salmon and, sardines, and to a much lesser 
extent, egg yolk and fortified foods. Vitamin D is mainly obtained through 
exposure of the skin to ultraviolet-B (UVB) radiation. Vitamin D is essential 
for optimal bone mineralization but recently it has also been found to play 
an important role in lung function and development and have a positive 
effect on immune functions (Hewison, 2012). Vitamin D deficiency is a 
global issue, especially during the winter in regions with high latitude such 
as the United Kingdom. In the UK, continuous synthesis of vitamin D from 
the UVB is not sufficient for approximately half of the year (Macdonald et 
al., 2008). Thus, in the winter months, foods rich in vitamin D become the 
only natural source of this micronutrient. 
Lung function is not only affected by asthma or other lung disease, it can 
also be affected by age in healthy individuals. FEV1 can be standardized in 
healthy people at age 25 years and then it could start to be declined 
(Calveley, 2015). The decline in lung function could be observed due to 
respiratory system anatomical, physiological and immunological changes 
associated with age (Goodwin, 2006). Previous studies estimated the 
decline in lung function in healthy individuals by 22 ml per year compared 
to 38 ml per year among people with asthma (Sears, 2007). In other study 
carried out in the USA among individuals from 18-30 years and followed up 
for 10 years, they found a decline in FEV1 by 8.5% in non-smokers healthy 
people compared to 10.1% in asthmatic people who are non-smokers 
(Apostol et al., 2002). On the light of above, we hypothesised that raising 
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vitamin D concentration could also lead to improve lung function in healthy 
individuals due to its effect on reducing lung remodelling.   
Studies that have explored the relationship between vitamin D status and 
lung function have tended thus far to be observational (Ji et al., 2010; 
Devereux and Wagner, 2011; Bozzetto et al., 2012). Associations in such 
studies may be highly susceptible to confounding bias or even reverse 
causation, therefore an experimental study design is warranted. In our 
previous study on asthma participants in Saudi Arabia (study 2), we 
examined the effects of an oral vitamin D supplement with different doses 
on serum 25(OH)D levels, lung function and airway inflammation among 
adults with asthma. We found that continuous low dose or single high dose 
of vitamin D increased 25(OH)D levels and increasing 25(OH)D improved 
FVC but not airway inflammation.  
A healthy diet has become a point of interest for individuals and people 
may prefer to obtain their vitamin and mineral needs from a healthy diet 
instead of using pharmacological supplementation. In this proposed study, 
we aimed to investigate the effect of consuming 15µg of vitamin D from 
dietary sources for three weeks on serum 25(OH)D level after the winter 
months and lung function including FEV1, FVC and FeNO. The specific 
objectives of this study were:  
1- To estimate the dietary vitamin D intake in healthy adults living in the UK 
2- To investigate the feasibility of consuming 15 µg of vitamin D daily for 
three weeks from food sources only 
3- To examine the effect of consumption of 15 µg of vitamin D from diet for 
three weeks on serum 25(OH)D levels  
4- To examine the effect of consumption of 15 µg of vitamin D from dietary 
sources for three weeks on lung function and airway inflammation  
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5.2. Participants baseline characteristics  
Forty-seven participants responded to the study advertisement and each 
participant signed an informed consent form before taking part in the 
study. Forty-two participants completed the study. Five were excluded 
from the study for a number of reasons: 
• One participant had a BMI greater than 30 kg/m². 
• One participant did not attend their second visit due to University 
exams 
•  One participant failed to complete the dietary intervention 
•  One participant had difficulties with transport. 
• One participant had an extremely high level of FeNO and was 
advised to visit their GP, they was subsequently diagnosed with 
asthma 
Of the 42 participants who completed the study visits, 21 were randomized 
to the control group (5 males, 16 females) and 21 were randomized to the 
dietary intervention group (11 males, 10 females). 
The mean age of the participants was 29±6.6 years. Sixteen participants 
(38%) were males and 62% were females. All of participants were healthy 
and were not taking any medication or dietary supplements. The World 
Health Organization (1946) defines health as “a state of complete physical, 
social and mental well-being, and not merely the absence of disease or 
infirmity”. In our study we asked participants if they suffer from any acute 
or chronic diseases, or had any diagnosed psychological disorder or if they 
were on any medication. If they did not have any diseases and were not on 
any medication, they were considered healthy and included in the study. 
Using the IPAQ tool to assess the physical activity of the participants, it was 
found that the majority of the participants were moderately active (58%) 
followed by very active (22%) and (19%) were inactive. 
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5.2.1. Baseline body weight status  
At the baseline, 60% of the participants had normal BMI and 40% were 
classified as overweight. Significant differences were found in weight, BMI, 
waist and hip circumference between participants in the (control group) CG 
and the (intervention group) IG (Table 5.1). However, these differences 
were only found among female participants (Table 5.2). No association was 
found between baseline serum 25(OH)D levels and weight (P 0.941), BMI (P 
0.292), IPAQ score (P 0.288) or fat percentage (P 0.352). 
Table 5.1. Physical characteristics of the participants in the control (CG) and 
intervention (IG) groups at baseline (means±SD) 
Variables CG,(n=21) IG,(n=21) P value  
Weight (kg)  
Height (cm) 
BMI (kg/m²) 
Fat percentage (%) 
Waist circumference (cm) 
Hip circumference (cm) 
Waist/Hip (ratio) 
63.0±10.0 
165.0±8.0 
23.1±3.0 
25.4±7.3 
74.3±8.0 
99.5±7.0 
0.74±0.1 
71.0±8.0 
168.0±8.6 
25.4±2.5 
23.7±11.0 
79.4±6.0 
104.4±6.3 
0.76±0.1 
0.004* 
0.246 
0.010* 
0.552 
0.032* 
0.029* 
0.380 
* Significant difference, Independent t-test used to compare the variables between control group and 
intervention group 
Table 5.2. Physical characteristics of males and females in the control group (CG) 
and intervention group (IG) at baseline (means±SD) 
Variables Males Females 
CG,(n=5) IG,(n=11) P value  CG,(n=16) IG,(n=10) P value  
Weight (kg)  
Height (cm) 
BMI (kg/m²) 
Fat percentage (%) 
Waist circumference (cm) 
Hip circumference (cm) 
Waist/Hip (ratio) 
73.4±9.6 
175.0±3.3 
24.0±3.0 
19.0±6.0 
83.0±7.4 
102.6±8.0 
0.80±0.2 
73.5±8.0 
173.5±7.0 
24.4±2.4 
15.0±5.3 
82.3±5.0 
102.8±7.0 
0.80±0.1 
0.993 
0.551 
0.780 
0.196 
0.854 
0.964 
0.734 
59.5±7.5 
161.6±5.7 
22.8±3.0 
27.5±6.6 
71.0±6.0 
98.3±6.4 
0.72±0.02 
67.0±7.0 
161.5±5.7 
26.4±5.3 
34.0±5.3 
76.2±6.2 
106.0±5.5 
0.72±0.06 
0.004* 
0.979 
0.002* 
0.013* 
0.064 
0.006* 
0.744 
           * Significant difference, Independent t-test used to compare the variables between males and females in 
both groups 
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5.2.2. Sunlight exposure pattern  
Using the Fitzpatrick skin type scale, most participants were classified as 
type 2 or type 3 skin colour. Twelve percent of the participants were having 
less than 10 minutes per day exposure to sunlight and 45% were exposing 
only their face and hands to sunlight (in the winter months) and 36% of 
participants were typically wearing a hat or hijab. Forty-seven percent 
reported having painful sunburn 1-2 times during the previous summer. 
Females in general applied sunscreen more often than males (Table 5.3) 
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Table 5.3. Sunlight exposure pattern of the participants in the control (CG) and 
intervention (IG) groups 
Sunlight exposure patterns All participants = 42 
n (%) 
CG = 21 
n (%) 
IG = 21 
n (%) 
Fitzpatrick skin colour types 
       Type 1 
       Type 2 
       Type 3 
       Type 4  
       Type 5 
       Type 6 
 
4 (10%) 
15 (36%) 
17 (41%) 
4 (10%) 
1 (2%) 
1 (2%) 
 
4(19%) 
6(29%) 
8(38%) 
3(14%) 
0 
0 
 
0 
9 (43%) 
9 (43%) 
1 (5%) 
1 (5%) 
1 (5%) 
Time exposing to the sunlight per 
day (by minutes)  
 
Less than 10 minutes  
       11-20 minutes  
       21-30 minutes  
       30-45 minutes  
       46-60 minutes  
       60-120 minutes 
       More than 120 minutes   
 
 
 
 
5 (12%) 
7 (17%) 
4 (10%) 
12 (29%) 
3 (7%) 
6 (14%) 
5 (12%) 
 
 
 
 
3 (14%) 
4 (19%) 
2 (10%) 
6 (29%) 
1 (5%) 
3 (14%) 
2 (10%) 
 
 
 
2 (10%) 
3 (14%) 
2 (10%) 
6 (29%) 
2 (10%) 
3 (14%) 
3 (14%) 
Parts of body usually exposed to 
the sunlight  
 
       Face only  
       Face and hands 
       Face, neck and hands  
       Face, neck and arms  
       Face, neck, arms and mid legs 
 
 
 
4 (10%) 
19 (45%) 
9 (21%) 
8 (19%) 
2 (5%) 
 
 
 
 
3 (14%) 
9 (43%) 
5 (24%) 
3 (14%) 
1 (5%) 
 
 
 
 
1 (5%) 
10 (48%) 
4 (19%) 
5 (24%) 
1 (5%) 
How often do you apply sunscreen? 
       Never  
       Occasionally  
       Most days  
       Every day  
 
 
15 (36%) 
16 (38%) 
5 (12%) 
6 (14%) 
 
5 (24%) 
7 (33%) 
4 (19%) 
5 (24%) 
 
10 (48%) 
9 (43%) 
1 (5%) 
1 (5%) 
Spend time in the sunlight for 
getting a tan 
       Never  
       Rarely  
       Sometimes 
       Often  
 
 
 
27 (64%) 
5 (12%) 
5 (12%) 
5 (12%) 
 
 
10 (48%) 
3 (14%) 
4 (19%) 
4 (19%) 
 
 
17 (81%) 
2 (10%) 
1 (5%) 
1 (5%) 
 
In the present study, daily sun exposure during the period between the 
second visit and the third visit were also estimated for each participant. 
Most of the days in the period of the study were cloudy and rainy. 
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However, the average minutes reported during the three weeks between 
the visits were calculated only if the weather was sunny. There was no 
difference in sunlight exposure between participants in the control group 
and in the intervention group (221±193 minutes and 387±331 minutes, 
respectively; P 0.175). Conducting this dietary intervention study in the 
winter months was to minimize the effect of sunlight on vitamin D status. 
No association was found between baseline 25(OH)D levels and sun-
exposure in minutes (r .060 P 0.706) or skin colour type (r -.070 P 0.661). 
 
5.2.3. Baseline lung function  
The mean forced expiratory volume in one second (FEV1) for the total 
sample at the baseline was 3.0±0.4 L (89.3±17 %) and the mean forced vital 
capacity (FVC) was 3.7±0.9L (92.5±21.7 %). The normal average of FEV1 % 
and FVC% is 80 % or above (Bellamy et al., 2005). The mean fractional 
exhaled nitric oxide level was 20.3±11 ppb. No significant differences were 
observed between the CG and IG (Table 5.4).  
 
Table 5.4. Lung function and FeNO levels among CG and IG at the baseline 
(means±SD) 
Variables CG,(n=21) IG,(n=21) P value 
FEV1 (L) 
FEV1% 
FVC (L) 
FVC% 
FEV1/FVC ratio 
FeNO ppb 
3.0±0.3 
92.2±17.4 
3.5±0.7 
94.2±21.0 
98.2±13.4 
22.0±13.0 
3.1±0.5 
86.3±17.0 
3.8±1.0 
91.0±22.8 
93.6±16.4 
18.6±8.5 
0.184 
0.268 
0.196 
0.630 
0.317 
0.338 
      *Independent t- test used to compare variables (FEV1%, FVC%, FEV1/FVC ratio) between groups 
      *Mann-Whitney test used to compare FeNO between groups  
 
5.2.4. Baseline vitamin D levels  
Vitamin D levels were assessed using serum levels of 25(OH)D and dietary 
intake estimation. Dietary intake was estimated at the baseline with FFQ 
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and a four-day diet record. Mean dietary vitamin D intake for all 42 
participants was 4.2±3.3 µg per day estimated by the FFQ. Ninety-five 
percent of the participants consumed less than 10 µg of vitamin D daily 
which is the daily requirement in the UK (SACN, 2016). Only two 
participants consumed the daily recommendation 10-15 µg. Seventy-three 
percent of the participants consumed less than 5 µg of vitamin D per day. 
Mean average dietary vitamin D intake measured by the 4-day diet record 
was 2.4±1.8 µg per day. No significant difference was found between the 
intakes of vitamin D estimated by FFQ between males and females (P 
0.404) or by 4-day diet record (P 0.233). 
At baseline, no differences were found in serum 25(OH)D, dietary vitamin 
D intake estimated by FFQ or by four-day record between participants in 
the CG and IG (Table 5.5). 
Table 5.5.Baseline serum 25(OH)D and dietary vitamin D intake in the CG and IG 
(means±SD) 
                           *Mann-Whitney test used to compare serum 25(OH)D, and dietary intake between the groups 
 
In all participants, estimated dietary vitamin D intake determined by the 4-
day diet record was significantly lower than the intake estimated by the 
FFQ (P ˂0.001) by Wilcoxon Signed rank test. However, Spearman rank 
correlation showed a significant correlation between the two methods, the 
FFQ and the 4-day diet record (r= 0.655, P <0.001; Figure 5.1).  
 
 
Vitamin D status CG,(n=21) IG,(n=21) P value 
Serum 25(OH)D (nmol/l) 
Dietary vitamin D by FFQ (µg/d) 
Dietary vitamin D by 24-h recall 
(µg/d) 
35±25 
3.8±3.0 
2.6±1.8 
40.2±39 
4.7±3.7 
2.2±1.6 
0.970 
0.270 
0.555 
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Figure 5.1. Correlation between dietary vitamin D intake estimated by the FFQ 
and the 4-day record  
 
Baseline mean serum 25(OH)D of all participants was 37.7±32.4 nmol/l. 
Vitamin D status is classified a deficiency if the 25(OH)D is <30 nmol/l, 
insufficiency if the level is between 30-50 nmol/l and sufficient at >50 
nmol/l. Fifty-five percent of the participants at the baseline were deficient, 
19% were classified as insufficient and 26 % had normal serum vitamin D 
level (Table 5.6). 
 
Table 5.6. Vitamin D status according to serum 25(OH)D levels among control (CG) 
and intervention groups (IG) at baseline  
Vitamin D status  All,(n=42) 
n (%) 
CG,(n=21) 
n (%) 
IG,(n=21) 
n (%) 
Deficiency , 25(OH)D <30 nmol/l 
Insufficiency , 25(OH)D =30-50 nmol/l 
Sufficient , 25(OH)D >50 nmol/l 
23 (55%) 
8 (19%) 
11 (26%) 
10 (48%) 
6 (29%) 
5 (24%) 
13 (62%) 
2 (10%) 
6 (29%) 
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There was a weak positive correlation between dietary vitamin D intakes 
estimated by the 4-day diet record and serum 25(OH)D levels (r 0.483 P 
0.002). No correlation was found between dietary intake of vitamin D 
estimated by FFQ and serum 25(OH)D (r 0.288 P 0.071). 
 
 
Figure 5.2. Correlation between serum levels of vitamin D and dietary intake (4-
day record) 
 
5.3. Effect of dietary intervention on serum 25(OH)D levels 
The consumption of a 15 µg of daily dietary vitamin D for three weeks 
increased the level of 25(OH)D significantly from the baseline (P 0.002; 
Table 5.7). There was no difference between serum 25(OH)D at baseline 
and after three weeks in the CG. The change in 25(OH)D was significantly 
higher in IG than CG (7.7±11.1 nmol/l and -1±4.7 nmol/l) respectively (P 
˂0.001).  
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Table 5.7. Serum 25(OH)D levels (nmol/l) at baseline and after three weeks 
(means±SD) 
Groups 
 
Baseline After 3 weeks P value 
CG, n=21 
 
IG, n=21 
 
35±25 nmol/l 
 
40.2±39.2 nmol/l 
34±24.2 nmol/l 
 
48±34.4 nmol/l 
0.366 
 
0.002* 
                 *Significant difference by Wilcoxon Signed Rank test comparing vitamin D at baseline and after 3 weeks  
 
Vitamin D deficiency among the participants was also reduced from 52 % 
to 33 % in IG while the percentage did not change after three weeks in CG 
(Table 5.8). 
 
Table 5.8. Vitamin D status according to serum levels at baseline and after three 
weeks  
 
Vitamin D status 
CG,(n=21) IG,(n=21) 
Baseline 
n (%) 
After 3 
weeks 
n (%) 
Baseline 
n (%) 
After 3 
weeks 
n (%) 
Deficiency,25(OH)D  <30 nmol/l 
Insufficiency,25(OH)D = 30-50 nmol/l 
Sufficiency, 25(OH)D >50 nmol/l 
10 (48%) 
6 (29%) 
5 (24%) 
9 (43%) 
6 (29%) 
6 (29%) 
13 (62%) 
2 (10%) 
6 (29%) 
8 (38%) 
6 (29%) 
7 (33%) 
 
To ensure compliance to the dietary intervention, each participant who 
was enrolled into IG filled out a short questionnaire after the three weeks 
of the dietary intervention (Appendix 19). Seventy-five percent of the 
participants had consumed 100 % of the provided food items, 20% 
consumed 80-100 % of the foods and 5 % consumed 60 % of the provided 
foods. The type of food items that were provided to the participants was 
not easy to consume for 20 % of the participants and the amount of 
provided food items was difficult to consume for 35 %. The dietary items 
most preferred were beverages (all types) followed by the flavoured 
yogurt; the most disliked foods were the cheese fingers and canned 
sardines.  
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5.4. Effect of the dietary intervention on lung function  
After three weeks of dietary intervention, no significant difference in lung 
function was found between CG and IG (Table 5.9). However, FVC (L) in IG 
was higher than CG after dietary vitamin D intervention for three weeks.   
 
Table 5.9. Lung function after three weeks of the intervention in CG and IG 
(means±SD), differences between groups 
Variables CG,(n=21) IG,(n=21) P value 
FEV1 (L)   
FEV1% 
FVC (L) 
FVC% 
FEV1/FVC ratio 
FeNO (ppb) 
3.1 ± 0.3 
94.6 ± 16.7 
3.6 ± 0.6 
96.5 ± 20.6 
98.1± 15.8 
19.2 ± 5.1 
3.3 ± 0.5 
90.9 ± 9.2 
4.2 ± 0.9 
98.1 ± 15.2 
94.1 ± 12.3 
18.8 ± 8.9 
0.073 
0.385 
0.031* 
0.781 
0.372 
0.319 
*Independent t-test used to compare variables (FEV1%, FVC%, FEV1/FVC ratio) between groups 
 *Mann-Whitney test used to compare FeNO between groups  
 
 
No significant differences were found in FEV1 (L), FEV1 %, FVC (L) and FVC 
% after three weeks of dietary intervention in IG (Table 5.10). However a 
trend of increase in FVC % was found after intervention in the IG. The 
changes in FEV1 % and FVC % between CG and IG after three weeks were; 
for FEV1 % (2.33±12.2 % in CG and 4.7±13.4 % in IG, P 0.920) and for FVC % 
(2.33±17.7 % in CG and 7.2±17 % in IG, P 0.513).   
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Table 5.10. Lung function and FeNO at the baseline and after three weeks, 
differences within the group   
Variables CG IG 
Baseline After 3 
weeks 
P value Baseline After 3 
weeks 
P 
value 
FEV1 (L) 
FEV1 % 
FVC (L) 
FVC % 
FEV1/FVC ratio 
FeNO (ppb) 
3.0±0.3 
92.2±17.3 
3.5±0.7 
94.2±20.9 
98.2±13.4 
22.0±12.8 
3.1±0.3 
94.6±16.7 
3.6±0.6 
96.5±20.6 
98.0±15.8 
19.2±5.1 
0.269 
0.390 
0.327 
0.553 
0.960 
0.371 
3.1±0.5 
86.3±16.6 
3.8±1.0 
91.0±22.8 
93.6±16.4 
18.6±8.5 
3.3±0.5 
91.0±9.2 
4.2±0.9 
98.1±15.2 
94.1±12.3 
18.8±8.9 
0.169 
0.135 
0.086 
0.066 
0.896 
0.900 
*Pared sample t-test used to compare variables (FEV1, FEV1%, FVC, FVC%, FEV1/FVC ratio) pre and post-
intervention 
*Wilicoxon Singed Rank test used to compare FeNO pre and post-intervention 
 
There was a trend for improvement in FEV1 % and FVC % in participant 
who had higher serum 25(OH)D at baseline (Table 5.11). Although there 
was a trend of improvement in lung function with higher vitamin D levels 
there was no significant correlation between lung function and 25(OH)D 
levels at the baseline for FEV1 % (r 0.241 P 0.125), FVC % (r 0.245 P 0.117), 
and FeNO (r 0.187 P 0.235). 
 
Table 5.11. Lung function and FeNO in the different vitamin D groups (means±SD) 
Variables 
Means 
Vitamin D deficiency 
25(OH)D <30 nmol/l 
n= 23 
Vitamin D insufficiency 
25(OH)D 30-50 nmol/l 
n= 8 
Vitamin D sufficiency 
25(OH)D >50 nmol/l 
n= 11 
P value 
FEV1% 
FVC% 
FeNO 
25(OH)D 
85±20 
87±24 
20.3±13 
5.9±2.8 
90.6±11.5 
94±14 
19.9±8.3 
16.7±1.6 
97±12 
101.6±20 
20.5±8 
33±12 
0.090 
0.249 
0.666 
˂0.001 
       *Kruskal-Wallis test used to compare variables between groups 
 
5.5. Discussion 
The UK Nutrient and Food based guidelines (2007) stated that most of 
healthy individuals are able to consume their daily dietary requirements 
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through healthy and balanced diet (Food Standards Agency, 2007). 
However, Vitamin D presents itself in very few foods and many people do 
not consume the daily recommended amount (Spiro and Buttriss, 2014; 
O´Connor and Benelam, 2011). The prevalence of vitamin D deficiency in 
high latitude countries such as the United Kingdom is high, especially in 
the winter months. Lack of sun-exposure and low dietary intake of 
vitamin D can lead to vitamin D insufficiency or deficiency levels 
(Cashman and Kiely, 2014).  
Vitamin D status is affected by seasons and in the Northern hemisphere, 
between October and March, vitamin D synthesis via sunlight is not enough 
to supply the amount needed per day and dietary intake becomes the only 
source of vitamin D (O´Connor and Benelam, 2011). The present study was 
conducted between February and April 2015. Measuring serum 25(OH)D at 
this period reflects vitamin D status after the winter months. The study 
aimed to minimize the effect of sunlight synthesis of vitamin D during the 
dietary intervention to better detect the effect of dietary sources of 
vitamin D on raising serum 25(OH)D.  
In this study the aim was to estimate the dietary intake of vitamin D and to 
measure serum 25(OH)D levels among healthy people living in the UK. In 
addition, to investigate whether consumption of daily 15 µg of vitamin D as 
a dietary intervention for three weeks will increase serum 25(OH)D levels 
significantly and improve lung function and airway inflammation marker 
post-winter. 
In the present study it was found that the daily vitamin D intake from diet 
measured by FFQ and by 4-day dietary record ranged from 2.4 µg to 4.2 
µg per day in healthy adults. Similarly, a previous study found that dietary 
vitamin D intake in Aberdeen and Surrey ranged from 80 to 100 IU (2.0 µg 
- 2.5 µg) per day (Macdonald et al., 2011). Two large studies in the UK 
reported that daily dietary intake of vitamin D in the UK population is 
about 2-3µg per day. They also found that the intake among men was 
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higher than women at 3.7 µg and 2.8 µg respectively. Older individuals 
(above 65) consumed slightly higher amounts of vitamin D than younger 
adults (4.1 µg for men and 2.9 µg for women) per day (Mavroeidi et al., 
2010; Gregory et al., 2000). Moreover, the UK NDNS study found that the 
mean intake of vitamin D in Irish adults was 4.2 µg per day (Gregory et al., 
2000). 
Although there are no daily recommendations for vitamin D intake for 
adults in the UK, the SACN stated that from 9 µg to 12 µg per day of dietary 
vitamin D is needed in winter to maintain serum 25(OH)D at 25 nmol/l or 
above (Buttriss, 2015). The US recommended dietary allowance (RDA) of 
vitamin D for healthy adults is 600IU (15 µg) per day and the estimated 
average requirement (EAR) is 400 IU (10 µg) per day (Ross et al., 2011). 
Vitamin D intake from food is therefore generally not enough to 
compensate for lack of continuous synthesis in winter. 
Low dietary intake of vitamin D could be due to number of reasons: few 
foods that are high vitamin D naturally, the food labels that shows the 
vitamin D content in the foods are not always available and the content of 
vitamin D of some foods such as salmon and sardines are not known when 
they were bought fresh from shops. A number of food sources such as 
animal organs are high in cholesterol and people prefer to avoid them from 
their diet. Also, food sources are more expensive than the natural source of 
sunlight exposure (Calvo and Whiting, 2006). Foods that are good source of 
vitamin D are more expensive than oral vitamin D supplementation. In this 
study for example to provide one participant with 15 µg of vitamin D per 
day cost from £ 5-6  (see the list of foods provided, table 2.1 in chapter 2) 
however, the oral vitamin D supplement for example, Fuiltum capsules, 
contain 20 µg per capsule cost £ 3.6  for 30 capsules, and £ 0.12 per 
capsule (BNF, 2016).   
It is difficult to determine the exact amount of vitamin D that is synthesized 
from sunlight. Questionnaires, diaries and specific watches can be used to 
133 
 
estimate vitamin D that is obtained from sunlight exposure (Hoon Lee et 
al., 2012; Rhodes et al., 2010; Webb et al., 2010). In the present study, the 
effect of sun-light exposure was small. Participants were exposed to the 
sunlight for a very short time, exposing small parts of their body to the 
sunlight, as it was winter. The weather during the study period was very 
often cloudy. In a study done in the UK the author stated that in winter, 
people usually only expose face, neck and hands and this equate to 6-10% 
of the body surface area BSA (Diffey, 2013). Exposing 5% of body surface to 
the sunlight can lead to no more than 14 ng/ml of serum 25(OH)D (Davie et 
al., 1982). This support our results that showed low serum 25(OH)D at the 
baseline and there was no increase in serum 25(OH)D levels in the CG who 
did not consume high vitamin D sources after three weeks.  
Lung function slightly improved after increasing 25(OH)D in the 
intervention group. This finding is similar to a large cross-sectional study 
(Berry et al., 2011) done in the UK, which aimed to investigate the 
correlation between 25(OH)D and lung function in adults. They found that 
each 4 ng/ml increase in serum 25(OH)D levels increased FEV1 by 8 ml and 
increased the FVC by 13 ml in British adults. They stated that this 
correlation was not explained by reducing respiratory infection. However, 
they suggested that this positive correlation could be due to the positive 
effect of vitamin D on immunity and reducing inflammation, VDR are 
presents in lung epithelial cells and reduction the proliferation effect of 
airway smooth muscle cells (Berry et al., 2011). Another study done among 
646 elderly disabled women, which aimed to investigate the correlation 
between vitamin D and lung function found that higher 25(OH)D levels 
were associated with higher FEV1 and FVC (Semba et al.,2011).  In our 
study, no significant improvement was found and this could be because 
participants had normal lung function at baseline. We did not find any 
significant improvement in FeNO levels and these findings could also be 
because participants had normal FeNO levels at baseline.  
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In summary, vitamin D deficiency is highly prevalent in the UK population 
after the winter months. Dietary vitamin D intake intends to be low among 
healthy participants living in Oxford. Dietary intervention involving 
consumption 15 µg per day for three weeks increased 25(OH)D levels 
significantly. Moreover, lung function was slightly improved after three 
weeks of vitamin D intervention, but not fractional exhaled nitric oxide. 
However, it was not very easy to consume 15 µg of vitamin D per day via 
diet and it was more expensive when compared to local available oral 
supplements.  
Improving dietary vitamin D consumption from different food sources is 
the most important application of this study, especially after winter 
months as vitamin D levels are low in most healthy individuals in the UK. 
The American Dietary Guidelines (2014) reported that nutritional 
requirements should be obtained from diet. However, oral vitamin D 
supplementation could be also effective to improve 25(OH)D status. 
However, increase the awareness of dietary sources of vitamin D such as 
salmon and sardines is necessary in winter months as vitamin D from 
sunlight exposure is not enough to maintain 25(OH)D concentration at the 
desirable level.    
The main limitations in this study were: short periods of dietary 
intervention due to time restriction (winter months); although all 
participants who were included in the study were living in the UK for at 
least six months, many ethnicities were included which could result in 
different responses to dietary intervention in raising 25(OH)D 
concentration and blood inflammatory biomarkers were not measured to 
give more information about the causality relationship between vitamin D 
and improved lung function. In addition, the FFQ used in this study to 
estimate vitamin D intake was not validated.     
Future studies could investigate the effect of the same dose of vitamin D 
intervention using dietary sources and oral supplementation and to 
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compare the effect in raising serum 25(OH)D concentration between the 
two sources (diet vs supplement). The food frequency questionnaire to 
estimate vitamin D intake validation is also needed. Doing the same study 
with a longer intervention period could be also beneficial to investigate the 
effect at the baseline, after three weeks and after six weeks.      
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Abstract and poster presented in the Annual meeting of the British Society 
of Allergy and Clinical Immunology (BSACI), Telford, 2015 
 
Dietary vitamin D intervention and lung function after the 
winter months 
S. Kokandi and H. Lightowler 
Functional Food Centre, Department of Sport & Health Sciences, Oxford Brookes 
University  
 
Background: Vitamin D deficiency is a common problem, especially after the 
winter months in high latitude countries such as the United Kingdom. It has been 
reported that lower vitamin D levels are associated with lower lung function and 
lung capacity.  
Objectives: (1) to estimate the dietary vitamin D intake and serum 25-hydroxy 
vitamin D (25OHD) levels among healthy adults in the UK; (2) to investigate the 
relationship between vitamin D and lung function in healthy UK adults; (3) to 
investigate the effect of a dietary intervention on serum 25OHD levels and lung 
functions in healthy UK adults.  
Methods: Healthy adult participants were recruited from Oxford Brookes 
University and randomly allocated to either a control group (CG) or intervention 
group (IG). The intervention was consumption of 15 µg/day vitamin D through 
food items for three weeks. Serum25OHD, forced expiratory volume (FEV1%), and 
forced vital capacity (FVC%) were measured. Dietary vitamin D intake was 
estimated using food frequency questionnaire (FFQ).  
Results: Forty-three participants, mean age 29±6.5 years, 21 CG and 22 IG, 
completed the study. At baseline for all participants, mean serum 25OHD was 
15±13 ng/ml, 84% had vitamin D insufficiency (˂25 ng/ml) and mean dietary 
vitamin D intake was 4.2±3.2 µg/D. In the IG, after 3 weeks of diet intervention, 
25OHD increased significantly by 3.1 ng/ml (P=0.001) and lung function improved, 
although changes were not significant: FEV1% was 85%±17 at baseline compared 
to91%±9 after 3 weeks; FVC% was 111%±17 at baseline compared to 112%±14 
after 3 weeks. No differences were found in CG. 
Conclusion: Vitamin D deficiency prevalence is high after winter among healthy 
adults in the UK. Dietary intake may not be adequate to maintain 25OHD levels, 
thus a dietary intervention may be necessary to improve serum vitamin D levels 
and improve lung function. 
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Chapter 6 
Comparison of two methods in measuring serum 25(OH)D 
 
6.1. Justification and aims  
Measuring serum 25(OH)D is important as it is the biological marker for 
vitamin D status in the body (Aspray et al., 2014). Vitamin D deficiency is 
associated with many disorders, particularly osteoporosis and rickets. In 
addition, other diseases have been found to be correlated with vitamin D 
deficiency such as diabetes, cardiovascular diseases, multiple sclerosis and 
asthma (Bischoff-Ferrari, 2010; Wang et al., 2008). Measurement of 
25(OH)D status is needed to investigate deficiency or very rarely toxicity. 
However, 25(OH)D levels are dependent on the test and the analysis 
methods used. Therefore, hospitals laboratories and research laboratories 
need a reliable method to measure 25(OH)D (Black et al., 2015; Kocak et 
al., 2015). 
A number of methods and kits are available to measure serum 25(OH)D 
and its metabolites such as chemiluminescence immunoassays (CLIA), radio 
immunoassay (RIA), enzyme-linked immunosorbent assay (ELISA), high 
performance liquid chromatography (HPLC) and liquid chromatography-
tandem mass spectrometry (LC-MS/MS). However, the two methods that 
are most commonly used in clinics and laboratories are immunoassays and 
HPLC (Wallace et al., 2010; Wootton, 2005). Each of these two methods 
has its strengths and limitations (see section 1.6). The requirements for 
laboratories that measure 25(OH)D are they should provide reliable, 
accurate and valid results and references and have a clear quality control 
systems, evaluation and repair services (Wootton, 2005). Additionally, the 
solutions and reagents need to be readily available and the method needs 
to be undertaken by skilled technicians (Wootton, 2005). 
Chemiluminescence immunoassays are widely used in clinics such as 
orthopedic clinics and endocrinology clinics (Wootton, 2005). The HPLC 
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method is not suitable for routine tests and large number of samples due 
to high cost. However, the HPLC and the LC-MS/MS methods are 
considered the gold standard for measuring 25(OH)D status and give the 
most valid results when compared to other methods (Snellman et al., 
2010). HPLC is also recommended for the UK National Diet and Nutrition 
Survey (Lai et al., 2011).  
In this thesis, for studies completed in chapter 3, chapter 4 and chapter 5, 
serum 25(OH)D status was measured using chemiluminescence 
immunoassays by Cobas (Roche, USA). In this chapter we aimed to 
investigate the agreement of the results of serum 25(OH)D and the data 
from Study 3 (chapter 5) to the gold standard method LC-MS/MS. 
6.2. Samples  
A blood sample was taken and serum samples were extracted from 
participants from Study 3 (chapter 5). Vitamin D levels in 43 healthy 
individuals, 22 in the control group and 21 in the intervention group, were 
measured by chemiluminescence immunoassays at baseline and after 
three weeks of the supplementation. A sample of 4 ml of whole blood was 
taken and serum was separated and collected in 0.5 ml aliquots. One 
aliquot of serum was stored at -40°C for approximately four months until 
the last participant completed the study visits. It has been reported that 
25(OH)D is stable and can be stored for up to a year at -20°C (Wootton, 
2005). Participants were informed that the extra serum would be stored 
and used in the next stage of the study. Each participant signed a consent 
form before taking part in the study. 
A total of 86 serum samples were sent to the Clinical Biochemistry 
Laboratory of City Hospital, Sandwell and West Birmingham Hospitals 
Trust. Here, total vitamin D status including D2 and D3 were measured for 
all samples using water LC-MS/MS. The column used was water Acquity 
UPLC BEH phenyl1,1.7 µm,2.1*50mm. The CV% of the method ranged from 
9% to 21% (Wallace et al., 2010). The lowest value of D2 detectable was 2.8 
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nmol/l. All participants had values less than 2.8 nmol/l, thus, for our 
participants D2 could not be detected.  
6.3. Serum 25(OH)D of participants by the methods  
Table 6.1: 25(OH)D values measured by CILA and LC-MS/MS methods  
Participant´s 
code 
25(OH)D at baseline  25(OH)D after three weeks  
CLIA (nmol/l) LC-MS/MS (nmol/l)  CLIA (nmol/l) LC-MS/MS(nmol/l) 
1 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
20 
21 
23 
24 
25 
26 
27 
28 
29 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
40.1 
95.4 
28.0 
49.9 
7.5 
28.1 
42.3 
7.5 
10.8 
10.9 
11.3 
49.1 
7.5 
150.7 
9.8 
41.6 
12.0 
62.9 
26.0 
93.2 
50.2 
79.3 
22.2 
10.7 
20.6 
19.1 
42.7 
110.6 
14.1 
20.2 
35.2 
7.5 
66.5 
19.3 
62.2 
38.3 
7.5 
7.5 
77.9 
16.3 
17.7 
57.4 
44.1 
39.7 
73.8 
29.8 
38.3 
9.3 
44.3 
43.4 
10.3 
11.2 
10.3 
20.2 
47.5 
11.8 
103.3 
16.2 
41.0 
17.6 
71.9 
28.0 
75.4 
45.0 
87.5 
31.0 
14.5 
24.5 
22.3 
35.3 
92.7 
17.4 
34.7 
30.1 
14.5 
76.7 
35.2 
78.0 
49.5 
14.3 
13.8 
91.1 
34.1 
25.0 
61.4 
61.5 
35.5 
84.2 
43.2 
61.1 
23.5 
35.5 
32.8 
10.4 
7.5 
22.6 
11.8 
50.2 
8.2 
123.8 
12.3 
43.6 
16.3 
58.5 
31.2 
94.0 
42.7 
81.4 
26.8 
11.0 
32.1 
35.6 
53.1 
104.1 
14.7 
14.0 
46.9 
8.1 
88.7 
32.7 
71.2 
35.1 
11.5 
17.6 
87.7 
15.7 
17.8 
52.3 
71.1 
32.6 
71.1 
57.7 
61.9 
48.8 
59.4 
41.9 
25.2 
13.0 
34.6 
23.5 
45.0 
12.4 
93.4 
20.8 
37.0 
17.7 
57.6 
31.3 
78.8 
42.6 
84.8 
39.9 
15.0 
50.7 
65.1 
41.8 
93.6 
29.5 
23.2 
50.5 
11.4 
99.8 
62.9 
79.5 
44.5 
35.5 
40.9 
109.7 
34.2 
35.9 
63.6 
86.2 
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6.4. Correlation between CILA and CL-MS/MS methods 
Strong significant correlations between the two methods were found, using 
Spearman rank correlation, at baseline (r 0.956 P <0.001) and after three 
weeks of the supplementation (r 0.905 P <0.001;  Figure 6.1 and Figure 
6.2).  
 
 
Figure 6.1. Correlation between CLIA method and LC-MS/MS method at baseline  
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Figure 6.2. Correlation between CLIA method and LC-MS/MS method after three 
weeks of supplementation  
 
Despite this strong correlation, it was found that fewer participants were 
classified as vitamin D deficient using the LC-MS/MS method (Table 6.2). 
Classifications of vitamin D status were as following; vitamin D deficiency 
25(OH)D<30 nmol/l, vitamin D insufficiency 30-50 nmol/l and vitamin D 
sufficiency >50 nmol/l (Spiro and Buttriss, 2014). However, these 
differences in vitamin D status classifications were in acceptable 
agreement by Kappa analysis at baseline, (weighted Kappa 0.780, 95%CI 
0.636 to 0.924) and after three weeks of the supplementation (weighted 
Kappa 0.619, 95%CI 0.456 to 0.782). Kappa values from 0.61 to 0.8 indicate 
good agreement (Altman, 1991).  
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Table 6.2: Vitamin D classification of participants using different methods  
Vitamin D 
status 
Baseline, n (%) After 3 weeks, n (%) 
CLIA LC-MS/MS Kappa 
value 
CLIA LC-MS/MS Kappa 
value 
Deficiency 
Insufficiency 
Sufficiency 
23 (54%) 
9 (21%) 
11 (26%) 
17 (40%) 
15 (35%) 
11 (26%) 
 
0.780 
17 (40%) 
12 (28%) 
14 (33%) 
10 (23%) 
15 (35%) 
18 (42%) 
 
0.619 
 
6.5. Agreement between CLIA and LC-MS/MS methods  
A Bland Altman test of the 43 serum samples measured by CLIA and LC-
MS/MS methods shows acceptable agreement at baseline (mean 
difference -2.4 nmol/l, 95% CI -6.06 to 1.30, limits of agreement -25.8 and 
21.08). However, the Passing-Bablok regression analysis (Intercept A -
5.4585, 95% CI -10.2904 to -2.0655, Slope B 1.0982, 95% CI 0.9287 to 
1.2656) shows that there was a systematic difference between the two 
methods (Intercept A not including zero), but there were no proportional 
differences between the two methods (Slope B included 1 value). However, 
there was no significant deviation from linearity by the Cusum test for 
linearity (P 0.82; Figure 6.3). 
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Figure 6.3 Bland Altman test and Passing-Bablok regression analysis between CLIA 
and LC-MS/MS methods at baseline (nmol/l) 
 
 
-30
-20
-10
0
10
20
30
40
50
0 20 40 60 80 100 120 140 160
Mean of CLIA and LC-MS/MS
C
LI
A
 - 
LC
-M
S
/M
S
Mean
-2.4
-1.96 SD
-25.8
+1.96 SD
21.1
144 
 
For the 43 serum samples after three weeks of the supplementation by 
both methods, Bland Altman showed acceptable agreement (mean 
difference -7.6 nmol/l, 95% CI -11.53 to -3.67. limits of agreement -32.6 
and 17.4). Passing-Bablok regression analysis (Intercept A -13.6005, 95% CI 
-21.7865 to -5.6828, Slope B 1.1062, 95% CI 0.9173 to 1.3016) shows that 
that there was a systematic difference between the two method (Intercept 
A not included zero), but there were no proportional differences between 
the two methods (Slope B included 1 value). However, there was no 
significant deviation from linearity by Cusum test for linearity (P 0.33; 
Figure 6.4). 
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Figure 6.4 Bland Altman test and Passing-Bablok regression analysis between CLIA 
and LC-MS/MS methods after three weeks of supplementation (nmol/l) 
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6.6. Discussion  
The present study shows that there was a strong correlation and good 
agreement between the two methods, CLIA and LC-MS/MS. However, 
more participants were classified as vitamin D deficient by the CLIA 
methods but these differences were acceptable by the Cusum test for 
linearity (Kocak et al., 2015).  
Previous studies and reviews have stated that Immunoassays are widely 
used in large laboratories; however, HPLC and LC-MS/MS methods are the 
gold standard for measurement of 25(OH)D levels (Kocak et al., 2015; Lai et 
al., 2011). Despite this, these two methods are not suitable for routine 
clinical investigations or for large sample size studies and laboratories need 
high throughput or with large number of samples. HPLC and LC-MS/MS 
methods are more expensive, have a longer run time, require more well-
skilled trained technicians and they are more complicated when compared 
to other methods (Lai et al., 2011).  
The results of the present study found a strong correlation between the 
CLIA and LC-MS/MS methods. However, the results showed that there 
were differences and variability in assigning vitamin D status between the 
two methods. The LC-MS/MS method tended to give higher values than 
CLIA. In our study we found that CLIA method had lower values of 25(OH)D 
and the average differences were 2.4 nmol/l at baseline and 7.6 nmol/l 
after three weeks of supplementation. The present results are in 
agreement with a study by Lai and colleagues (2011) who found that the 
LC-MS/MS method gave higher 25(OH)D values compared to DiaSorin 
Liaison (Chemiluminescent immunoassay) by 11.6 nmol/l. They also found 
that fewer participants were classified as having vitamin D deficiency when 
LC-MS/MS was used and that the Pearson correlation coefficient between 
the methods was 0.86 (Lai et al., 2011). Another study by Kocak et al (2015) 
found good agreement between CLIA method and LC-MS/MS method in 
measuring 25(OH)D with a mean bias of -14% by the Bland Altman test. 
They also found that CLIA gave lower values of 25(OH)D than LC-MS/MS 
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and more participants were classified as vitamin D deficient with the CLIA 
method (Kocak et al., 2015). Black et al (2015) found the same results, LC-
MS/MS method gave higher values of 25(OH)D (mean of values 65.5±22.7 
nmol/l) when compared to CLIA method (mean of values 54.4±25.6 nmol/l)  
and more participants were classified as vitamin D deficient by CLIA (41%) 
compared to the LC-MS/MS (24%).  
However, a study by Enko et al (2014) found a lower correlation between 
the LC-MS/MS method and CLIA in 133 participants in Austria (r 0.46) and 
they concluded that a standard method is needed in clinical practice. 
Another study curried out in Saudi Arabia found a significant difference 
between values measured by CLIA and by LC-MS/MS methods. They found 
that CLIA gave lower mean values (13.86±12.65 ng/ml) compared to LC-
MS/MS (21.65±13.7 ng/ml) and a low correlation between methods (r 
0.53), as well as more patients were classified as deficient when 25(OH)D 
concentrations was measured by CLIA (81%) compared to LC-MS/MS 
(57%). Moreover, the authors concluded that the high prevalence of 
vitamin D deficiency in Saudi Arabia could be due to low measurement 
values assessed by immunoassays that are commonly used in Saudi Arabia 
laboratories (Sadat-Ali et al., 2014). 
There are a number of possible reasons that could explain the different 
values of 25(OH)D measured by the LC-MS/MS and by the CLIA methods. 
Firstly, 25(OH)D is a lipophilic component and has a strong binding affinity 
to its binding protein. Separation of 25(OH)D from its binding protein is 
important to measure 25(OH)D concentration. The separation in the LC-
MS/MS assay is done by solvent extraction while, in the CLIA method, 
blocking agents are used to displace 25(OH)D from its binding protein. 
Therefore, incomplete separation can lead to lower measurement values 
(Black et al., 2015; Kocak et al., 2015). Secondly, the cross-reactivity 
between 25(OH)D and its metabolites in the sample may have an impact 
on the values. In immunoassays, the antibodies used in the method bind to 
the 25(OH)D carbon skeleton, in C1-C22 site and this binding can also 
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happen to 25(OH)D2 and any metabolites that have the same C1-C22 
structure such as 24,25(OH)2D (Black et al., 2015). Thirdly, the matrix 
effect may explain some of the difference in values. Roche calibrators 
(used in the CLIA method) include human serum as a matrix and 
confounding substances in the matrix such as lipid could lead to an 
interaction between the matrix, calibrators and the patient sample, which 
in turn could lead to high or low measurement values in 25(OH)D 
concentrations (Enko et al., 2014; Black et al., 2015). Finally, a different 
calibrator used in each assay, method standardization, equipment 
maintenance and water quality could also affect 25(OH)D concentrations 
(Black et al., 2015).  
The main limitation of this study is that the reliability of the assay methods 
themselves was not investigated. Duplicate tests for the same sample may 
be useful to investigate the reliability of CLIA or the LC-MS/MS method. In 
this study the agreement between the two methods was analysed, but not 
within the same method (within assay). For future research, duplicate 
samples for each method would be recommended. Total 25(OH)D reflects 
the vitamin D status from food and sun-light and comprises the total value 
of both D2 and D3. In this study Cobas e401 was used to measure total 
25(OH)D as it is not able to measure D2 and D3 separately, whereas the LC-
MS/MS method measured both D2 and D3. The sum of D2 and D3 gives the 
total 25(OH)D (Snellman, 2010). However, in the present study none of 
participants had D2 of ˃2.8 nmol/l, which is the lowest value detectable by 
the LC-MS/MS method used. None of the participants were on vitamin D 
supplementation including D2 supplements form, in addition that all food 
sources of vitamin D contain D3 form except mushrooms that containing 
the D2 form (Holick, 2007; Holick et al., 2011).  
In conclusion, there was a strong correlation between the two methods 
with acceptable agreement; however, there was variability in the vitamin D 
classification of the participants. Immunoassays are widely used in clinical 
laboratories in order to analyze a large number of samples each day due to 
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high throughput, higher speed when compared to other methods and 
lower cost (Wallace et al., 2010). Although LC-MS/MS has been considered 
a gold standard in measuring 25(OH)D due it sensitivity and accuracy, Black 
et al (2015) stated that the LC-MS/MS accuracy is dependent on the 
performance of the laboratory and considerable differences have been 
found between laboratories using the LC-MS/MS method compared to a 
laboratory that was certified to the standard reference method (by the 
National Institute of Standards and Technology and Ghent University). In 
addition to the high cost and the demand of highly skilled technicians, all of 
these reasons contribute to clinical laboratories using immunoassays more 
widely.  
In conclusion, despite the wide usage of CLIA method in measuring vitamin 
D concentration, the LC-MS/MS method is still considered as the gold 
standard method and the recommended method to be used in the future 
studies due to its sensitivity and accuracy (SACN, 2016). 
Finally, in the present study, both methods CLIA and LC-MS/MS gave an 
acceptable measurement of 25(OH)D concentrations. However, 
researchers and clinicians should be aware of the strength and limitation of 
each method and consider this when treating patients. They also need to 
be aware of the measuring method that is available in their care centre. 
Using same method is also needed when compare the patients results 
before and post treatment because underestimation of 25(OH)D lead to 
more patients classified as deficient, and maybe consumption unnecessary 
vitamin D supplementation, at the same time, overestimation of 25(OH)D 
values, patients who need an intervention could be left without treatment. 
Standardizing the methods used in laboratories against a certified 
laboratory may be a good solution to have valid and reliable values of 
25(OH)D concentration and better treatment quality (Sadat-Ali et al., 2014; 
Black et al., 2015).  
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Chapter 7 
General discussion and conclusion   
 
7.1. General discussion and findings   
Vitamin D deficiency is a worldwide health issue (Holick and Chen, 2008). 
The prevalence of vitamin D deficiency is high in Gulf countries such as 
Saudi Arabia (Alharbi et al., 2013) and in high latitude countries such as the 
United Kingdom (Ruston et al., 2002).  
Vitamin D is an important element for human health and is involved in 
many body functions such as bone calcification and calcium homoeostasis 
(Jovicic et al., 2012; Weaver, 2007), prevention of diabetes (Al-Daghri et al., 
2012), cardiovascular diseases (Maki et al., 2011) and colon cancer 
(Feskanich et al., 2004). Vitamin D and its non-calcaemic effects have 
become a topic of interest for many researchers (Spiro and Buttriss, 2014; 
Bischoff-Ferrari, 2010). Previous studies have shown positive correlations 
between vitamin D and asthma outcomes as well as improving lung 
function (Bozzetto et al., 2012; Chinellato et al., 2011). However, most of 
these studies are observational studies and only a few clinical trials have 
been conducted. Thus, more intervention studies and clinical trials are 
needed to study the causal correlation between vitamin D and asthma 
outcomes or other diseases (Aspray et al., 2014).    
Four studies were conducted to complete this thesis. These consisted of a 
cross-sectional study (Chapter 3), two intervention studies (Chapters 4 and 
5) and a comparison study (Chapter 6) to assess the measurement of 
serum 25(OH)D concentrations using the CLIA method and the gold 
standard method LC-MS/MS.  
To the best of our knowledge, the current studies (Chapters 3 and 4) are 
the first to investigate the prevalence of vitamin D deficiency among adult 
asthma patients in Saudi Arabia and to undertake an intervention study 
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using two doses of oral vitamin D3 supplement. The cross-sectional study 
(Chapter 3) is important because it is one of the few investigating the 
outcomes and characteristics of adult asthma patients in Saudi Arabia. A 
number of studies have previously been undertaken, but these have been 
carried out in asthmatic children (Aldubi et al., 2015). Therefore, this cross-
sectional study (Chapter 3) provided baseline characteristics of adult 
asthma outcomes in Saudi Arabia. The second intervention study (Chapter 
5) in this thesis was a dietary intervention study aimed at investigating the 
effect of consuming 15 µg vitamin D via diet on the serum 25(OH)D levels 
after the winter months in healthy adults in the UK. This is of importance as 
there is currently no reference nutrient intake (RNI) for vitamin D for 
healthy adults aged 18 to 65 years in the UK as it is assumed that this age 
group is able to achieve adequate vitamin D levels from a balanced diet 
and sufficient sun exposure (SACN, 2015). However, new Public Health 
England (PHE) guidance published on 21st July 2016 suggested that a daily 
10 µg of vitamin D is necessary for children and adults in the UK, especially 
during the winter and autumn months, and throughout the seasons in 
individuals who do not consume high vitamin D dietary sources (Public 
Health England, 2016).  
 
Many individuals in the UK do not obtain sufficient sun light exposure 
during the winter months and during cloudy weather, which can be for half 
of the year (O´Connor and Benelam, 2011). Moreover, Ruston and 
colleagues (2002) in the National Diet and Nutrition Survey (NDNS) found 
that 24% adult males and 28% adult females in the UK have vitamin D 
deficiency. Thus, the importance of our study will be to determine if 
sufficient vitamin D can be consumed through diet alone to reduce the 
incidence of vitamin D deficiency after the winter months. 
 
Cashman et al (2008) estimated that healthy adults in the UK require 7.2-
41.1 µg dietary vitamin D per day to maintain serum 25(OH)D above 25-80 
nmol/l during the winter season. However, Henderson et al (2003) found 
152 
 
that the mean dietary vitamin D intake in adults in the UK is about 3.7 µg 
per day in males and 2.8 mcg per day in females. Our study (Chapter 5) 
investigated the effect of consuming 15 µg per day of dietary vitamin D for 
three weeks on the total 25(OH)D and lung function adding the novelty of 
studying the effect of a dietary intervention on vitamin D level and lung 
function and the feasibility to consume this amount via diet only. To the 
best of our knowledge, this is the first study (Chapter 5) to investigate the 
effect of a dietary intervention on serum 25(OH)D, lung function and 
airway inflammation in the UK among healthy individuals. 
 
After completion of the first study (Chapter 3), it was found that the 
prevalence of vitamin D deficiency among adult asthma patients from 
Saudi Arabia was 86 %. Dietary vitamin D intake was very low among these 
patients. Sunlight exposure was low among asthma participants due to hot 
weather and the traditional style dress in Saudi Arabia, which can lead to 
lower 25(OH)D concentration (Mansour and Alhadidi, 2012; Christie and 
Mason, 2011). No correlation was found between 25(OH)D and lung 
function or air way inflammation. However, forced vital capacity improved 
significantly among asthma participants after the high dose of vitamin D 
supplement (Chapter 4). 
The first intervention study (Chapter 4) found that oral vitamin D3 
supplementation as a single high dose increased serum 25(OH)D more than 
the continuous low dose after three weeks. However, after six weeks both 
single high dose and the continuous low dose were effective in significantly 
improving serum 25(OH)D. Raising serum vitamin D levels after 
supplementation by both doses also improved lung function in asthma 
patients. However, after three weeks of the single high dose of vitamin D 
supplement, FVC was significantly improved. Vitamin D supplementation 
did not affect airway inflammation or other inflammatory biomarkers.  This 
finding could be explained by the small sample size and the sand storms 
that occurred during the study period. Sand storms contain bacteria and 
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fungi and may exacerbate asthma symptoms and increase the 
inflammation, which may lead to increase the FeNO levels (Meo et al., 
2013; Kwaasi et al., 1998; Alangari et al., 2015).  
Similar to the first study (Chapter 3), the third study (Chapter 5) found that 
the prevalence of vitamin D deficiency was high in the UK after the winter 
months with 81 % of healthy adults being vitamin D deficient. Daily dietary 
intake of vitamin D was also low. The dietary intervention of 15 µg per day 
of dietary vitamin D increased serum 25(OH)D significantly after three 
weeks among healthy adults in the UK after the winter months. Similar to 
the second study (Chapter 4), improved vitamin D status resulted in 
improved lung function, but did not reach the significant level. No 
correlation was found between 25(OH)D and FeNO levels.  
The last study (Chapter 6) found a strong correlation between the values of 
serum 25(OH)D measured by CLIA and by the gold standard method 
LC/MS-MS (r 0.956, P ˂0.001). However, more participants were classified 
with vitamin D deficiency when the sample was measured by the CLIA 
method. In general, the CLIA method gave lower values than the LC/MS-MS 
method, although good agreement was found between the two methods 
using the Kappa analysis and Bland Altman test. This result was in 
agreement with previous research (Lai et al., 2011).   
 
The study has important implications and applications. Firstly, assessing 
vitamin D status by measuring 25(OH)D and estimating the dietary intake 
could be essential for asthma patients living in Saudi Arabia. Assessing 
vitamin D status could also be necessary for adults in the UK over the 
winter months. Secondly, health care providers and dietitians should 
encourage people to increase their sunlight exposure, as well as increasing 
their awareness of high vitamin D sources depending on the available food 
sources on the market.  
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Thirdly, over the counter vitamin D supplementation in both forms D2 or 
D3, such as tablets containing 10–15 µg vitamin D per day, could also be 
considered for individuals who are at risk of vitamin D deficiency; however, 
severe vitamin D deficiency may necessitate a high dose vitamin D 
supplement under a Physician’s supervision. It was reported that vitamin D 
supplements as D3 form is more effective in raising serum 25(OH)D when 
consumed as a bolus doses compared to the form D2 (Tripkovic et al, 
2012). It is also necessary for the food production market and policy 
makers to investigate different methods to fortify more foods with vitamin 
D.  
Increasing vitamin D status could be effective in improving lung function in 
asthmatic patients and in healthy adults. Encouraging individuals to 
consume more vitamin D rich foods is necessary after winter months in the 
UK to maintain the desirable vitamin D status.  
Finally, researchers and Physicians should be aware of the method used in 
their laboratory in measuring vitamin D status due to the differences in 
vitamin D status classifications. Although in this study it has been found 
that CLIA method and LC-MS/MS method showed a good agreement, the 
CLIA method gave lower 25(OH)D concentration compared to the LC-
MS/MS method. Standardization of the method in measuring vitamin D is 
necessary.   
 
The main limitations of this project were that: non-asthmatic participants 
as a control group in the first and second study were not included and 
blood inflammatory biomarkers were not measured for all participants due 
to financial constraints.  
In the second study (Chapter 4), a small sample size was also a limitation 
and there was a large drop-out rate in participants due to a new virus that 
appeared in the hospitals in Saudi Arabia and most of participants were 
very anxious to complete their visits. The increases in inflammatory 
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biomarkers could be affected by the sand storms that happened during the 
study period. This may also have affected the results of these biomarkers in 
the second study (Kwaasi et al., 1998; Alangari et al., 2015). 
Finally, the sunlight exposure questionnaire that was used in all studies to 
investigate the sunlight exposure pattern was not validated. Also, the 
developed food frequency questionnaire to estimate vitamin D dietary 
intake that used in studies was not valid. Using non-valid food frequency 
questionnaire to estimate vitamin D dietary intake may non-valid dietary 
vitamin D intake. However, there was no valid FFQ to estimate vitamin D 
intake in the UK population or to measure vitamin D intake in Saudi Arabia.    
In the third study (Chapter 5), baseline data and post three weeks data 
were obtained. Post six weeks data was not measured due to financial 
constraints. Blood inflammatory biomarkers were also not measured in this 
study.  
In the fourth study (Chapter 6, comparison of two method in measuring 
25(OH)D concentration), duplicate measurements for each sample were 
not tested due to financial constraints. Duplicate measurements for each 
sample would add more information about the reliability of the methods 
used.    
7.2. Conclusion  
Vitamin D deficiency and insufficiency were highly prevalent with 86% in 
asthma participants in Saudi Arabia. Vitamin D deficiency and insufficiency 
were also highly prevalent with 81% in healthy adults in the UK after the 
winter months. 
Vitamin D intervention using a single high dose supplement or a continuous 
low dose supplement for three weeks and six weeks was effective in raising 
serum 25(OH)D levels. A dietary intervention as consumption of 15 µg 
vitamin D per day for three weeks was also effective in raising 25(OH)D 
concentrations after the winter months. 
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Increasing serum 25(OH)D concentrations using the vitamin D 
supplementation in  a single high dose or a continuous low dose and by 
rich vitamin D foods improved lung function in asthma participants and in 
healthy adults, but not airway inflammation or biomarkers.    
Future studies that can provide more conclusive evidence could be: 
• Investigating the correlation between vitamin D status and lung 
function as well as FeNO in asthma patients and non-asthma 
patients. 
• Including a larger sample size to investigate the vitamin D 
intervention could provide better information about the effect of 
vitamin D supplementation on serum 25(OH)D and lung function. 
• To estimate how much vitamin D as µg/day is needed to achieve 
and maintain vitamin D levels among people living in Saudi Arabia 
with minimum sunlight exposure. 
• Validation study for a food frequency questionnaire to estimate 
vitamin D intake from diet, using the available food in Saudi Arabia 
and in the UK, as there is no valid FFQ to estimate vitamin D in 
these countries.  
• Investigate the effect of the same dose of vitamin D given by oral 
supplementation or by high vitamin D foods to compare the effect 
on 25(OH)D levels. 
• Investigate the effect of high vitamin D foods on 25(OH)D levels 
over a longer period (longer than three weeks). 
• Comparing the methods used to determine 25(OH)D, such as the 
CLIA method and LC-MS/MS method with duplicate tests for the 
same samples would be useful to study the reliability of the 
methods.   
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Variable
s 
FeNO <26 
ppb
FeNO >26 
ppb
Serum
25OHD, 
mean
34.66 
nmol/l
29.6 nmol/l
FEV1%, 
mean
81% 76%
FVC%, 
mean
86% 84%
High Dose Oral Vitamin D3 Supplement Improves 
Lung Functions in Asthmatics 
Samih Kokandi¹, Helen Lightowler¹, Simon Wheeler², Emad Koshak³ and Ahmed Al-Amoudi³
1; Oxford Brookes University – UK, 2; University of Cambridge – UK , 3; King Abdul Aziz University - KSA  
BACKGROUND RESULTS 
METHODS 
OBJECTIVES 
CONCLUSION 
Globally and locally, vitamin D deficiency is a 
common health issue. Few studies have been 
done to investigate the effect of vitamin D 
supplementation on asthma.
The aim of this study was to investigate the 
effect of different doses of oral vitamin D3
supplements on lung function and airway 
inflammation in asthma patients.
Adult asthma patients were recruited
from an allergy and asthma clinic 
in KAUH in Jeddah.
62 patients were screened and 
32 were randomly enrolled to
receive either a single 
high dose (200 000 IU, n=15) or low continues 
dose (800 IU per day, n=17) of vitamin D3 
supplement.
Serum 25(OH)D, serum calcium, fractional 
exhaled nitric oxide (FeNO), forced expiratory 
volume in one second (FEV1) and forced vital 
capacity (FVC) were assessed at the baseline and 
after three weeks. 
serum vitamin D increased significantly by 30.21
nmol (from 21.89±11.85 to 52.10±16.46) after 
three weeks of the high dose supplement 
(p<0.001) and increased by only 4.61 nmol (from 
36.01±21.52 to 40.62±15.28) after continuous 
low dose (p=0.071).
Predicted FVC improved significantly from 88% 
to 98 % (p=0.025) in the high dose group and 
from 82% to 87% in the low dose group (p=0.06). 
Predicted FEV1 increased from 82% to 86% and 
from 77 % to 79 % respectively.
Calcium level did not differ significantly in both 
groups.
FeNO level (inflammatory biomarker) increased 
significantly from 26 ppb to 37ppb (p=0.016) 
after the high dose supplement and increased 
from 43 ppb to 46 ppb (p=0.607) after the low 
dose. 
Vitamin D deficiency is common in asthmatics 
from Saudi Arabia. Oral high dose vitamin D 
intake is safe and well tolerated in deficient 
patients and could be helpful in improving lung 
functions but not inflammatory marker. 
Variables
High dose group, single dose of 200 000 
IU
n= 15
Low dose group, daily dose of 800 IU 
n= 17
At baseline
Means (SD)
After 3 weeks 
Means (SD)
Sig
At baseline
Means (SD)
After 3 weeks 
Means (SD)
Sig
Vitamin D 21.89 (11.85) 52.1 (16.46) <0.001* 36.01 (21.52) 40.62 (15.28) 0.071
Calcium 2.22 (0.06) 2.24 (0.11) 0.77 2.22 (0.11) 2.22 (0.08) 0.849
FEV1 % 81.64 (19.76) 86.07 (10.82) 0.261 77.29 (14.56) 79.12 (15.77) 0.302
FVC % 88.14 (19.01) 98.07 (14.03) 0.025* 81.94 (12.13) 86.47 (12.84) 0.06
FeNO (ppb) 26.29 (18.76) 37 (21.39) 0.016* 42.82 (44.38) 45.82 (43.52) 0.607
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Food used in the dietary intervention 
